LncRNA name,Cancer name,Methods,Expression pattern,Pubmed ID,Remarks,No. of Transcript variants,NCBI Reference Number,Total No. of PQS,No. of 2G PQS,No. of 3G PQS,No. of 4G PQS,RefSeq status,Total No. of PQS.1,G4Hunter Scores of PQS,Similarity between PQS from QGRS mapper vs PQS from G4 hunter,Total No. of PQS.2,G4Hunter Scores of PQS.1,Similarity between PQS from QGRS mapper vs PQS from G4 hunter.1,aka
ADAMTS9-AS1,prostate cancer,qRT-PCR,differential expression,32153626.0,,2,"NR_110150.1, NR_110151.1","14, 14","14,14","0, 0","0,0",VALIDATED,,,,,,,ADAMTS9 antisense RNA 1;ADAMTS9 antisense RNA 1 (non-protein coding);HSALNG0026576;NONHSAG035332.2;ADAMTS9-AS1
AFAP1-AS1,prostate cancer,"qRT-PCR, RIP, Luciferase reporter gene assay, Western blot",up-regulated,31669642.0,"Also Known As: AFAP1-AS, AFAP1AS",1,NR_026892.1,37,36,1,0,REVIEWED,,,,,,,AFAP1AS; AFAP1-AS
AFAP1-AS1,prostate cancer,"qRT-PCR , Western blot , in vitro knockdown etc.",up-regulated,31081081.0,"Also Known As: AFAP1-AS, AFAP1AS",1,NR_026892.1,37,36,1,0,REVIEWED,,,,,,,AFAP1AS; AFAP1-AS
"ANRASSF1 
RASSF1-AS1",prostate cancer,"RNA-seq, qPCR, RNAi, Western blot, RIP, ChIP, Cell proliferation assay etc.",up-regulated,23990798.0,Also known as: RASSF1-AS1 ; ANRASSF1,1 (RASSF1-AS1) ,RASSF1-AS1 (NR_109831),11 (RASSF1-AS1) ,8 (RASSF1-AS1) ,3 (RASSF1-AS1) ,0 (RASSF1-AS1) ,VALIDATED (RASSF1-AS1) ,"10 (2-3G, 2-2G, 6-C-rich)","['0.911, 0.911 (3G); 0.82, 0.92 (2G); '-0.911, -0.872, -0.911, -0.683, -0.854, -0.924 (C-rich)]",The PQS 1 (3G) of QGRS mapper  is similar to / a part of PQS 1  (3G) of G4 Hunter,0,0,No PQS found in G4 hunter,ANRASSF1
"ANRIL
CDKN2B-AS1",prostate cancer,qPCR etc.,up-regulated,20541999.0,"Also Known As: ANRIL; p15AS; PCAT12; CDKN2B-AS1; CDKN2BAS; CDKN2B-AS; NCRNA00089

Some (older) ANRIL ncRNA for antisense noncoding RNA in the INK4 locus transcript ""antisense RNA"" ncRNA (AB548314.1) with PQS-15 was also there in result.

Some (older-not checked for PQS) antisense noncoding RNA in the INK4 locus splice variant (ANRIL) ""antisense RNA"" ncRNA (partial sequence, alternatively spliced-EU741058.1; note=""similar to GenBank Accession Number BF002632; contains exons 1, 5, 6, 7, and 13; alternatively spliced"") was also there in result.

Some (older-not checked for PQS) CDKNBAS ""antisense RNA"" ncRNA [TPA(CDKN2B-AS1 gene): HG975381.1] and ""antisense RNA: ncRNA alternatively spliced variants (complete sequnece-GQ495918.1, GQ495919.1, GQ495920.1, GQ495921.1, GQ495922.1, GQ495923.1, GQ495924.1, GQ495925.1, GQ495926.1) were also there in result.",14 (CDKN2B-AS1),"CDKN2B-AS1 (NR_003529.3, NR_047532.1, NR_047543.1, NR_047534.1, NR_047535.1, NR_047536.1, NR_047537.1, NR_047538.1, NR_047539.1, NR_047540.1, NR_047541.1, NR_047542.1, NR_047533.1, NR_120536.1)","21, 16, 10, 10, 9, 7, 9, 7, 17, 10, 10, 8, 6, 6 (CDKN2B-AS1)","21, 16, 10, 10, 9, 7, 9, 7, 17, 10, 10, 8, 6, 6 (CDKN2B-AS1)","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 (CDKN2B-AS1)","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 (CDKN2B-AS1)",REVIEWED (CDKN2B-AS1),"1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);",-0.829 (C-rich),No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter,ANRIL; p15AS; PCAT12; CDKN2BAS; CDKN2B-AS; NCRNA00089
"ANRIL
CDKN2B-AS1",prostate cancer,"RT-PCR, Western blot, in vitro knockdown",up-regulated,29278879.0,"Also Known As: ANRIL; p15AS; PCAT12; CDKN2B-AS1; CDKN2BAS; CDKN2B-AS; NCRNA00089

Some (older) ANRIL ncRNA for antisense noncoding RNA in the INK4 locus transcript ""antisense RNA"" ncRNA (AB548314.1) with PQS-15 was also there in result.

Some (older-not checked for PQS) antisense noncoding RNA in the INK4 locus splice variant (ANRIL) ""antisense RNA"" ncRNA (partial sequence, alternatively spliced-EU741058.1; note=""similar to GenBank Accession Number BF002632; contains exons 1, 5, 6, 7, and 13; alternatively spliced"") was also there in result.

Some (older-not checked for PQS) CDKNBAS ""antisense RNA"" ncRNA [TPA(CDKN2B-AS1 gene): HG975381.1] and ""antisense RNA: ncRNA alternatively spliced variants (complete sequnece-GQ495918.1, GQ495919.1, GQ495920.1, GQ495921.1, GQ495922.1, GQ495923.1, GQ495924.1, GQ495925.1, GQ495926.1) were also there in result.",14 (CDKN2B-AS1),"CDKN2B-AS1 (NR_003529.3, NR_047532.1, NR_047543.1, NR_047534.1, NR_047535.1, NR_047536.1, NR_047537.1, NR_047538.1, NR_047539.1, NR_047540.1, NR_047541.1, NR_047542.1, NR_047533.1, NR_120536.1)","21, 16, 10, 10, 9, 7, 9, 7, 17, 10, 10, 8, 6, 6 (CDKN2B-AS1)","21, 16, 10, 10, 9, 7, 9, 7, 17, 10, 10, 8, 6, 6 (CDKN2B-AS1)","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 (CDKN2B-AS1)","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 (CDKN2B-AS1)",REVIEWED (CDKN2B-AS1),"1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);
1 (C-rich);",-0.829 (C-rich),No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter,ANRIL; p15AS; PCAT12; CDKN2BAS; CDKN2B-AS; NCRNA00089
ARlnc1,prostate cancer,"RNA-seq, Microarray, qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RNAi, RIP",differential expression,29808028.0,Also Known As: PRCAT47; LINC02170,2,"NR_131947.1, NR_131948.1","12, 12","2, 2","0, 0","0, 0",VALIDATED,"2 (C-rich);
0","[-0.88, -0.872 (C-rich)];
0",No similarity to any PQS (2G) from QGRS mapper,"0;
0","0;
0",No PQS found in G4 Hunter,PRCAT47; LINC02170
ARlnc1,prostate cancer,"RNA-seq, qPCR, Northern blot etc.",differential expression,29808028.0,Also Known As: PRCAT47; LINC02170,2,"NR_131947.1, NR_131948.1","12, 12","2, 2","0, 0","0, 0",VALIDATED,"2 (C-rich);
0","[-0.88, -0.872 (C-rich)];
0",No similarity to any PQS (2G) from QGRS mapper,"0;
0","0;
0",No PQS found in G4 Hunter,PRCAT47; LINC02170
BCAR4,prostate cancer,"qPCR, Luciferase reporter assay, in vitro knockdown, etc.",up-regulated,30513511.0,,5,"NR_024049.1, NR_024050.1, NR_131216.1, NR_131217.1, NR_131222.1","5, 2, 1, 2, 2","5, 2, 1, 2, 2","0, 0, 0, 0, 0","0, 0, 0, 0, 0",VALIDATED,0,0,No PQS found in G4 Hunter,0,0,No PQS found in G4 hunter,"breast cancer anti-estrogen resistance 4;breast cancer anti-estrogen resistance 4 (non-protein coding);breast cancer antiestrogen resistance 4 protein;BCAR4;HSALNG0109621;NONHSAG018621.2;Breast cancer antiestrogen resistance 4 protein;HCG1814062, isoform CRA_a"
BDNF-AS,prostate cancer,"qPCR, in vitro knockdown etc.",down-regulated,29710528.0,Also Known As: BDNF-AS; BDNF; BDNFAS; BDNFOS; BDNF-AS1; ANTI-BDNF; NCRNA00049,"5 (BDNF-AS_Variant BT1A, BT1B, BT1C, BT2A, BT2B)","BDNF-AS_Variant BT1A, BT1B, BT1C, BT2A, BT2B (NR_033313.1, NR_033315.1, NR_033312.1, NR_033314.1, NR_002832.2 respectively)","3, 5, 7, 8, 10 (BDNF-AS_Variant BT1A, BT1B, BT1C, BT2A, BT2B)","3, 5, 7, 7, 9 (BDNF-AS_Variant BT1A, BT1B, BT1C, BT2A, BT2B)","0, 0, 0, 1, 1 (BDNF-AS_Variant BT1A, BT1B, BT1C, BT2A, BT2B)","0, 0, 0, 0, 0 (BDNF-AS_Variant BT1A, BT1B, BT1C, BT2A, BT2B)",VALIDATED,"0;
0;
0;
2 (2G);
2 (2G)","0;
0;
0;
[0.571, 0.889 (2G)];
[0.571, 0.889 (2G)]",No similarity to any PQS (2G) from QGRS mapper,0; 0; 0; 0; 0,0; 0; 0; 0; 0,No PQS found in G4 Hunter,BDNF; BDNFAS; BDNFOS; BDNF-AS1; ANTI-BDNF; NCRNA00049
BLACAT1,prostate cancer,"RT-PCR, Western blotting, Luciferase Assays, RIP",down-regulated,31957820.0,Also Known As: BLACAT1; LINC00912; linc-UBC1; onco-lncRNA-30,1,NR_103783.1,21,21,0,0,VALIDATED,"6 (2-2G, 4-C-rich)","[0.821,0.922 (2G); '-0.815, 0.603, '-, -0.938, -0.891 (C-rich)]",No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter,BLACAT1 overlapping LEMD1 locus;linc-UBC1;LINC00912;onco-lncRNA-30;long intergenic noncoding RNA up-regulated in bladder cancer;long intergenic non-protein coding RNA 912;bladder cancer associated transcript 1 (non-protein coding);bladder cancer associated transcript 1;NONHSAG004054.2;HSALNG0009941;BLACAT1;Bladder cancer-associated transcript 1
"BRE-AS1 
BABAM2-AS1",prostate cancer,qPCR,down-regulated,30833361.0,Also Known As: BABAM2-AS1; BRE-AS1,1 (BABAM2-AS1),BABAM2-AS1 (NR_028308.1),16 (BABAM2-AS1),12 (BABAM2-AS1),4 (BABAM2-AS1),0 (BABAM2-AS1),VALIDATED (BABAM2-AS1),"20 (4-2G, 8-3G, 8-C-rich)  ","[0.875, 0.913, 0.78, 
0.854 (2G); 0.875, 0.897,
0.929, 0.911, 0.915, 
0.778, 0.938, 0.911, 
0.953 (3G); -0.913, 
-0.938, -0.882, -0.652,
-0.1.053, -0.933, -0.913, -0.898 (C-rich)]
","The PQS 1 (3G) of QGRS Mapper is similar to / a part of PQS 1 (3G) of G4 Hunter, with a right frame-shift in G4 Hunter

 PQS 3 (3G) of QGRS  Mapper is similar to / a part of PQS 8 (3G) of G4 Hunter. , with a right frame-shift in G4 Hunter

By looking at all the PQS, it is visible that there is a slight overlap between PQS 2,3,4 and PQS 5,6,7 (3G) and can be considered as two PQS.","2 (1-C-rich, 1-3G)","[-1.208 (C-rich);
1.4 (3G)","PQS 1 (3G) of QGRS Mapper 
is similar to / a part of PQS 1 (3G) of G4 
Hunter, with a right frame-shift in G4 Hunter",BRE-AS1
CASC15,prostate cancer,"qPCR, Luciferase reporter assay, in vitro knockdown",up-regulated,31646560.0,Also Known As: CACS15 [mentioned in title of paper (PubMed-31665008) refereed in NR_015410.2]; CASC15; CANT; LINC00340; lnc-SOX4-1,1,NR_015410.2,18,18,0,0,REVIEWED,0,0,,0,0,No PQS found in G4 hunter,CANT; LINC00340; lnc-SOX4-1
CASC2,prostate cancer,"qPCR, Luciferase reporter assay, in vitro knockdown",down-regulated,29373811.0,Also Known As: C10orf5,3,"NR_026939.1, NR_026940.1, NR_026941.1","17, 17, 9","15, 15, 7","2, 2, 2","0, 0, 0",VALIDATED,"7 (4- 3G, 3-2G);
7 (4- 3G, 3-2G);
6 (4 -3G, 2-2G)","[1.043, 0.746, 0.956, 0.956 (3G) 0.933, 0.891 0.707(2G)] ;

[1.043, 0.746, 0.956, 0.956 (3G) 0.933, 0.891 0.707(2G)] ;

[1.043, 0.746, 0.956, 0.956 (3G) 0.933, 0.891 (2G)]","PQS 1 (3G) of QGRS mapper is similar to / a part of PQS 2 (3G) from G4 hunter

PQS 2 (3G) of QGRS mapper  is similar to / a part of PQS 3 (3G) of G4 hunter","0,0,0","0,0,0",No PQS found in G4 hunter,C10orf5
CCAT1,prostate cancer,"qRT-PCR, Western blot",up-regulated,32089062.0,"Also Known As: CARLO5; CARLo-5; onco-lncRNA-40

Some (older-not checked for PQS) colon cancer associated transcript 1 (CCAT1) RNA ""other"" ncRNA (RNA, complete sequence - HM358356.1) was also there in result.",1,NR_108049.1,9,9,0,0,REVIEWED,2 (C-rich),"['-0.835, -0.914 (C-rich)]",,0,0,No PQS found in G4 hunter,CARLO5; CARLo-5; onco-lncRNA-40
CCAT1,prostate cancer,"qPCR, Western blot, in vitro knockdown",up-regulated,29863242.0,"Also Known As: CARLO5; CARLo-5; onco-lncRNA-40

Some (older-not checked for PQS) colon cancer associated transcript 1 (CCAT1) RNA ""other"" ncRNA (RNA, complete sequence - HM358356.1) was also there in result.",1,NR_108049.1,9,9,0,0,REVIEWED,2 (C-rich),"['-0.835, -0.914 (C-rich)]",,0,0,No PQS found in G4 hunter,CARLO5; CARLo-5; onco-lncRNA-40
CCAT1,prostate cancer,"qPCR, Western blot, Luciferase reporter assay, other",up-regulated,30221381.0,"Also Known As: CARLO5; CARLo-5; onco-lncRNA-40

Some (older-not checked for PQS) colon cancer associated transcript 1 (CCAT1) RNA ""other"" ncRNA (RNA, complete sequence - HM358356.1) was also there in result.",1,NR_108049.1,9,9,0,0,REVIEWED,2 (C-rich),"['-0.835, -0.914 (C-rich)]",,0,0,No PQS found in G4 hunter,CARLO5; CARLo-5; onco-lncRNA-40
CCAT1,prostate cancer,"qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP",up-regulated,31387890.0,"Also Known As: CARLO5; CARLo-5; onco-lncRNA-40

Some (older-not checked for PQS) colon cancer associated transcript 1 (CCAT1) RNA ""other"" ncRNA (RNA, complete sequence - HM358356.1) was also there in result.",1,NR_108049.1,9,9,0,0,REVIEWED,2 (C-rich),"['-0.835, -0.914 (C-rich)]",,0,0,No PQS found in G4 hunter,CARLO5; CARLo-5; onco-lncRNA-40
CCAT1,prostate cancer,qPCR etc.,up-regulated,28945760.0,"Also Known As: CARLO5; CARLo-5; onco-lncRNA-40

Some (older-not checked for PQS) colon cancer associated transcript 1 (CCAT1) RNA ""other"" ncRNA (RNA, complete sequence - HM358356.1) was also there in result.",1,NR_108049.1,9,9,0,0,REVIEWED,2 (C-rich),"['-0.835, -0.914 (C-rich)]",,0,0,No PQS found in G4 hunter,CARLO5; CARLo-5; onco-lncRNA-40
CCAT1,prostate cancer,qPCR etc.,up-regulated,29863242.0,"Also Known As: CARLO5; CARLo-5; onco-lncRNA-40

Some (older-not checked for PQS) colon cancer associated transcript 1 (CCAT1) RNA ""other"" ncRNA (RNA, complete sequence - HM358356.1) was also there in result.",1,NR_108049.1,9,9,0,0,REVIEWED,2 (C-rich),"['-0.835, -0.914 (C-rich)]",,0,0,No PQS found in G4 hunter,CARLO5; CARLo-5; onco-lncRNA-40
CCAT2,prostate cancer,"qPCR, RNAi, Western blot, Cell proliferation assay etc.",up-regulated,27558961.0,"Also Known As: NCCP1; LINC00873

Some (older-not checked for PQS) CCAT2 short and long variants ncRNA; ""other"" ncRNA (complete sequence - GQ911591.1 and GQ911592.1 respectively) were also there in result.",1,NR_109834.1,6,6,0,0,REVIEWED,0,0,,0,0,No PQS found in G4 hunter,NCCP1; LINC00873
CRNDE,prostate cancer,"qPCR, Luciferase reporter assay etc",up-regulated,32182608.0,Also Known As: CRNDEP; PNAS-108; lincIRX5; LINC00180; NCRNA00180,5,"NR_034105.4, NR_034106.3, NR_110453.2, NR_110454.2, NR_170995.1","5, 9, 5, 9, 9","5, 7, 5, 7, 7","0, 2, 0, 2, 2","0, 0, 0, 0, 0",VALIDATED,"0
5 (2-C-rich, 3-3G)
0
5 (2-C-rich, 3-3G)
5 (2-C-rich, 3-3G)","[-0.855, -0.8 (C-rich), 0.898, 0.911, 0.657(3G)] ;

[-0.855, -0.8 (C-rich) 0.898, 0.911, 0.657(3G)]; 

[-0.855, -0.8 (C-rich) 0.898, 0.911, 0.657(3G)]; ","The PQS 2 (3G) of QGRS mapper is similar to / a part of PQS 1 (3G) of G4 hunter, with a left frame shift in G4 hunter.

By looking at all 3 PQS (3G) from G4 hunter, it appears that at a time only 1 PQS can be formed as all the 3 PQS have few common G-tracts due to overlap amongst them.

The above situation is same for all the variants","0,0,0,0,0","0,0,0,0,0",No PQS found in G4 hunter,CRNDEP; PNAS-108; lincIRX5; LINC00180; NCRNA00180
CTBP1-AS,prostate cancer,"qPCR, Western blot, Northern blot, RIP etc.",up-regulated,23644382.0,Also Known As:  PCAT10,1,NR_104331.1,52,46,6,0,VALIDATED,"27 (11-2G, 16- C-rich)","[-0.872, -0.911, -0.936, -0.722, 0.848, -0.911, -0.911, 0.99, -0.942, -0.906, -0.75, -0.865, -0.933, 0.957, -0.891, -0.71, 0.823, 1, 0.828, 0.903, 0.911, -0.957, 0.911, 0.911, 0.83]",No similarity to any PQS (2G) from QGRS mapper,2 (3G),"[1.37, 1.282 (3G)]","PQS 1 has no similarity to PQS from QGRS mapper

PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 2 (3G) from G4 hunter

PQS 2 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.",PCAT10
DANCR,prostate cancer,"qPCR, Western blot, Luciferase reporter assay, etc.",up-regulated,31486484.0,"Also Known As: AGU2; ANCR; DANCR; SNHG13; KIAA0114; lncRNA-ANCR

Some (older) transcribed RNA, ANCR, Variant 1, 2 and 3 ""lncRNA"" ncRNA (complete sequence-LC128577.1, LC128578.1 and LC128579.1 respectively) with PQS- 7, 7, 7 respectively, were also there in result. ",3,"NR_024031.2, NR_145129.1, NR_145130.1","6, 7, 7","5, 6, 6 ","1, 1, 1","0, 0, 0",REVIEWED,"3 (3-C-rich)
1 (C-rich)
1 (C-rich)","[-0.62, -0.921, -0.787 (C-rich)];

[-0.62(C-rich)] ;

[-0.62(C-rich)]",No similarity to any PQS (2G) from QGRS mapper,"1(C-rich);
1(C-rich);
1(C-rich);

","[-1.444 (C-rich)] ;

[-1.444 (C-rich)] ;

[-1.444 (C-rich)]",No similarity to any PQS  from QGRS mapper,AGU2; ANCR; SNHG13; KIAA0114; lncRNA-ANCR
DANCR,prostate cancer,"qPCR, RNAi, Western blot, ChIP etc.",up-regulated,27191265.0,"Also Known As: AGU2; ANCR; DANCR; SNHG13; KIAA0114; lncRNA-ANCR

Some (older) transcribed RNA, ANCR, Variant 1, 2 and 3 ""lncRNA"" ncRNA (complete sequence-LC128577.1, LC128578.1 and LC128579.1 respectively) with PQS- 7, 7, 7 respectively, were also there in result. ",3,"NR_024031.2, NR_145129.1, NR_145130.1","6, 7, 7","5, 6, 6 ","1, 1, 1","0, 0, 0",REVIEWED,"3 (3-C-rich)
1 (C-rich)
1 (C-rich)","[-0.62, -0.921, -0.787 (C-rich)];

[-0.62(C-rich)] ;

[-0.62(C-rich)]",No similarity to any PQS (2G) from QGRS mapper,"1(C-rich);
1(C-rich);
1(C-rich);

","[-1.444 (C-rich)] ;

[-1.444 (C-rich)] ;

[-1.444 (C-rich)]",No similarity to any PQS  from QGRS mapper,AGU2; ANCR; SNHG13; KIAA0114; lncRNA-ANCR
DANCR,prostate cancer,"RNA-seq, Microarray, qPCR, RNAi, Northern blot etc.",up-regulated,23728290.0,"Also Known As: AGU2; ANCR; DANCR; SNHG13; KIAA0114; lncRNA-ANCR

Some (older) transcribed RNA, ANCR, Variant 1, 2 and 3 ""lncRNA"" ncRNA (complete sequence-LC128577.1, LC128578.1 and LC128579.1 respectively) with PQS- 7, 7, 7 respectively, were also there in result. ",3,"NR_024031.2, NR_145129.1, NR_145130.1","6, 7, 7","5, 6, 6 ","1, 1, 1","0, 0, 0",REVIEWED,"3 (3-C-rich)
1 (C-rich)
1 (C-rich)","[-0.62, -0.921, -0.787 (C-rich)];

[-0.62(C-rich)] ;

[-0.62(C-rich)]",No similarity to any PQS (2G) from QGRS mapper,"1(C-rich);
1(C-rich);
1(C-rich);

","[-1.444 (C-rich)] ;

[-1.444 (C-rich)] ;

[-1.444 (C-rich)]",No similarity to any PQS  from QGRS mapper,AGU2; ANCR; SNHG13; KIAA0114; lncRNA-ANCR
DGCR5,prostate cancer,"RT-qPCR, Western-Blotting",down-regulated,31920375.0,"Also Known As: DGCR9; DGS-A; DGS-B; DGCR10; LINC00037; POM121L5P; NCRNA00037

2 sequences for DGCR5 (NR_026651.1, NR_024159.1) without any mentioning of transcript variants, while 3 sequences of DGCR5 with clear mentioning of transcipt variants.

PREDICTED REFSEQ (NR_026651.1): This record has not been reviewed and the function is unknown. The reference sequence was derived from BU584104.1, AC000095.5, L77559.1 and BM681417.1.

All transcriprt variants of DGCR5 (NR_002733.2, NR_045121.1, NR_110533.1, NR_026651.1 and NR_024159.1) are reported (Gene Cards - GCID: GC22P019556)

PQS 2 obtained in DGCR5_Variant 2 (NR_045121.1) when search parameter was set to Min G-Group Size: 2 was replaced by another PQS of same score (by shifting G-Group/Quartet frame) when search parameter was set to Min G-Group Size: 3. Rest two PQS were same in both search parameters.
For further consideration, PQS when search parameter was set to Min G-Group Size: 3 was taken.","3 (DGCR5)
+
2 (DGCR5 unknown variants)
=5","DGCR5 (NR_002733.2, NR_045121.1, NR_110533.1)
+
DGCR5 unknown variants (NR_026651.1, NR_024159.1)","32, 32, 11 (DGCR5)
+
7, 28 (DGCR5 unknown variants)","29, 29, 11 (DGCR5)
+
5, 25 (DGCR5 unknown variants)","3, 3, 0 (DGCR5)
+
2, 3 (DGCR5 unknown variants)

PQS 2 of 2nd variant (NR_045121.1) is same to the PQS 2 of 1st variant (NR_002733.2) when search parameter was set to Min G-Group Size: 3 but it is different (but same G-score) from PQS 2 of 1st variant when search parameter was set to Min G-Group Size: 2 (due to shifting of G-Group/Quartet frame).
All PQS of both DGCR5 unknown variants are different from each others and other variants as well.","0, 0, 0 (DGCR5)
+
0, 0 (DGCR5 unknown variants)","VALIDATED (DGCR5)

PREDICTED (DGCR5 unknown variant-NR_026651.1)

VALIDATED (DGCR5 unknown variant-NR_024159.1)","12 (4-C-rich, 8-2G);
12 (4-C-rich, 8-2G)
5 (4-C-rich, 1-2G)
","[-0.894, -0.854, -0.902, -0.933 (C-rich); 0.911, 0.903, 0.86, 0.808, 0.87, 0.915, 0.973 (2G)];

[-0.894, -0.854, -0.902, -0.933 (C-rich); 0.911, 0.903, 0.86, 0.808, 0.87, 0.915, 0.973 (2G)];

[0.911 (2G), -0.894, -0.854, -0.902, -0.933 (C-rich)]",No similarity to any PQS (2G) from QGRS mapper,"0,0,0","0,0,0",No PQS found in G4 Hunter,DGCR9; DGS-A; DGS-B; DGCR10; LINC00037; POM121L5P; NCRNA00037
DRAIC,prostate cancer,"qPCR, RIP",down-regulated,31900260.0,,1,NR_026979.1,10,10,0,0,VALIDATED,3 (C-rich),"[-0.796, -0.873, -0.907 (C-rich)]",No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,"downregulated RNA in cancer, inhibitor of cell invasion and migration;downregulated RNA in androgen independent cells;lnc-RPLP1-12;HSALNG0106873;HSALNG0106861;HSALNG0106864;HSALNG0106856;NONHSAG017288.2;NONHSAG017290.2;HSALNG0106871;NONHSAG017294.2;HSALNG0106875;HSALNG0106878;HSALNG0106865"
DRAIC,prostate cancer,"qPCR, Western blot etc.",down-regulated,25700553.0,,1,NR_026979.1,10,10,0,0,VALIDATED,3 (C-rich),"[-0.796, -0.873, -0.907 (C-rich)]",No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,"downregulated RNA in cancer, inhibitor of cell invasion and migration;downregulated RNA in androgen independent cells;lnc-RPLP1-12;HSALNG0106873;HSALNG0106861;HSALNG0106864;HSALNG0106856;NONHSAG017288.2;NONHSAG017290.2;HSALNG0106871;NONHSAG017294.2;HSALNG0106875;HSALNG0106878;HSALNG0106865"
DUXAP10,prostate cancer,"qRT-PCR , Western blot , in vitro knockdown etc.",down-regulated,31114994.0,"Homo sapiens double homeobox A pseudogene 10 (DUXAP10), non-coding RNA

transcribed RNA-misc_RNA (mentioned as lncRNA in title of paper; PubMed - 31576658)

Gene type - pseudo

Some LINC01297-DUXAP10-NBEAP6 readthrough (LINC01297-DUXAP10-NBEAP6), transcript variant 1, 2 and 3; ""lncRNA"" ncRNA (NR_164308.1, NR_164309.1 and NR_164310.1 respectively) with PQS-57, 29, 60 respectively were also there in result.

LINC01297-DUXAP10-NBEAP6 readthrough (This locus represents naturally occurring readthrough transcription between the neighboring LINC01297 (long intergenic non-protein coding RNA 1297), DUXAP10 (double homeobox A pseudogene 10) and NBEAP6 (neurobeachin pseudogene 6) genes on chromosome 14. The readthrough transcripts at this locus contain multiple, short ORFs and are unlikely to produce a protein product-provided by RefSeq, Sep 2019).",1,NR_110526.1,12,12,0,0,VALIDATED,0,0,No PQS found in G4 Hunter,0,0,No PQS found in G4 hunter,double homeobox A pseudogene 10
EGOT,prostate cancer,"RNA-seq, Microarray, qPCR, RNAi, Northern blot etc.",down-regulated,23728290.0,"Also Known As: EGO, NCRNA00190",1,NR_004428.1,10,9,1,0,VALIDATED,"6 (4 - 2G, 2 - C-rich)
","[-0.911, -0.941 (C-rich), 0.891, 0.816, 0.894, 0.907 (2G)]
",,0,0,No PQS found in G4 Hunter,EGO; NCRNA00190
"FAL1 
FALEC",prostate cancer,"qPCR, RNA pull-down assay etc.",up-regulated,25203321.0,Also Known As: FALEC; FAL1; ncRNA-a1; LINC00568,1 (FALEC),FALEC (NR_051960.1),8 (FALEC),8 (FALEC),0 (FALEC),0 (FALEC),VALIDATED (FALEC),"3 (2-2G, 1-C-rich)","[0.88, 0.851 (2G), -0.921 (C-rich)]",No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,FAL1; ncRNA-a1; LINC00568
FALEC,prostate cancer,"qPCR, Western blot, Luciferase reporter assay etc.",up-regulated,28585762.0,"Also Known As: FAL1, ncRNA-a1; LINC00568",1,NR_051960.1,8,8,0,0,VALIDATED,"3 (2-2G, 1-C-rich)","[0.88, 0.851 (2G), -0.921 (C-rich)]",No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,FAL1; ncRNA-a1; LINC00568
FENDRR,neuroendocrine prostate cancer,"RNA-seq, Microarray, qPCR etc.",down-regulated,29757368.0,"Also Known As: FOXF1AS1; FOXF1-AS1; lincFOXF1; TCONS_00024240; onco-lncRNA-21

Some (older) FENDRR transcript variant 3 lncRNA ""lncRNA"" ncRNA (complete sequence-MK522493.1) was also there in result.","2 (FENDRR_Variant 1 and 2)
+
1 [FENDRR_Variant 3 (older)]
=3","FENDRR_variant 1 and 2 (NR_033925.1, NR_036444.1)
+
FENDRR_variant 3 (older) MK522493.1","14, 24 (FENDRR_Variant 1 and 2)
+
26 [FENDRR_Variant 3 (older)]","14, 23 (FENDRR_Variant 1 and 2)
+
25 [FENDRR_Variant 3 (older)]","0, 1 (FENDRR_Variant 1 and 2)
+
 1 [FENDRR_Variant 3 (older)]","0, 0 (FENDRR_Variant 1 and 2)
+
 0 [FENDRR_Variant 3 (older)]",REVIEWED (Variant 1 and 2),"3 (1 - 2G, 2- C-rich);
4 (3 - 2G, 1- C-rich);
8 (3 - 2G, 5- C-rich);","[0.803 (2G); -0.982, -0.867 (C-rich)];
[0.803, 0.859, 0.86 (2G), -0.909 (C-rich)];
[0.803, 0.86 (2G), -0.8, -0.911, -0.88, -0.896, 0.859, -0.909 (C-rich)]",No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter,FOXF1AS1; FOXF1-AS1; lincFOXF1; TCONS_00024240; onco-lncRNA-21
FENDRR,prostate cancer,"qPCR, Luciferase reporter assay, in vitro knockdown",down-regulated,29465000.0,"Also Known As: FOXF1AS1; FOXF1-AS1; lincFOXF1; TCONS_00024240; onco-lncRNA-21

Some (older) FENDRR transcript variant 3 lncRNA ""lncRNA"" ncRNA (complete sequence-MK522493.1) was also there in result.","2 (FENDRR_Variant 1 and 2)
+
1 [FENDRR_Variant 3 (older)]
=3","FENDRR_variant 1 and 2 (NR_033925.1, NR_036444.1)
+
FENDRR_variant 3 (older) MK522493.1","14, 24 (FENDRR_Variant 1 and 2)
+
26 [FENDRR_Variant 3 (older)]","14, 23 (FENDRR_Variant 1 and 2)
+
25 [FENDRR_Variant 3 (older)]","0, 1 (FENDRR_Variant 1 and 2)
+
 1 [FENDRR_Variant 3 (older)]","0, 0 (FENDRR_Variant 1 and 2)
+
 0 [FENDRR_Variant 3 (older)]",REVIEWED (Variant 1 and 2),"3 (1 - 2G, 2- C-rich);
4 (3 - 2G, 1- C-rich);
8 (3 - 2G, 5- C-rich);","[0.803 (2G); -0.982, -0.867 (C-rich)];
[0.803, 0.859, 0.86 (2G), -0.909 (C-rich)];
[0.803, 0.86 (2G), -0.8, -0.911, -0.88, -0.896, 0.859, -0.909 (C-rich)]",No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter,FOXF1AS1; FOXF1-AS1; lincFOXF1; TCONS_00024240; onco-lncRNA-21
FER1L4,prostate cancer,"RT-qPCR, Western blot",down-regulated,32140077.0,"Homo sapiens fer-1 like family member 4 (pseudogene) (FER1L4), non-coding RNA

Also Known As: C20orf124

transcribed RNA-misc_RNA (mentioned as lncRNA in title of papers; PubMed - 31473323 and 31115514)

Gene type - pseudo",1,NR_119376.1,85,83,2,0,VALIDATED,"20 (10 -2G, 10- C-rich)","[0.947, -0.774, -1.022, -0.911, -0.894, -0.872, 0.741, 0.911, -0.744, -0.902, -0.843, 0.885, 0.833, 0.854, 0.765, -0.796, -0.82, 0.933, 0.911, 0.75]",No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter,C20orf124
FEZF1-AS1,prostate cancer,"qPCR, Western blot etc",up-regulated,32196579.0,,1,NR_036484.1,22,21,1,0,VALIDATED,"11 (6-2G, 5-C-rich)","[0.911, 0.933, 0.898, 1.021, 0.894 (2G); 0.875 -0.755, -0.891, -0.789, -0.913, -1 (C-rich)]",No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,FEZF1 antisense RNA 1;FEZF1 antisense RNA 1 (non-protein coding);HSALNG0060982;FEZF1-AS1;NONHSAG048666.2
FEZF1-AS1,prostate cancer,"qPCR, Western blot",up-regulated,31298365.0,,1,NR_036484.1,22,21,1,0,VALIDATED,"11 (6-2G, 5-C-rich)","[0.911, 0.933, 0.898, 1.021, 0.894 (2G); 0.875 -0.755, -0.891, -0.789, -0.913, -1 (C-rich)]",No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,FEZF1 antisense RNA 1;FEZF1 antisense RNA 1 (non-protein coding);HSALNG0060982;FEZF1-AS1;NONHSAG048666.2
FOXC2-AS1,prostate cancer,"qPCR, Western blot, Luciferase reporter assay, other",up-regulated,30389560.0,Also known as: ODRUL,1,NR_125795.1,3,3,0,0,VALIDATED,0,0,No PQS found in G4 Hunter,0,0,No PQS found in G4 Hunter,ODRUL
FOXP4-AS1,prostate cancer,"qPCR, Western blot, Luciferase reporter assay, RIP",up-regulated,31209207.0,,3,"NR_126415.1, NR_126416.1, NR_126417.1","2, 2, 1","2, 2, 1","0, 0, 0","0, 0, 0",VALIDATED,"2 (C-rich), 0, 0","-0.911, -0.959 (C-rich)",No similarity to any PQS (2G) from QGRS mapper,"0,0,0","0,0,0",No PQS found in G4 Hunter,FOXP4 antisense RNA 1;FOXP4-AS1;HSALNG0050030;NONHSAG043770.2;HSALNG0050034
GAS5,prostate cancer,"qPCR, other",down-regulated,31423164.0,"Also Known As: SNHG2; NCRNA00030

Some (older-not checked for PQS) GAS5 ""snoRNA"" ncRNA (TPA: HG975395.1) was also there in result.",15,"NR_002578.3, NR_152521.1, NR_152522.1, NR_152523.1, NR_152524.1, NR_152525.1, NR_152526.1, NR_152527.1, NR_152528.1, NR_152529.1, NR_152530.1, NR_152531.1, NR_152532.1, NR_152533.1, NR_152534.1","5, 6, 5, 5, 5, 5, 5, 3, 4, 3, 5, 5, 5, 5, 5","5, 6, 5, 5, 5, 5, 5, 3, 4, 3, 5, 5, 5, 5, 5","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0",REVIEWED,"0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
","0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
",No PQS found in G4 hunter,"0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
","0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
",No PQS found in G4 Hunter,SNHG2; NCRNA00030
GAS5,prostate cancer,"qPCR, Western blot etc.",down-regulated,28396462.0,"Also Known As: SNHG2; NCRNA00030

Some (older-not checked for PQS) GAS5 ""snoRNA"" ncRNA (TPA: HG975395.1) was also there in result.",15,"NR_002578.3, NR_152521.1, NR_152522.1, NR_152523.1, NR_152524.1, NR_152525.1, NR_152526.1, NR_152527.1, NR_152528.1, NR_152529.1, NR_152530.1, NR_152531.1, NR_152532.1, NR_152533.1, NR_152534.1","5, 6, 5, 5, 5, 5, 5, 3, 4, 3, 5, 5, 5, 5, 5","5, 6, 5, 5, 5, 5, 5, 3, 4, 3, 5, 5, 5, 5, 5","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0",REVIEWED,"0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
","0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
",No PQS found in G4 hunter,"0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
","0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
",No PQS found in G4 Hunter,SNHG2; NCRNA00030
GAS5,prostate cancer,qPCR etc.,down-regulated,27922078.0,"Also Known As: SNHG2; NCRNA00030

Some (older-not checked for PQS) GAS5 ""snoRNA"" ncRNA (TPA: HG975395.1) was also there in result.",15,"NR_002578.3, NR_152521.1, NR_152522.1, NR_152523.1, NR_152524.1, NR_152525.1, NR_152526.1, NR_152527.1, NR_152528.1, NR_152529.1, NR_152530.1, NR_152531.1, NR_152532.1, NR_152533.1, NR_152534.1","5, 6, 5, 5, 5, 5, 5, 3, 4, 3, 5, 5, 5, 5, 5","5, 6, 5, 5, 5, 5, 5, 3, 4, 3, 5, 5, 5, 5, 5","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0",REVIEWED,"0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
","0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
",No PQS found in G4 hunter,"0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
","0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
",No PQS found in G4 Hunter,SNHG2; NCRNA00030
GAS5,prostate cancer,"qPCR, RNAi, Cell proliferation assay etc.",down-regulated,25650269.0,"Also Known As: SNHG2; NCRNA00030

Some (older-not checked for PQS) GAS5 ""snoRNA"" ncRNA (TPA: HG975395.1) was also there in result.",15,"NR_002578.3, NR_152521.1, NR_152522.1, NR_152523.1, NR_152524.1, NR_152525.1, NR_152526.1, NR_152527.1, NR_152528.1, NR_152529.1, NR_152530.1, NR_152531.1, NR_152532.1, NR_152533.1, NR_152534.1","5, 6, 5, 5, 5, 5, 5, 3, 4, 3, 5, 5, 5, 5, 5","5, 6, 5, 5, 5, 5, 5, 3, 4, 3, 5, 5, 5, 5, 5","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0",REVIEWED,"0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
","0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
",No PQS found in G4 hunter,"0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
","0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
",No PQS found in G4 Hunter,SNHG2; NCRNA00030
GAS5,prostate cancer,"qPCR, RNAi etc.",up-regulated,23676682.0,"Also Known As: SNHG2; NCRNA00030

Some (older-not checked for PQS) GAS5 ""snoRNA"" ncRNA (TPA: HG975395.1) was also there in result.",15,"NR_002578.3, NR_152521.1, NR_152522.1, NR_152523.1, NR_152524.1, NR_152525.1, NR_152526.1, NR_152527.1, NR_152528.1, NR_152529.1, NR_152530.1, NR_152531.1, NR_152532.1, NR_152533.1, NR_152534.1","5, 6, 5, 5, 5, 5, 5, 3, 4, 3, 5, 5, 5, 5, 5","5, 6, 5, 5, 5, 5, 5, 3, 4, 3, 5, 5, 5, 5, 5","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0",REVIEWED,"0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
","0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
",No PQS found in G4 hunter,"0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
","0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
",No PQS found in G4 Hunter,SNHG2; NCRNA00030
GAS5,prostate cancer,qPCR etc.,down-regulated,18836484.0,"Also Known As: SNHG2; NCRNA00030

Some (older-not checked for PQS) GAS5 ""snoRNA"" ncRNA (TPA: HG975395.1) was also there in result.",15,"NR_002578.3, NR_152521.1, NR_152522.1, NR_152523.1, NR_152524.1, NR_152525.1, NR_152526.1, NR_152527.1, NR_152528.1, NR_152529.1, NR_152530.1, NR_152531.1, NR_152532.1, NR_152533.1, NR_152534.1","5, 6, 5, 5, 5, 5, 5, 3, 4, 3, 5, 5, 5, 5, 5","5, 6, 5, 5, 5, 5, 5, 3, 4, 3, 5, 5, 5, 5, 5","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0",REVIEWED,"0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
","0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
",No PQS found in G4 hunter,"0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
","0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
",No PQS found in G4 Hunter,SNHG2; NCRNA00030
GAS5,prostate cancer,"qPCR, RNAi, Western blot, Dual luciferase reporter assay, Cell proliferation assay, ISH etc.",down-regulated,27743383.0,"Also Known As: SNHG2; NCRNA00030

Some (older-not checked for PQS) GAS5 ""snoRNA"" ncRNA (TPA: HG975395.1) was also there in result.",15,"NR_002578.3, NR_152521.1, NR_152522.1, NR_152523.1, NR_152524.1, NR_152525.1, NR_152526.1, NR_152527.1, NR_152528.1, NR_152529.1, NR_152530.1, NR_152531.1, NR_152532.1, NR_152533.1, NR_152534.1","5, 6, 5, 5, 5, 5, 5, 3, 4, 3, 5, 5, 5, 5, 5","5, 6, 5, 5, 5, 5, 5, 3, 4, 3, 5, 5, 5, 5, 5","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0",REVIEWED,"0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
","0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
",No PQS found in G4 hunter,"0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
","0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
",No PQS found in G4 Hunter,SNHG2; NCRNA00030
GAS5,prostate cancer,"qPCR, RNA interference and transient transfection etc.",up-regulated,28771526.0,"Also Known As: SNHG2; NCRNA00030

Some (older-not checked for PQS) GAS5 ""snoRNA"" ncRNA (TPA: HG975395.1) was also there in result.",15,"NR_002578.3, NR_152521.1, NR_152522.1, NR_152523.1, NR_152524.1, NR_152525.1, NR_152526.1, NR_152527.1, NR_152528.1, NR_152529.1, NR_152530.1, NR_152531.1, NR_152532.1, NR_152533.1, NR_152534.1","5, 6, 5, 5, 5, 5, 5, 3, 4, 3, 5, 5, 5, 5, 5","5, 6, 5, 5, 5, 5, 5, 3, 4, 3, 5, 5, 5, 5, 5","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0",REVIEWED,"0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
","0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
",No PQS found in G4 hunter,"0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
","0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
",No PQS found in G4 Hunter,SNHG2; NCRNA00030
GAS5,prostate cancer,"RNA-seq, Microarray, qPCR, RNAi, Northern blot etc.",up-regulated,23728290.0,"Also Known As: SNHG2; NCRNA00030

Some (older-not checked for PQS) GAS5 ""snoRNA"" ncRNA (TPA: HG975395.1) was also there in result.",15,"NR_002578.3, NR_152521.1, NR_152522.1, NR_152523.1, NR_152524.1, NR_152525.1, NR_152526.1, NR_152527.1, NR_152528.1, NR_152529.1, NR_152530.1, NR_152531.1, NR_152532.1, NR_152533.1, NR_152534.1","5, 6, 5, 5, 5, 5, 5, 3, 4, 3, 5, 5, 5, 5, 5","5, 6, 5, 5, 5, 5, 5, 3, 4, 3, 5, 5, 5, 5, 5","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0",REVIEWED,"0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
","0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
",No PQS found in G4 hunter,"0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
","0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
",No PQS found in G4 Hunter,SNHG2; NCRNA00030
"GASL1 
GASAL1",prostate cancer,"RT-qPCR, Western blotting  etc.",up-regulated,31186749.0,Also Known As: GASAL1; GASL1,1 (GASAL1),NR_149020.1 (GASAL1),45 (GASAL1),37 (GASAL1),6 (GASAL1),2 (GASAL1),VALIDATED (GASAL1),"22 (9-C-rich, 2-4G, 3-2G, 7-3G)","[-1, -0.833, -0.925,
-0.911, -0.911, -1.065,
-0.911, -1.074, -0.911
(C-rich); 0.696, 0.911,0.913 
(2G); 0.888, 1.125 (4G);
0.971, 0.933, 0.911,
0.911, 0.911, 0.872, 0.775, 0.92 (3G)]","The PQS 1 (3G) of QGRS Mapper is similar to / a part of PQS 2 (4G) of G4 Hunter, with a right frame-shift in G4 Hunter

 PQS 3 (3G) of QGRS  Mapper is similar to / a part of PQS 6 (3G) of G4 Hunter, with a left frame-shift in G4 Hunter

 PQS 4 (3G) of QGRS  Mapper is similar to / a part of PQS 7 (3G) of G4 Hunter. 

By looking at all the PQS, it is visible that there is a slight overlap between PQS 2,3,4,5,6 of G4 hunter (3G) and can be considered as one PQS.","9 (4-C-rich, 5","[-1.426, -1.246, -1.388, 
-1.326 (C-rich); 1.185,
 1.467 (4G) 1.291, 1.383, 1.4 (3G)]","PQS 1 (3G) of QGRS Mapper is similar to / a part of PQS 2 (4G) of G4 Hunter, with a right frame-shift in G4 Hunter

PQS 1 (3G) of QGRS  Mapper is similar to / a part of PQS 2 (4G) of G4 Hunter, with a left frame-shift in G4 Hunter

By looking at all PQS, it is visible that there is a slight overlap between PQS 2,3,4,5 of G4 hunter (3G) and can be considered as one PQS. This one entire PQS inlcudes G-tracts from
three 3G PQS of QGRS Mapper.
",GASL1
GHET1,prostate cancer,"qPCR, Western blot, in vitro knockdown, etc.",up-regulated,30609158.0,Also Known As: ncRNA-GHET1,1,NR_130107.1,10,9,1,0,REVIEWED,"5 (1-2G, 1-3G, 3-C-rich)
","[0.891, 0.644 (2G); 0.973 (3G); '-0.911, -0.79, -0.959 (C-rich)]", PQS 10 (3G) of QGRS Mapper is similar / a part of PQS 6 (3G) of G4 hunter with a left frame shift in G4 hunter,1,1.413,PQS 10 (3G) of QGRS Mapper is similar / a part of PQS 1 (3G) of G4 hunter with the same main G4 tracts.,lncRNA-GHET1
GLIDR,prostate cancer,qPCR etc.,up-regulated,28211799.0,"Also Known As: LINC01172, TCONS_00015562",4,"NR_015363.2, NR_126044.1, NR_12045.1, NR_126046.1","21, 17, 9, 8","19, 15, 9, 8","2, 2, 0, 0","0, 0, 0, 0",VALIDATED,"7 (5-2G, 2-C-rich);
7 (5-2G, 2-C-rich);
3 (C-rich)
"," [0.937, 1.167, 1.052, 0.898, 0.911 [2G]; 0.843, -0.909 [C-rich]];

 [0.937, 1.167, 1.052, 0.898, 0.911 [2G]; 0.843, -0.909 [C-rich]];

[-0.843, -0.925, -0.909 (C-rich)]
",No similarity to any PQS (2G) from QGRS mapper,"2 (3G);
2 (3G);
0;
0","[1.422, 1.443 [3G]];
[1.422, 1.443 [3G]];
0;
0","PQS 1  (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 2 (3G) from G4 hunter

No PQS found in G4 Hunter for variants 3 and 4.",glioblastoma down-regulated RNA;MGC21881;TCONS_00015562;FAM88A;family with sequence similarity 88 member A;long intergenic non-protein coding RNA 1172;LINC01172;HSALNG0071221;GLIDR;NONHSAG052261.2
H19,prostate cancer,"qPCR, Western blot, Microarray",differential expression,32146726.0,"Also Known As: ASM; BWS; WT2; ASM1; D11S813E; MIR675HG; LINC00008; NCRNA00008

Some (older-not checked for PQS) H19 ""other"" ncRNA endogenous virus human endogenous retrovirus H clone (partial sequence-MG598802.1) with note - non-coding HERV-H transcript, was also there in result.

PQS 6 [Position-625 (3G)] obtained in 1st and 2nd variants when search parameter was set to Min G-Group Size: 2 was replaced by another PQS of same score (by shifting G-Group/Quartet frame) when search parameter was set to Min G-Group Size: 3.

H19 1st and 2nd variants showed 2 (4G) PQS in QGRS mapper when search parameter was set to Min G-Group Size: 2, while it showed 2 (3G) and 1 (4G) PQS when search parameter was set to Min G-Group Size: 3, as PQS 1 (3G) 2 (4G) obtained when search parameter was set to Min G-Group Size: 3 was replaced by 1 PQS (4G) of different G-score (by taking PQS 1, flanking region and parts from PQS 2), while PQS 2 (4G) and 3 (3G) were replaced by 1 PQS (4G) of different G-score (by taking parts from PQS 2 and; flanking region and; parts from PQS 3) when search parameter was set to Min G-Group Size: 2.
For further consideration, PQS when search parameter was set to Min G-Group Size: 2 was taken.",3,"NR_002196.2, NR_131223.1, NR_131224.1","38, 37, 12","27, 26, 11","9, 9, 1","2, 2, 0",REVIEWED,"32 (1 - 4G, 9 - 2G, 13 - 3G, 8 - C-rich);

32 (1 - 4G, 9 - 2G, 13 - 3G, 8 - C-rich); 

5 (C-rich)","[1.305 (4G), 0.837, 0.882, 0.833, 0.607, 0.824, 0.978, 0.891, 0.933, 0.911 (2G), 0.962, 0.891, 0.93,  0.934, 0.894, 0.803, 0.911, 0.859, 0.804, 0.933, 0.958,  1.061,  0.953 (3G), -0.911, -0.911, -0.957, -0.621, -0.911, -0.911, -1, -0.8, -0.71 (C-rich)]; 

[1.305 (4G), 0.837, 0.882, 0.833, 0.607, 0.824, 0.978, 0.891, 0.933, 0.911 (2G), 0.962, 0.891, 0.93,  0.934, 0.894, 0.803, 0.911, 0.859, 0.804, 0.933, 0.958,  1.061,  0.953 (3G), -0.911, -0.911, -0.957, -0.621, -0.911, -0.911, -1, -0.8, -0.71 (C-rich)]; 

[-0.911, -0.911, -1, -0.8, -0.71 (C-rich)]","PQS 7 (3G) of  QGRS mapper and PQS 8 (3G) of G4 hunter have similar G tracts. 

PQS 14 (3G) of QGRS mapper and the PQS 15 (3G) of G4 hunter have similar G tracts. 

PQS 16 (3G) of QGRS mapper and the PQS 18 (3G) of G4 hunter have similar G tracts.

PQS 20 (3G) of QGRS mapper and the PQS 21 (3G) of G4 hunter have similar G tracts.

PQS 21 (3G) of QGRS mapper and the PQS 22 (3G) of G4 hunter have similar G tracts.

By looking at PQS 2 and 3 (3G) of variants 1 and 2 in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. 

By looking at PQS 4 and 5 (3G) of variants 1 and 2 in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. 

By looking at PQS 14, 15 and 16 (3G) of variants 1 and 2 in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. ","2;
 
2;

0 (3G)","[1.583 (4G), 1.37 (3G)];

[1.583 (4G), 1.37 (3G)];

[0]","In variant 1 and 2, PQS 1 (4G) of QGRS mapper and the PQS 1 (4G) of G4 hunter have similar G tracts.

In variant 1 and 2, PQS 3 (3G) of QGRS mapper and the PQS 2 (3G) of G4 hunter have similar G tracts.

No PQS found in G4 hunter.",ASM; BWS; WT2; ASM1; D11S813E; MIR675HG; LINC00008; NCRNA00008
H19,prostate cancer,qPCR etc,up-regulated,32356434.0,"Also Known As: ASM; BWS; WT2; ASM1; D11S813E; MIR675HG; LINC00008; NCRNA00008

Some (older-not checked for PQS) H19 ""other"" ncRNA endogenous virus human endogenous retrovirus H clone (partial sequence-MG598802.1) with note - non-coding HERV-H transcript, was also there in result.

PQS 6 [Position-625 (3G)] obtained in 1st and 2nd variants when search parameter was set to Min G-Group Size: 2 was replaced by another PQS of same score (by shifting G-Group/Quartet frame) when search parameter was set to Min G-Group Size: 3.

H19 1st and 2nd variants showed 2 (4G) PQS in QGRS mapper when search parameter was set to Min G-Group Size: 2, while it showed 2 (3G) and 1 (4G) PQS when search parameter was set to Min G-Group Size: 3, as PQS 1 (3G) 2 (4G) obtained when search parameter was set to Min G-Group Size: 3 was replaced by 1 PQS (4G) of different G-score (by taking PQS 1, flanking region and parts from PQS 2), while PQS 2 (4G) and 3 (3G) were replaced by 1 PQS (4G) of different G-score (by taking parts from PQS 2 and; flanking region and; parts from PQS 3) when search parameter was set to Min G-Group Size: 2.
For further consideration, PQS when search parameter was set to Min G-Group Size: 2 was taken.",3,"NR_002196.2, NR_131223.1, NR_131224.1","38, 37, 12","27, 26, 11","9, 9, 1","2, 2, 0",REVIEWED,"32 (1 - 4G, 9 - 2G, 13 - 3G, 8 - C-rich);

32 (1 - 4G, 9 - 2G, 13 - 3G, 8 - C-rich); 

5 (C-rich)","[1.305 (4G), 0.837, 0.882, 0.833, 0.607, 0.824, 0.978, 0.891, 0.933, 0.911 (2G), 0.962, 0.891, 0.93,  0.934, 0.894, 0.803, 0.911, 0.859, 0.804, 0.933, 0.958,  1.061,  0.953 (3G), -0.911, -0.911, -0.957, -0.621, -0.911, -0.911, -1, -0.8, -0.71 (C-rich)]; 

[1.305 (4G), 0.837, 0.882, 0.833, 0.607, 0.824, 0.978, 0.891, 0.933, 0.911 (2G), 0.962, 0.891, 0.93,  0.934, 0.894, 0.803, 0.911, 0.859, 0.804, 0.933, 0.958,  1.061,  0.953 (3G), -0.911, -0.911, -0.957, -0.621, -0.911, -0.911, -1, -0.8, -0.71 (C-rich)]; 

[-0.911, -0.911, -1, -0.8, -0.71 (C-rich)]","PQS 7 (3G) of  QGRS mapper and PQS 8 (3G) of G4 hunter have similar G tracts. 

PQS 14 (3G) of QGRS mapper and the PQS 15 (3G) of G4 hunter have similar G tracts. 

PQS 16 (3G) of QGRS mapper and the PQS 18 (3G) of G4 hunter have similar G tracts.

PQS 20 (3G) of QGRS mapper and the PQS 21 (3G) of G4 hunter have similar G tracts.

PQS 21 (3G) of QGRS mapper and the PQS 22 (3G) of G4 hunter have similar G tracts.

By looking at PQS 2 and 3 (3G) of variants 1 and 2 in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. 

By looking at PQS 4 and 5 (3G) of variants 1 and 2 in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. 

By looking at PQS 14, 15 and 16 (3G) of variants 1 and 2 in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. ","2;
 
2;

0 (3G)","[1.583 (4G), 1.37 (3G)];

[1.583 (4G), 1.37 (3G)];

[0]","In variant 1 and 2, PQS 1 (4G) of QGRS mapper and the PQS 1 (4G) of G4 hunter have similar G tracts.

In variant 1 and 2, PQS 3 (3G) of QGRS mapper and the PQS 2 (3G) of G4 hunter have similar G tracts.

No PQS found in G4 hunter.",ASM; BWS; WT2; ASM1; D11S813E; MIR675HG; LINC00008; NCRNA00008
H19,prostate cancer,"qPCR, Western blot, other",down-regulated,31426484.0,"Also Known As: ASM; BWS; WT2; ASM1; D11S813E; MIR675HG; LINC00008; NCRNA00008

Some (older-not checked for PQS) H19 ""other"" ncRNA endogenous virus human endogenous retrovirus H clone (partial sequence-MG598802.1) with note - non-coding HERV-H transcript, was also there in result.

PQS 6 [Position-625 (3G)] obtained in 1st and 2nd variants when search parameter was set to Min G-Group Size: 2 was replaced by another PQS of same score (by shifting G-Group/Quartet frame) when search parameter was set to Min G-Group Size: 3.

H19 1st and 2nd variants showed 2 (4G) PQS in QGRS mapper when search parameter was set to Min G-Group Size: 2, while it showed 2 (3G) and 1 (4G) PQS when search parameter was set to Min G-Group Size: 3, as PQS 1 (3G) 2 (4G) obtained when search parameter was set to Min G-Group Size: 3 was replaced by 1 PQS (4G) of different G-score (by taking PQS 1, flanking region and parts from PQS 2), while PQS 2 (4G) and 3 (3G) were replaced by 1 PQS (4G) of different G-score (by taking parts from PQS 2 and; flanking region and; parts from PQS 3) when search parameter was set to Min G-Group Size: 2.
For further consideration, PQS when search parameter was set to Min G-Group Size: 2 was taken.",3,"NR_002196.2, NR_131223.1, NR_131224.1","38, 37, 12","27, 26, 11","9, 9, 1","2, 2, 0",REVIEWED,"32 (1 - 4G, 9 - 2G, 13 - 3G, 8 - C-rich);

32 (1 - 4G, 9 - 2G, 13 - 3G, 8 - C-rich); 

5 (C-rich)","[1.305 (4G), 0.837, 0.882, 0.833, 0.607, 0.824, 0.978, 0.891, 0.933, 0.911 (2G), 0.962, 0.891, 0.93,  0.934, 0.894, 0.803, 0.911, 0.859, 0.804, 0.933, 0.958,  1.061,  0.953 (3G), -0.911, -0.911, -0.957, -0.621, -0.911, -0.911, -1, -0.8, -0.71 (C-rich)]; 

[1.305 (4G), 0.837, 0.882, 0.833, 0.607, 0.824, 0.978, 0.891, 0.933, 0.911 (2G), 0.962, 0.891, 0.93,  0.934, 0.894, 0.803, 0.911, 0.859, 0.804, 0.933, 0.958,  1.061,  0.953 (3G), -0.911, -0.911, -0.957, -0.621, -0.911, -0.911, -1, -0.8, -0.71 (C-rich)]; 

[-0.911, -0.911, -1, -0.8, -0.71 (C-rich)]","PQS 7 (3G) of  QGRS mapper and PQS 8 (3G) of G4 hunter have similar G tracts. 

PQS 14 (3G) of QGRS mapper and the PQS 15 (3G) of G4 hunter have similar G tracts. 

PQS 16 (3G) of QGRS mapper and the PQS 18 (3G) of G4 hunter have similar G tracts.

PQS 20 (3G) of QGRS mapper and the PQS 21 (3G) of G4 hunter have similar G tracts.

PQS 21 (3G) of QGRS mapper and the PQS 22 (3G) of G4 hunter have similar G tracts.

By looking at PQS 2 and 3 (3G) of variants 1 and 2 in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. 

By looking at PQS 4 and 5 (3G) of variants 1 and 2 in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. 

By looking at PQS 14, 15 and 16 (3G) of variants 1 and 2 in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. ","2;
 
2;

0 (3G)","[1.583 (4G), 1.37 (3G)];

[1.583 (4G), 1.37 (3G)];

[0]","In variant 1 and 2, PQS 1 (4G) of QGRS mapper and the PQS 1 (4G) of G4 hunter have similar G tracts.

In variant 1 and 2, PQS 3 (3G) of QGRS mapper and the PQS 2 (3G) of G4 hunter have similar G tracts.

No PQS found in G4 hunter.",ASM; BWS; WT2; ASM1; D11S813E; MIR675HG; LINC00008; NCRNA00008
H19,neuroendocrine prostate cancer,"RNA-seq, Microarray, qPCR etc.",up-regulated,29757368.0,"Also Known As: ASM; BWS; WT2; ASM1; D11S813E; MIR675HG; LINC00008; NCRNA00008

Some (older-not checked for PQS) H19 ""other"" ncRNA endogenous virus human endogenous retrovirus H clone (partial sequence-MG598802.1) with note - non-coding HERV-H transcript, was also there in result.

PQS 6 [Position-625 (3G)] obtained in 1st and 2nd variants when search parameter was set to Min G-Group Size: 2 was replaced by another PQS of same score (by shifting G-Group/Quartet frame) when search parameter was set to Min G-Group Size: 3.

H19 1st and 2nd variants showed 2 (4G) PQS in QGRS mapper when search parameter was set to Min G-Group Size: 2, while it showed 2 (3G) and 1 (4G) PQS when search parameter was set to Min G-Group Size: 3, as PQS 1 (3G) 2 (4G) obtained when search parameter was set to Min G-Group Size: 3 was replaced by 1 PQS (4G) of different G-score (by taking PQS 1, flanking region and parts from PQS 2), while PQS 2 (4G) and 3 (3G) were replaced by 1 PQS (4G) of different G-score (by taking parts from PQS 2 and; flanking region and; parts from PQS 3) when search parameter was set to Min G-Group Size: 2.
For further consideration, PQS when search parameter was set to Min G-Group Size: 2 was taken.",3,"NR_002196.2, NR_131223.1, NR_131224.1","38, 37, 12","27, 26, 11","9, 9, 1","2, 2, 0",REVIEWED,"32 (1 - 4G, 9 - 2G, 13 - 3G, 8 - C-rich);

32 (1 - 4G, 9 - 2G, 13 - 3G, 8 - C-rich); 

5 (C-rich)","[1.305 (4G), 0.837, 0.882, 0.833, 0.607, 0.824, 0.978, 0.891, 0.933, 0.911 (2G), 0.962, 0.891, 0.93,  0.934, 0.894, 0.803, 0.911, 0.859, 0.804, 0.933, 0.958,  1.061,  0.953 (3G), -0.911, -0.911, -0.957, -0.621, -0.911, -0.911, -1, -0.8, -0.71 (C-rich)]; 

[1.305 (4G), 0.837, 0.882, 0.833, 0.607, 0.824, 0.978, 0.891, 0.933, 0.911 (2G), 0.962, 0.891, 0.93,  0.934, 0.894, 0.803, 0.911, 0.859, 0.804, 0.933, 0.958,  1.061,  0.953 (3G), -0.911, -0.911, -0.957, -0.621, -0.911, -0.911, -1, -0.8, -0.71 (C-rich)]; 

[-0.911, -0.911, -1, -0.8, -0.71 (C-rich)]","PQS 7 (3G) of  QGRS mapper and PQS 8 (3G) of G4 hunter have similar G tracts. 

PQS 14 (3G) of QGRS mapper and the PQS 15 (3G) of G4 hunter have similar G tracts. 

PQS 16 (3G) of QGRS mapper and the PQS 18 (3G) of G4 hunter have similar G tracts.

PQS 20 (3G) of QGRS mapper and the PQS 21 (3G) of G4 hunter have similar G tracts.

PQS 21 (3G) of QGRS mapper and the PQS 22 (3G) of G4 hunter have similar G tracts.

By looking at PQS 2 and 3 (3G) of variants 1 and 2 in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. 

By looking at PQS 4 and 5 (3G) of variants 1 and 2 in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. 

By looking at PQS 14, 15 and 16 (3G) of variants 1 and 2 in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. ","2;
 
2;

0 (3G)","[1.583 (4G), 1.37 (3G)];

[1.583 (4G), 1.37 (3G)];

[0]","In variant 1 and 2, PQS 1 (4G) of QGRS mapper and the PQS 1 (4G) of G4 hunter have similar G tracts.

In variant 1 and 2, PQS 3 (3G) of QGRS mapper and the PQS 2 (3G) of G4 hunter have similar G tracts.

No PQS found in G4 hunter.",ASM; BWS; WT2; ASM1; D11S813E; MIR675HG; LINC00008; NCRNA00008
H19,prostate cancer,"qPCR, Western blot etc.",down-regulated,24988946.0,"Also Known As: ASM; BWS; WT2; ASM1; D11S813E; MIR675HG; LINC00008; NCRNA00008

Some (older-not checked for PQS) H19 ""other"" ncRNA endogenous virus human endogenous retrovirus H clone (partial sequence-MG598802.1) with note - non-coding HERV-H transcript, was also there in result.

PQS 6 [Position-625 (3G)] obtained in 1st and 2nd variants when search parameter was set to Min G-Group Size: 2 was replaced by another PQS of same score (by shifting G-Group/Quartet frame) when search parameter was set to Min G-Group Size: 3.

H19 1st and 2nd variants showed 2 (4G) PQS in QGRS mapper when search parameter was set to Min G-Group Size: 2, while it showed 2 (3G) and 1 (4G) PQS when search parameter was set to Min G-Group Size: 3, as PQS 1 (3G) 2 (4G) obtained when search parameter was set to Min G-Group Size: 3 was replaced by 1 PQS (4G) of different G-score (by taking PQS 1, flanking region and parts from PQS 2), while PQS 2 (4G) and 3 (3G) were replaced by 1 PQS (4G) of different G-score (by taking parts from PQS 2 and; flanking region and; parts from PQS 3) when search parameter was set to Min G-Group Size: 2.
For further consideration, PQS when search parameter was set to Min G-Group Size: 2 was taken.",3,"NR_002196.2, NR_131223.1, NR_131224.1","38, 37, 12","27, 26, 11","9, 9, 1","2, 2, 0",REVIEWED,"32 (1 - 4G, 9 - 2G, 13 - 3G, 8 - C-rich);

32 (1 - 4G, 9 - 2G, 13 - 3G, 8 - C-rich); 

5 (C-rich)","[1.305 (4G), 0.837, 0.882, 0.833, 0.607, 0.824, 0.978, 0.891, 0.933, 0.911 (2G), 0.962, 0.891, 0.93,  0.934, 0.894, 0.803, 0.911, 0.859, 0.804, 0.933, 0.958,  1.061,  0.953 (3G), -0.911, -0.911, -0.957, -0.621, -0.911, -0.911, -1, -0.8, -0.71 (C-rich)]; 

[1.305 (4G), 0.837, 0.882, 0.833, 0.607, 0.824, 0.978, 0.891, 0.933, 0.911 (2G), 0.962, 0.891, 0.93,  0.934, 0.894, 0.803, 0.911, 0.859, 0.804, 0.933, 0.958,  1.061,  0.953 (3G), -0.911, -0.911, -0.957, -0.621, -0.911, -0.911, -1, -0.8, -0.71 (C-rich)]; 

[-0.911, -0.911, -1, -0.8, -0.71 (C-rich)]","PQS 7 (3G) of  QGRS mapper and PQS 8 (3G) of G4 hunter have similar G tracts. 

PQS 14 (3G) of QGRS mapper and the PQS 15 (3G) of G4 hunter have similar G tracts. 

PQS 16 (3G) of QGRS mapper and the PQS 18 (3G) of G4 hunter have similar G tracts.

PQS 20 (3G) of QGRS mapper and the PQS 21 (3G) of G4 hunter have similar G tracts.

PQS 21 (3G) of QGRS mapper and the PQS 22 (3G) of G4 hunter have similar G tracts.

By looking at PQS 2 and 3 (3G) of variants 1 and 2 in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. 

By looking at PQS 4 and 5 (3G) of variants 1 and 2 in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. 

By looking at PQS 14, 15 and 16 (3G) of variants 1 and 2 in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. ","2;
 
2;

0 (3G)","[1.583 (4G), 1.37 (3G)];

[1.583 (4G), 1.37 (3G)];

[0]","In variant 1 and 2, PQS 1 (4G) of QGRS mapper and the PQS 1 (4G) of G4 hunter have similar G tracts.

In variant 1 and 2, PQS 3 (3G) of QGRS mapper and the PQS 2 (3G) of G4 hunter have similar G tracts.

No PQS found in G4 hunter.",ASM; BWS; WT2; ASM1; D11S813E; MIR675HG; LINC00008; NCRNA00008
H19,prostate cancer,qPCR etc.,down-regulated,24063685.0,"Also Known As: ASM; BWS; WT2; ASM1; D11S813E; MIR675HG; LINC00008; NCRNA00008

Some (older-not checked for PQS) H19 ""other"" ncRNA endogenous virus human endogenous retrovirus H clone (partial sequence-MG598802.1) with note - non-coding HERV-H transcript, was also there in result.

PQS 6 [Position-625 (3G)] obtained in 1st and 2nd variants when search parameter was set to Min G-Group Size: 2 was replaced by another PQS of same score (by shifting G-Group/Quartet frame) when search parameter was set to Min G-Group Size: 3.

H19 1st and 2nd variants showed 2 (4G) PQS in QGRS mapper when search parameter was set to Min G-Group Size: 2, while it showed 2 (3G) and 1 (4G) PQS when search parameter was set to Min G-Group Size: 3, as PQS 1 (3G) 2 (4G) obtained when search parameter was set to Min G-Group Size: 3 was replaced by 1 PQS (4G) of different G-score (by taking PQS 1, flanking region and parts from PQS 2), while PQS 2 (4G) and 3 (3G) were replaced by 1 PQS (4G) of different G-score (by taking parts from PQS 2 and; flanking region and; parts from PQS 3) when search parameter was set to Min G-Group Size: 2.
For further consideration, PQS when search parameter was set to Min G-Group Size: 2 was taken.",3,"NR_002196.2, NR_131223.1, NR_131224.1","38, 37, 12","27, 26, 11","9, 9, 1","2, 2, 0",REVIEWED,"32 (1 - 4G, 9 - 2G, 13 - 3G, 8 - C-rich);

32 (1 - 4G, 9 - 2G, 13 - 3G, 8 - C-rich); 

5 (C-rich)","[1.305 (4G), 0.837, 0.882, 0.833, 0.607, 0.824, 0.978, 0.891, 0.933, 0.911 (2G), 0.962, 0.891, 0.93,  0.934, 0.894, 0.803, 0.911, 0.859, 0.804, 0.933, 0.958,  1.061,  0.953 (3G), -0.911, -0.911, -0.957, -0.621, -0.911, -0.911, -1, -0.8, -0.71 (C-rich)]; 

[1.305 (4G), 0.837, 0.882, 0.833, 0.607, 0.824, 0.978, 0.891, 0.933, 0.911 (2G), 0.962, 0.891, 0.93,  0.934, 0.894, 0.803, 0.911, 0.859, 0.804, 0.933, 0.958,  1.061,  0.953 (3G), -0.911, -0.911, -0.957, -0.621, -0.911, -0.911, -1, -0.8, -0.71 (C-rich)]; 

[-0.911, -0.911, -1, -0.8, -0.71 (C-rich)]","PQS 7 (3G) of  QGRS mapper and PQS 8 (3G) of G4 hunter have similar G tracts. 

PQS 14 (3G) of QGRS mapper and the PQS 15 (3G) of G4 hunter have similar G tracts. 

PQS 16 (3G) of QGRS mapper and the PQS 18 (3G) of G4 hunter have similar G tracts.

PQS 20 (3G) of QGRS mapper and the PQS 21 (3G) of G4 hunter have similar G tracts.

PQS 21 (3G) of QGRS mapper and the PQS 22 (3G) of G4 hunter have similar G tracts.

By looking at PQS 2 and 3 (3G) of variants 1 and 2 in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. 

By looking at PQS 4 and 5 (3G) of variants 1 and 2 in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. 

By looking at PQS 14, 15 and 16 (3G) of variants 1 and 2 in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. ","2;
 
2;

0 (3G)","[1.583 (4G), 1.37 (3G)];

[1.583 (4G), 1.37 (3G)];

[0]","In variant 1 and 2, PQS 1 (4G) of QGRS mapper and the PQS 1 (4G) of G4 hunter have similar G tracts.

In variant 1 and 2, PQS 3 (3G) of QGRS mapper and the PQS 2 (3G) of G4 hunter have similar G tracts.

No PQS found in G4 hunter.",ASM; BWS; WT2; ASM1; D11S813E; MIR675HG; LINC00008; NCRNA00008
H19,prostate cancer,"qPCR, ISH etc.",up-regulated,15525575.0,"Also Known As: ASM; BWS; WT2; ASM1; D11S813E; MIR675HG; LINC00008; NCRNA00008

Some (older-not checked for PQS) H19 ""other"" ncRNA endogenous virus human endogenous retrovirus H clone (partial sequence-MG598802.1) with note - non-coding HERV-H transcript, was also there in result.

PQS 6 [Position-625 (3G)] obtained in 1st and 2nd variants when search parameter was set to Min G-Group Size: 2 was replaced by another PQS of same score (by shifting G-Group/Quartet frame) when search parameter was set to Min G-Group Size: 3.

H19 1st and 2nd variants showed 2 (4G) PQS in QGRS mapper when search parameter was set to Min G-Group Size: 2, while it showed 2 (3G) and 1 (4G) PQS when search parameter was set to Min G-Group Size: 3, as PQS 1 (3G) 2 (4G) obtained when search parameter was set to Min G-Group Size: 3 was replaced by 1 PQS (4G) of different G-score (by taking PQS 1, flanking region and parts from PQS 2), while PQS 2 (4G) and 3 (3G) were replaced by 1 PQS (4G) of different G-score (by taking parts from PQS 2 and; flanking region and; parts from PQS 3) when search parameter was set to Min G-Group Size: 2.
For further consideration, PQS when search parameter was set to Min G-Group Size: 2 was taken.",3,"NR_002196.2, NR_131223.1, NR_131224.1","38, 37, 12","27, 26, 11","9, 9, 1","2, 2, 0",REVIEWED,"32 (1 - 4G, 9 - 2G, 13 - 3G, 8 - C-rich);

32 (1 - 4G, 9 - 2G, 13 - 3G, 8 - C-rich); 

5 (C-rich)","[1.305 (4G), 0.837, 0.882, 0.833, 0.607, 0.824, 0.978, 0.891, 0.933, 0.911 (2G), 0.962, 0.891, 0.93,  0.934, 0.894, 0.803, 0.911, 0.859, 0.804, 0.933, 0.958,  1.061,  0.953 (3G), -0.911, -0.911, -0.957, -0.621, -0.911, -0.911, -1, -0.8, -0.71 (C-rich)]; 

[1.305 (4G), 0.837, 0.882, 0.833, 0.607, 0.824, 0.978, 0.891, 0.933, 0.911 (2G), 0.962, 0.891, 0.93,  0.934, 0.894, 0.803, 0.911, 0.859, 0.804, 0.933, 0.958,  1.061,  0.953 (3G), -0.911, -0.911, -0.957, -0.621, -0.911, -0.911, -1, -0.8, -0.71 (C-rich)]; 

[-0.911, -0.911, -1, -0.8, -0.71 (C-rich)]","PQS 7 (3G) of  QGRS mapper and PQS 8 (3G) of G4 hunter have similar G tracts. 

PQS 14 (3G) of QGRS mapper and the PQS 15 (3G) of G4 hunter have similar G tracts. 

PQS 16 (3G) of QGRS mapper and the PQS 18 (3G) of G4 hunter have similar G tracts.

PQS 20 (3G) of QGRS mapper and the PQS 21 (3G) of G4 hunter have similar G tracts.

PQS 21 (3G) of QGRS mapper and the PQS 22 (3G) of G4 hunter have similar G tracts.

By looking at PQS 2 and 3 (3G) of variants 1 and 2 in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. 

By looking at PQS 4 and 5 (3G) of variants 1 and 2 in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. 

By looking at PQS 14, 15 and 16 (3G) of variants 1 and 2 in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. ","2;
 
2;

0 (3G)","[1.583 (4G), 1.37 (3G)];

[1.583 (4G), 1.37 (3G)];

[0]","In variant 1 and 2, PQS 1 (4G) of QGRS mapper and the PQS 1 (4G) of G4 hunter have similar G tracts.

In variant 1 and 2, PQS 3 (3G) of QGRS mapper and the PQS 2 (3G) of G4 hunter have similar G tracts.

No PQS found in G4 hunter.",ASM; BWS; WT2; ASM1; D11S813E; MIR675HG; LINC00008; NCRNA00008
HCG11,prostate cancer,"qPCR, Western blot, Luciferase reporter assay",down-regulated,31228307.0,"Also Known As: CTA-14H9.3, bK14H9.3",1,NR_026790.1,35,31,4,0,VALIDATED,"6 (2 - 2G, 2 - 3G, 2 - C-rich)
","[0.904, 0.833, (3G), -0.754, -0.911 (C-rich), 0.648, 0.778  (2G)]","PQS 7 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 1 (3G) from G4 hunter has a left frame-shift as compared to PQS 7 (3G) from QGRS mapper. 

PQS 30 (3G) of QGRS mapper and the PQS 6 (3G) of G4 hunter have similar G tracts.

PQS 6 (3G) from G4 hunter has a right frame-shift as compared to PQS 30 (3G) from QGRS mapper. ",2 (3G),"[1.236, 1.319 (3G)]","PQS 29 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 1 (3G) from G4 hunter has a left frame-shift as compared to PQS 29 (3G) from QGRS mapper. 

PQS 30 (3G) of QGRS mapper and the PQS 2 (3G) of G4 hunter have similar G tracts.

PQS 2 (3G) from G4 hunter has a left frame-shift as compared to PQS 30 (3G) from QGRS mapper. ",bK14H9.3; CTA-14H9.3
HCG11,prostate cancer,qPCR etc.,down-regulated,27522256.0,"Also Known As: CTA-14H9.3, bK14H9.3",1,NR_026790.1,35,31,4,0,VALIDATED,"6 (2 - 2G, 2 - 3G, 2 - C-rich)
","[0.904, 0.833, (3G), -0.754, -0.911 (C-rich), 0.648, 0.778  (2G)]","PQS 7 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 1 (3G) from G4 hunter has a left frame-shift as compared to PQS 7 (3G) from QGRS mapper. 

PQS 30 (3G) of QGRS mapper and the PQS 6 (3G) of G4 hunter have similar G tracts.

PQS 6 (3G) from G4 hunter has a right frame-shift as compared to PQS 30 (3G) from QGRS mapper. ",2 (3G),"[1.236, 1.319 (3G)]","PQS 29 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 1 (3G) from G4 hunter has a left frame-shift as compared to PQS 29 (3G) from QGRS mapper. 

PQS 30 (3G) of QGRS mapper and the PQS 2 (3G) of G4 hunter have similar G tracts.

PQS 2 (3G) from G4 hunter has a left frame-shift as compared to PQS 30 (3G) from QGRS mapper. ",bK14H9.3; CTA-14H9.3
HCP5,prostate cancer,"RT-qPCR, Western blot",up-regulated,31746434.0,Also Known As: P5-1; 6S2650E; D6S2650E,1,NR_040662.1,23,21,2,0,VALIDATED,"2 (1 - 3G, 1 - C-rich)","[0.913 (3G), -0.857 (C-rich)]","
PQS 18 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.",0,0,No PQS found in G4 hunter,P5-1; 6S2650E; D6S2650E
HOTAIR,prostate cancer,"RNA-seq, qPCR, Western blot, in vitro knockdown",up-regulated,29944905.0,"Also Known As: HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072

Some (older-not checked for PQS) Long non-coding antisense RNA HOTAIR (HOTAIR gene) ""antisense RNA"" ncRNA (TPA: HG975398.1) was also there in result.",3,"NR_047517.1, NR_003716.3, NR_047518.1","18, 17, 16, ","17, 16, 15","1, 1, 1","0, 0, 0",REVIEWED,"9 (7 - 2G, 2 - C-rich);

8 (7 - 2G, 1 - C-rich)

9 (8 - 2G, 1 - C-rich)","[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.891, -0.635 (C-rich)];

[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)];

[0.658, 0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)]",,"0;

","0;

","No PQS found in G4 hunter

",HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072
HOTAIR,prostate cancer,"qPCR, Western blot, Luciferase reporter assay",down-regulated,29807357.0,"Also Known As: HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072

Some (older-not checked for PQS) Long non-coding antisense RNA HOTAIR (HOTAIR gene) ""antisense RNA"" ncRNA (TPA: HG975398.1) was also there in result.",3,"NR_047517.1, NR_003716.3, NR_047518.1","18, 17, 16, ","17, 16, 15","1, 1, 1","0, 0, 0",REVIEWED,"9 (7 - 2G, 2 - C-rich);

8 (7 - 2G, 1 - C-rich)

9 (8 - 2G, 1 - C-rich)","[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.891, -0.635 (C-rich)];

[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)];

[0.658, 0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)]",,"0;

","0;

","No PQS found in G4 hunter

",HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072
HOTAIR,prostate cancer,"qPCR, Western blot, in vitro knockdown etc.",down-regulated,29221985.0,"Also Known As: HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072

Some (older-not checked for PQS) Long non-coding antisense RNA HOTAIR (HOTAIR gene) ""antisense RNA"" ncRNA (TPA: HG975398.1) was also there in result.",3,"NR_047517.1, NR_003716.3, NR_047518.1","18, 17, 16, ","17, 16, 15","1, 1, 1","0, 0, 0",REVIEWED,"9 (7 - 2G, 2 - C-rich);

8 (7 - 2G, 1 - C-rich)

9 (8 - 2G, 1 - C-rich)","[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.891, -0.635 (C-rich)];

[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)];

[0.658, 0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)]",,"0;

","0;

","No PQS found in G4 hunter

",HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072
HOTAIR,prostate cancer,"qPCR, RNAi, Western blot, Flow cytometry assay etc.",up-regulated,26962687.0,"Also Known As: HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072

Some (older-not checked for PQS) Long non-coding antisense RNA HOTAIR (HOTAIR gene) ""antisense RNA"" ncRNA (TPA: HG975398.1) was also there in result.",3,"NR_047517.1, NR_003716.3, NR_047518.1","18, 17, 16, ","17, 16, 15","1, 1, 1","0, 0, 0",REVIEWED,"9 (7 - 2G, 2 - C-rich);

8 (7 - 2G, 1 - C-rich)

9 (8 - 2G, 1 - C-rich)","[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.891, -0.635 (C-rich)];

[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)];

[0.658, 0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)]",,"0;

","0;

","No PQS found in G4 hunter

",HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072
HOTAIR,prostate cancer,"qPCR, Western blot, ChIP, Dot blot etc.",differential expression,27922078.0,"Also Known As: HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072

Some (older-not checked for PQS) Long non-coding antisense RNA HOTAIR (HOTAIR gene) ""antisense RNA"" ncRNA (TPA: HG975398.1) was also there in result.",3,"NR_047517.1, NR_003716.3, NR_047518.1","18, 17, 16, ","17, 16, 15","1, 1, 1","0, 0, 0",REVIEWED,"9 (7 - 2G, 2 - C-rich);

8 (7 - 2G, 1 - C-rich)

9 (8 - 2G, 1 - C-rich)","[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.891, -0.635 (C-rich)];

[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)];

[0.658, 0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)]",,"0;

","0;

","No PQS found in G4 hunter

",HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072
HOTAIR,prostate cancer,"qPCR, Western blot, ChIP, Luciferase reporter assay etc.",up-regulated,25895025.0,"Also Known As: HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072

Some (older-not checked for PQS) Long non-coding antisense RNA HOTAIR (HOTAIR gene) ""antisense RNA"" ncRNA (TPA: HG975398.1) was also there in result.",3,"NR_047517.1, NR_003716.3, NR_047518.1","18, 17, 16, ","17, 16, 15","1, 1, 1","0, 0, 0",REVIEWED,"9 (7 - 2G, 2 - C-rich);

8 (7 - 2G, 1 - C-rich)

9 (8 - 2G, 1 - C-rich)","[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.891, -0.635 (C-rich)];

[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)];

[0.658, 0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)]",,"0;

","0;

","No PQS found in G4 hunter

",HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072
HOTAIR,prostate cancer,"qPCR, RIP, ChIP, RNA pull-down assay etc.",up-regulated,26411689.0,"Also Known As: HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072

Some (older-not checked for PQS) Long non-coding antisense RNA HOTAIR (HOTAIR gene) ""antisense RNA"" ncRNA (TPA: HG975398.1) was also there in result.",3,"NR_047517.1, NR_003716.3, NR_047518.1","18, 17, 16, ","17, 16, 15","1, 1, 1","0, 0, 0",REVIEWED,"9 (7 - 2G, 2 - C-rich);

8 (7 - 2G, 1 - C-rich)

9 (8 - 2G, 1 - C-rich)","[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.891, -0.635 (C-rich)];

[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)];

[0.658, 0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)]",,"0;

","0;

","No PQS found in G4 hunter

",HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072
HOTAIR,prostate cancer,"Microarray, qPCR etc.",up-regulated,23936419.0,"Also Known As: HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072

Some (older-not checked for PQS) Long non-coding antisense RNA HOTAIR (HOTAIR gene) ""antisense RNA"" ncRNA (TPA: HG975398.1) was also there in result.",3,"NR_047517.1, NR_003716.3, NR_047518.1","18, 17, 16, ","17, 16, 15","1, 1, 1","0, 0, 0",REVIEWED,"9 (7 - 2G, 2 - C-rich);

8 (7 - 2G, 1 - C-rich)

9 (8 - 2G, 1 - C-rich)","[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.891, -0.635 (C-rich)];

[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)];

[0.658, 0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)]",,"0;

","0;

","No PQS found in G4 hunter

",HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072
HOTAIR,prostate cancer,"qPCR, Western blot etc.",differential expression,29807357.0,"Also Known As: HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072

Some (older-not checked for PQS) Long non-coding antisense RNA HOTAIR (HOTAIR gene) ""antisense RNA"" ncRNA (TPA: HG975398.1) was also there in result.",3,"NR_047517.1, NR_003716.3, NR_047518.1","18, 17, 16, ","17, 16, 15","1, 1, 1","0, 0, 0",REVIEWED,"9 (7 - 2G, 2 - C-rich);

8 (7 - 2G, 1 - C-rich)

9 (8 - 2G, 1 - C-rich)","[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.891, -0.635 (C-rich)];

[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)];

[0.658, 0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)]",,"0;

","0;

","No PQS found in G4 hunter

",HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072
HOTAIR,prostate cancer,"qPCR, RNA-seq, ChIP-Seq, etc.",up-regulated,29944905.0,"Also Known As: HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072

Some (older-not checked for PQS) Long non-coding antisense RNA HOTAIR (HOTAIR gene) ""antisense RNA"" ncRNA (TPA: HG975398.1) was also there in result.",3,"NR_047517.1, NR_003716.3, NR_047518.1","18, 17, 16, ","17, 16, 15","1, 1, 1","0, 0, 0",REVIEWED,"9 (7 - 2G, 2 - C-rich);

8 (7 - 2G, 1 - C-rich)

9 (8 - 2G, 1 - C-rich)","[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.891, -0.635 (C-rich)];

[0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)];

[0.658, 0.871, 0.857, 0.889, 0.911, 0.851, 0.935, 0.939 (2G), -0.635 (C-rich)]",,"0;

","0;

","No PQS found in G4 hunter

",HOXAS; HOXC-AS4; HOXC11-AS1; NCRNA00072
HOTTIP,prostate cancer,"qPCR, Western blot, Luciferase reporter assay, in vitro knockdown",up-regulated,29884766.0,"Also Known As: HOXA-AS6; HOXA13-AS1; NCRNA00213

Some (older-not checked for PQS) HoxA transcript at the distal tip RNA antisense RNA (HOTTIP) ""antisense RNA"" ncRNA (complete sequence - GU724873.1) was also there in result.",1,NR_037843.3,40,37,3,0,REVIEWED,"16 (2 - 3G, 14 - C-rich)
","[0.837, 0.935 (3G), -0.776, -0.91, -0.689, -0.796, -0.911, -0.771, -0.946, -0.911, -0.821, -0.831, -0.891, -0.889, -0.778, -0.891 (C-rich)]","PQS 1 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 1 (3G) from G4 hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper.

PQS 1 (3G) of QGRS mapper and the PQS 2 (3G) of G4 hunter have similar G tracts.

PQS 2 (3G) from G4 hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper.

By looking at PQS 1 and 2 (3G) in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. ",3 (C-rich);,"[-1.34, -1.276, -1.23 (C-rich)]
",No similarity to any PQS from QGRS mapper,HOXA-AS6; HOXA13-AS1; NCRNA00213
HOTTIP,prostate cancer,"qPCR, Western blot",up-regulated,30809864.0,"Also Known As: HOXA-AS6; HOXA13-AS1; NCRNA00213

Some (older-not checked for PQS) HoxA transcript at the distal tip RNA antisense RNA (HOTTIP) ""antisense RNA"" ncRNA (complete sequence - GU724873.1) was also there in result.",1,NR_037843.3,40,37,3,0,REVIEWED,"16 (2 - 3G, 14 - C-rich)
","[0.837, 0.935 (3G), -0.776, -0.91, -0.689, -0.796, -0.911, -0.771, -0.946, -0.911, -0.821, -0.831, -0.891, -0.889, -0.778, -0.891 (C-rich)]","PQS 1 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 1 (3G) from G4 hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper.

PQS 1 (3G) of QGRS mapper and the PQS 2 (3G) of G4 hunter have similar G tracts.

PQS 2 (3G) from G4 hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper.

By looking at PQS 1 and 2 (3G) in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. ",3 (C-rich);,"[-1.34, -1.276, -1.23 (C-rich)]
",No similarity to any PQS from QGRS mapper,HOXA-AS6; HOXA13-AS1; NCRNA00213
HOTTIP,prostate cancer,qRT-PCR etc.,up-regulated,31570281.0,"Also Known As: HOXA-AS6; HOXA13-AS1; NCRNA00213

Some (older-not checked for PQS) HoxA transcript at the distal tip RNA antisense RNA (HOTTIP) ""antisense RNA"" ncRNA (complete sequence - GU724873.1) was also there in result.",1,NR_037843.3,40,37,3,0,REVIEWED,"16 (2 - 3G, 14 - C-rich)
","[0.837, 0.935 (3G), -0.776, -0.91, -0.689, -0.796, -0.911, -0.771, -0.946, -0.911, -0.821, -0.831, -0.891, -0.889, -0.778, -0.891 (C-rich)]","PQS 1 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 1 (3G) from G4 hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper.

PQS 1 (3G) of QGRS mapper and the PQS 2 (3G) of G4 hunter have similar G tracts.

PQS 2 (3G) from G4 hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper.

By looking at PQS 1 and 2 (3G) in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. ",3 (C-rich);,"[-1.34, -1.276, -1.23 (C-rich)]
",No similarity to any PQS from QGRS mapper,HOXA-AS6; HOXA13-AS1; NCRNA00213
HOTTIP,prostate cancer,"RNA-seq, Microarray, qPCR, RNAi, Northern blot etc.",down-regulated,23728290.0,"Also Known As: HOXA-AS6; HOXA13-AS1; NCRNA00213

Some (older-not checked for PQS) HoxA transcript at the distal tip RNA antisense RNA (HOTTIP) ""antisense RNA"" ncRNA (complete sequence - GU724873.1) was also there in result.",1,NR_037843.3,40,37,3,0,REVIEWED,"16 (2 - 3G, 14 - C-rich)
","[0.837, 0.935 (3G), -0.776, -0.91, -0.689, -0.796, -0.911, -0.771, -0.946, -0.911, -0.821, -0.831, -0.891, -0.889, -0.778, -0.891 (C-rich)]","PQS 1 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 1 (3G) from G4 hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper.

PQS 1 (3G) of QGRS mapper and the PQS 2 (3G) of G4 hunter have similar G tracts.

PQS 2 (3G) from G4 hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper.

By looking at PQS 1 and 2 (3G) in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. ",3 (C-rich);,"[-1.34, -1.276, -1.23 (C-rich)]
",No similarity to any PQS from QGRS mapper,HOXA-AS6; HOXA13-AS1; NCRNA00213
HOTTIP,prostate cancer,"qPCR, Luciferase reporter assay, Western blot, etc.",up-regulated,29884766.0,"Also Known As: HOXA-AS6; HOXA13-AS1; NCRNA00213

Some (older-not checked for PQS) HoxA transcript at the distal tip RNA antisense RNA (HOTTIP) ""antisense RNA"" ncRNA (complete sequence - GU724873.1) was also there in result.",1,NR_037843.3,40,37,3,0,REVIEWED,"16 (2 - 3G, 14 - C-rich)
","[0.837, 0.935 (3G), -0.776, -0.91, -0.689, -0.796, -0.911, -0.771, -0.946, -0.911, -0.821, -0.831, -0.891, -0.889, -0.778, -0.891 (C-rich)]","PQS 1 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 1 (3G) from G4 hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper.

PQS 1 (3G) of QGRS mapper and the PQS 2 (3G) of G4 hunter have similar G tracts.

PQS 2 (3G) from G4 hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper.

By looking at PQS 1 and 2 (3G) in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. ",3 (C-rich);,"[-1.34, -1.276, -1.23 (C-rich)]
",No similarity to any PQS from QGRS mapper,HOXA-AS6; HOXA13-AS1; NCRNA00213
HOXA11-AS,prostate cancer,"qPCR, Western blot",up-regulated,31971633.0,Also Known As: HOXA11S; HOXA-AS5; HOXA11AS; HOXA11-AS1; NCRNA00076,1,NR_002795.2,18,16,2,0,REVIEWED,"12 (3 - 2G, 4 - 3G, 5 - C-rich)","[0.857, 0.737, 0.911 (2G), 0.833, 0.918, 0.87, 1.064 (3G) -0.642, -0.638, -0.911, -0.957, -0.831 (C-rich)] ","PQS 2 (3G) of QGRS mapper and the PQS 3 (3G) of G4 hunter have similar G tracts.

PQS 17 (3G) of QGRS mapper and the PQS 10 (3G) of G4 hunter have similar G tracts.

PQS 10 (3G) from G4 hunter has a left frame-shift as compared to PQS 17 (3G) from QGRS mapper.

PQS 17 (3G) of QGRS mapper and the PQS 11 (3G) of G4 hunter have similar G tracts.

PQS 11 (3G) from G4 hunter has a left frame-shift as compared to PQS 17 (3G) from QGRS mapper.

PQS 17 (3G) of QGRS mapper and the PQS 12 (3G) of G4 hunter have similar G tracts.

By looking at PQS 10, 11 and 12 (3G) in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. ",0,0,Not PQS found in G4 hunter,HOXA11S; HOXA-AS5; HOXA11AS; HOXA11-AS1; NCRNA00076
HOXD-AS1,prostate cancer,"Microarray Analysis, western blot, RNAi, GhIP etc.",up-regulated,28487115.0,Also Known As: HAGLR; HOXD-AS1; MIR7704HG,12,"NR_110458.1, NR_110459.1, NR_110460.1, NR_110461.1, NR_110462.1, NR_110463.1, NR_110464.1, NR_110465.1, NR_110466.1, NR_033979.2, NR_110467.1, NR_110468.1","27, 25, 25, 23, 27, 25, 25, 23, 23, 22, 24, 24","25, 23, 23, 22, 25, 24, 24, 21, 21, 20, 23, 23","2, 2, 2, 1, 2, 1, 1, 2, 2, 2, 1, 1

PQS 1 of 1st and 5th variants is same.
PQS 1 of 2nd variant is same to the PQS 1 of 3rd, 8th and 9th variants.
PQS 1 of 10th variant is different from all other variants. 
PQS 2 of 1st variant is same to the PQS 1 of 4th, 6th, 7th, 11th and 12th variants; and same to the PQS 2 of 2nd, 3rd, 5th, 8th, 9th and 10th variants.","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0",VALIDATED,"18 (5 - 2G, 2 - 3G, 11 - C-rich);

22 (5 - 2G, 3 - 3G, 14 - C-rich);

21 (4 - 2G, 3 - 3G, 14 - C-rich);

15 (4 - 2G, 11 - C-rich);

18 (5 - 2G, 2 - 3G, 11 - C-rich);

15 (4 - 2G, 11 - C-rich);

15 (4 - 2G, 11 - C-rich);

21 (4 - 2G, 3 - 3G, 14 - C-rich);

20 (2 - 2G, 2 - 3G, 14 - C-rich);

15 (4 - 2G, 11 - C-rich);

15 (4 - 2G, 11 - C-rich);

15 (4 - 2G, 11 - C-rich)","[0.983, 1 (3G), 0.808, 0.891, 1.118, 0.911, 0.833 (2G), -0.636, -0.849, -0.947, -0.911, -0.957, -0.849, -1, -0.864, -0.667, -0.984, -0.911 (C-rich)];

[0.721, 1, 0.891 (3G), 0.763, 0.891, 1.118, 0.911, 0.833 (2G), -0.796, -0.86, -0.891,  -0.636, -0.849, -0.947, -0.911, -0.957, -0.849, -1, -0.864, -0.667, -0.984, -0.911 (C-rich)];

[0.721, 1, 0.891 (3G),  0.891, 1.118, 0.911, 0.833 (2G), -0.796, -0.86, -0.891, -0.636, -0.849, -0.947, -0.911, -0.957, -0.849, -1, -0.864, -0.667, -0.984, -0.911 (C-rich)];

[0.891, 1.118, 0.911, 0.833 (2G), -0.636, -0.849, -0.947, -0.911, -0.957, -0.849, -1, -0.864, -0.667, -0.984, -0.911 (C-rich)];

[0.983, 1 (3G), 0.808, 0.891, 1.118, 0.911, 0.833 (2G), -0.636, -0.849, -0.947, -0.911, -0.957, -0.849, -1, -0.864, -0.667, -0.984, -0.911 (C-rich)];

[0.891, 1.118, 0.911, 0.833 (2G), -0.636, -0.849, -0.947, -0.911, -0.957, -0.849, -1, -0.864,  -0.667, -0.984, -0.911 (C-rich)];

[0.891, 1.118, 0.911, 0.833 (2G), -0.636, -0.849, -0.947, -0.911, -0.957, -0.849, -1, -0.864, -0.667, -0.984, -0.911 (C-rich)];

[0.721, 1, 0.891 (3G),  0.891, 1.118, 0.911, 0.833 (2G), -0.796, -0.86, -0.891, -0.636, -0.849, -0.947, -0.911, -0.957, -0.849, -1, -0.864, -0.667, -0.984, -0.911 (C-rich)];

[0.721, 1 (3G), 0.891, 1.118, 0.911, 0.833 (2G), -0.796, -0.86, -0.891, -0.636, -0.849, -0.947, -0.911, -0.957, -0.849, -1, -0.864, -0.667, -0.984, -0.911 (C-rich)];

[0.891, 1.118, 0.911, 0.833 (2G), -0.636, -0.849, -0.947, -0.911, -0.957, -0.849, -1, -0.864, -0.667, -0.984, -0.911 (C-rich)];

[0.891, 1.118, 0.911, 0.833 (2G), -0.636, -0.849, -0.947, -0.911, -0.957, -0.849, -1, -0.864, -0.667, -0.984, -0.911 (C-rich)];

[0.891, 1.118, 0.911, 0.833 (2G), -0.636, -0.849, -0.947, -0.911, -0.957, -0.849, -1, -0.864, -0.667, -0.984, -0.911 (C-rich)]","In variants 1 and 5, PQS 4 (3G) of QGRS mapper is similar to / a part of PQS 2 (3G) of G4 hunter 

In variant 2, PQS 1 (3G) of QGRS mapper is similar to / a part of PQS 4 (3G) of G4 hunter 

PQS 4 (3G) from G4 hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper.

PQS 1 (3G) of QGRS mapper is similar to / a part of PQS 5 (3G) of G4 hunter 

PQS 1 (3G) of QGRS mapper is similar to / a part of PQS 6 (3G) of G4 hunter 

By looking at PQS 4, 5 and 6 (3G) in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. 

In variants 3 and 8, PQS 1 (3G) of QGRS mapper is similar to / a part of PQS 4 (3G) of G4 hunter 

PQS 1 (3G) of QGRS mapper is similar to / a part of PQS 5 (3G) of G4 hunter 

PQS 1 (3G) of QGRS mapper is similar to / a part of PQS 6 (3G) of G4 hunter 

By looking at PQS 4, 5 and 6 (3G) in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. 

In variant 9, PQS 1 (3G) of QGRS mapper is similar to / a part of PQS 4 (3G) of G4 hunter 

PQS 4 (3G) from G4 hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper.

PQS 1 (3G) of QGRS mapper is similar to / a part of PQS 5 (3G) of G4 hunter ","3 (C-rich);

3 (C-rich);

3 (C-rich);

3 (C-rich);

3 (C-rich);

3 (C-rich);

3 (C-rich);

3 (C-rich);

3 (C-rich);

3 (C-rich);

3 (C-rich);

3 (C-rich)","[-1.4, -1.4, -1.258 (C-rich)]; 

[-1.4, -1.4, -1.258 (C-rich)]; 

[-1.4, -1.4, -1.258 (C-rich)]; 

[-1.4, -1.4, -1.258 (C-rich)]; 

[-1.4, -1.4, -1.258 (C-rich)]; 

[-1.4, -1.4, -1.258 (C-rich)]; 

[-1.4, -1.4, -1.258 (C-rich)]; 

[-1.4, -1.4, -1.258 (C-rich)]; 

[-1.4, -1.4, -1.258 (C-rich)]; 

[-1.4, -1.4, -1.258 (C-rich)]; 

[-1.4, -1.4, -1.258 (C-rich)]; 

[-1.4, -1.4, -1.258 (C-rich)]",No similarity to any PQS (2G) from QGRS mapper.,Mdgt; HOXD-AS1; MIR7704HG
HULC,prostate cancer,"qPCR, Western blot, RNAi",down-regulated,29694502.0,"Also Known As: HCCAT1; LINC00078; NCRNA00078

Some (older-not checked for PQS) Long non-coding RNA HULC (HULC gene) ""lncRNA"" ncRNA (TPA: HG975403.1) was also there in result.",1,NR_004855.2,1,1,0,0,REVIEWED,0,0,No PQS found in G4 hunter,0,0,No PQS found in G4 hunter,HCCAT1; LINC00078; NCRNA00078
HULC,prostate cancer,"qPCR, Western blot, Luciferase reporter assay etc.",up-regulated,29765457.0,"Also Known As: HCCAT1; LINC00078; NCRNA00078

Some (older-not checked for PQS) Long non-coding RNA HULC (HULC gene) ""lncRNA"" ncRNA (TPA: HG975403.1) was also there in result.",1,NR_004855.2,1,1,0,0,REVIEWED,0,0,No PQS found in G4 hunter,0,0,No PQS found in G4 hunter,HCCAT1; LINC00078; NCRNA00078
HULC,prostate cancer,"RNA-seq, Microarray, qPCR, RNAi, Northern blot etc.",up-regulated,23728290.0,"Also Known As: HCCAT1; LINC00078; NCRNA00078

Some (older-not checked for PQS) Long non-coding RNA HULC (HULC gene) ""lncRNA"" ncRNA (TPA: HG975403.1) was also there in result.",1,NR_004855.2,1,1,0,0,REVIEWED,0,0,No PQS found in G4 hunter,0,0,No PQS found in G4 hunter,HCCAT1; LINC00078; NCRNA00078
IDH1-AS1,prostate cancer,"qRT-PCR , Luciferase reporter assay , Western blot , RIP , in vitro knockdown etc.",up-regulated,31570703.0,,1,NR_046452.1,4,4,0,0,VALIDATED,1 (2G),[0.911 (2G)],No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,IDH1 antisense RNA 1;IDH1 antisense RNA 1 (non-protein coding);HSALNG0021909;IDH1-AS1;NONHSAG030384.2
IGF2AS,prostate cancer,"qPCR, other",down-regulated,30423304.0,Also known as: PEG8; IGF2AS; IGF2-AS1,3,"___, NR_028043.2, NR_133657.1","___, 27, 27","___, 24, 25","___, 3, 2","___, 0, 0",REVIEWED,"25 (9 - 2G, 5 - 3G, 11 - C-rich);

24 (9 - 2G, 5 - 3G, 10 - C-rich)","[0.842, 0.81, 1.109, 0.883, 0.741 (3G), 0.942, 0.911, 0.911, 0.913, 0.935, 0.957, 0.935, 0.936, 0.808 (2G), -1.041, -0.933, -0.897, -0.961, -0.854, -0.957, -0.933, -0.991, -0.933, -0.872, -0.742 (C-rich)];

[0.842, 0.81, 1.109, 0.883, 0.935 (3G), 0.942, 0.911, 0.911, 0.913, 0.957, 0.935, 0.936, 0.808, 0.741 (2G), -1.041, -0.933, -0.897, -0.854, -0.957, -0.933, -0.991, -0.933, -0.872, -0.742 (C-rich)]","In variant 2, PQS 14 (3G) of QGRS mapper is similar to / a part of PQS 12 (3G) of G4 hunter 

PQS 19 (3G) of QGRS mapper is similar to / a part of PQS 19 (3G) of G4 hunter 

In variant 3, PQS 14 (3G) of QGRS mapper is similar to / a part of PQS 11 (3G) of G4 hunter 

PQS 19 (3G) of QGRS mapper is similar to / a part of PQS 18 (3G) of G4 hunter 

PQS 24 (3G) of QGRS mapper is similar to / a part of PQS 21 (3G) of G4 hunter ","8 (3 - 3G, 5 - C-rich);

8 (3 - 3G, 5 - C-rich)","(-1.244, 1.4, 1.391, 1.36, -1.319, -1.413, -1.4, -1.286)

(-1.244, 1.4, 1.391, 1.36, -1.319, -1.413, -1.4, -1.286)","In variants 2 and 3, PQS 14 (3G) of QGRS mapper and the PQS 2 (3G) of G4 hunter have similar G tracts.

PQS 14 (3G) of QGRS mapper and the PQS 3 (3G) of G4 hunter have similar G tracts.

PQS 14 (3G) of QGRS mapper and the PQS 4 (3G) of G4 hunter have similar G tracts.

By looking at PQS 2, 3 and 4 (3G) in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. ",PEG8; IGF2AS; IGF2-AS1
"ILF3-AS1 
ILF3-DT",prostate cancer,RNA-seq,differential expression,30906477.0,Also Known As: ILF3-DT; ILF3-AS1,1 (ILF3-DT),ILF3-DT (NR_024333.1),19 (ILF3-DT),19 (ILF3-DT),0 (ILF3-DT),0 (ILF3-DT),VALIDATED (ILF3-DT),3 (C-rich),"[-0.857, -0.979, -0.911 (C-rich)]",No similarity to any PQS (2G) from QGRS mapper.,0,0,No PQS found in G4 Hunter,ILF3-AS1
INXS,prostate cancer,"qPCR, RACE-PCR etc.",down-regulated,24992962.0,Also known as: ABALON; Results include sequence for ABALON lncRNA ,1,KC505631.1 ,18,16,2,0,VALIDATED,"12 (4 - 2G, 12 - C-rich)","[0.911,  0.961, 1 (2G); -0.891, -0.81, -0.957, -0.933, -0.941, -0.911, -0.911, -0.829,  -0.911 (C-rich)]",No similarity to any PQS (2G) from QGRS mapper,2 (C-rich),"[-1.236, -1.4 (C-rich)]",No similarity to PQS (3G) from QGRS mapper,apoptotic BCL2L1-antisense long non-coding RNA;INXS;apoptotic BCL-X-associated long ncRNA;intronic BCL-XS-inducing lncRNA;HSALNG0129511
KCNQ1OT1,prostate cancer,"RNA-seq, Microarray, qPCR, RNAi, Northern blot etc.",up-regulated,23728290.0,"Also Known As: LIT1; Kncq1; KvDMR1; KCNQ10T1; KCNQ1-AS2; KvLQT1-AS; NCRNA00012

Some (older-not checked for PQS) Long non-coding sense-intronic RNA Kcnq1ot1 (Kncq1 gene) ""lncRNA"" ncRNA (TPA: HG975405.1) was also there in result.",1,NR_002728.3,581,538,41,2,REVIEWED,"185 (59 - 2G, 32 - 3G, 3 - 4G, 91 - C-rich)","[0.914, 0.978, 1.23 (4G) 0.938, 0.942, 1.021, 0.911, 0.94, 1.008,  0.941, 0.627, 0.911, 0.765, 0.904, 0.691, 1.043, 0.886, 1.086, 0.911, 0.821, 0.957, 0.9, 0.852, 0.85, 0.73, 0.944, 0.754, 0.891, 0.857, 0.979, 0.958, 0.936, 1.021, 0.867, 1.071 (3G), 0.872, 0.911, 0.891, 0.852, 0.879, 1.019, 0.911, 0.933, 0.891, 0.933, 0.804, 0.911, 0.9, 0.891, 0.933, 0.911, 0.911, 0.918, 0.979, 1, 0.811, 0.852, 0.875, 0.911, 0.891, 0.827, 0.978, 0.915, 0.808, 0.863, 0.745, 0.902, 1.021, 0.825,  0.894, 0.891, 0.878, 0.902, 0.911, 0.741, 0.965, 0.86, 0.935, 0.84, 0.638, 0.872, 0.875, 0.911, 0.891, 0.791, 0.811, 0.872, 0.933, 0.721, 0.854, 0.891, 0.957, 0.9, 0.828 (2G), -0.891, -0.875, -0.911, -0.933, -0.788, -0.882, -0.911, -0.824, -0.906, -1.086, -0.915, -0.87, -0.894, -0.861, -0.957, -0.718, -0.75, -0.826, -0.911, -0.911, -0.911, -0.733, -0.851, -0.773, -0.757, -1.021, -0.965, -0.911, -1.043, -0.894, -0.766, -0.87, -0.891, -0.942, -0.945, -0.891, -0.916, -0.872, -0.891, -1, -0.911,  -0.719, -0.882, -0.891, -0.917, -0.911, -1.022, -0.911, -0.911, -0.894, -0.698, -0.894, -1, -0.935, -0.943, -0.857,  -0.707, -0.911, -0.942, -0.827, -0.981, -0.959, -0.911, -0.933, -0.943, -0.8, -0.911, -0.911, -0.872, -0.93, -0.978, -0.956, -0.896, -0.933, -0.843, -0.915, -0.891, -0.911, -0.855, -0.671, -0.891, -0.677, -0.911, -0.956, -0.944, -1, -0.911, -0.957, -0.86, -0.872, -0.872 (C-rich)]","PQS 22 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 24 (3G) of QGRS mapper and the PQS 2 (3G) of G4 hunter have similar G tracts.

PQS 24 (3G) of QGRS mapper and the PQS 4 (3G) of G4 hunter have similar G tracts.

PQS 57 (3G) of QGRS mapper and the PQS 13 (3G) of G4 hunter have similar G tracts.

PQS 72 (3G) of QGRS mapper and the PQS 18 (3G) of G4 hunter have similar G tracts.

PQS 81 (3G) of QGRS mapper and the PQS 24 (3G) of G4 hunter have similar G tracts.

PQS 24 (3G) from G4 hunter has a left frame-shift as compared to PQS 81 (3G) from QGRS mapper.

PQS 103 (3G) of QGRS mapper and the PQS 31 (3G) of G4 hunter have similar G tracts.

PQS 116 (3G) of QGRS mapper and the PQS 41 (3G) of G4 hunter have similar G tracts.

PQS 41 (3G) from G4 hunter has a left frame-shift as compared to PQS 116 (3G) from QGRS mapper.

PQS 132 (3G) of QGRS mapper and the PQS 46 (3G) of G4 hunter have similar G tracts.

PQS 143 (3G) of QGRS mapper and the PQS 48 (3G) of G4 hunter have similar G tracts.

PQS 48 (3G) from G4 hunter has a left frame-shift as compared to PQS 143 (3G) from QGRS mapper.

PQS 187 (3G) of QGRS mapper and the PQS 65 (3G) of G4 hunter have similar G tracts.

PQS 65 (3G) from G4 hunter has a left frame-shift as compared to PQS 187 (3G) from QGRS mapper.

PQS 215 (3G) of QGRS mapper and the PQS 69 (3G) of G4 hunter have similar G tracts.

PQS 219 (3G) of QGRS mapper and the PQS 70 (3G) of G4 hunter have similar G tracts.

PQS 262 (3G) of QGRS mapper and the PQS 89 (3G) of G4 hunter have similar G tracts.

PQS 297 (3G) of QGRS mapper and the PQS 105 (3G) of G4 hunter have similar G tracts.

PQS 299 (3G) of QGRS mapper and the PQS 108 (3G) of G4 hunter have similar G tracts.

PQS 310 (3G) of QGRS mapper and the PQS 115 (3G) of G4 hunter have similar G tracts.

PQS 317 (3G) of QGRS mapper and the PQS 117 (3G) of G4 hunter have similar G tracts.

PQS 345 (4G) of QGRS mapper and the PQS 128 (4G) of G4 hunter have similar G tracts.

PQS 351 (3G) of QGRS mapper and the PQS 133 (3G) of G4 hunter have similar G tracts.

PQS 362 (3G) of QGRS mapper and the PQS 135 (3G) of G4 hunter have similar G tracts.

PQS 381 (3G) of QGRS mapper and the PQS 139 (3G) of G4 hunter have similar G tracts.

PQS 397 (3G) of QGRS mapper and the PQS 147 (3G) of G4 hunter have similar G tracts.

PQS 398 (3G) of QGRS mapper and the PQS 148 (3G) of G4 hunter have similar G tracts.

PQS 148 (3G) from G4 hunter has a left frame-shift as compared to PQS 398 (3G) from QGRS mapper.

PQS 400 (3G) of QGRS mapper and the PQS 150 (3G) of G4 hunter have similar G tracts.

PQS 150 (3G) from G4 hunter has a left frame-shift as compared to PQS 400 (3G) from QGRS mapper.

PQS 400 (3G) of QGRS mapper and the PQS 151 (3G) of G4 hunter have similar G tracts.

PQS 480 (3G) of QGRS mapper and the PQS 171 (3G) of G4 hunter have similar G tracts.

PQS 577 (3G) of QGRS mapper and the PQS 185 (3G) of G4 hunter have similar G tracts.

PQS 185 (3G) from G4 hunter has a left frame-shift as compared to PQS 577 (3G) from QGRS mapper.

By looking at PQS 69 and 70 (3G) in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. ",24 (  12 - C-rich)  ,"[-1.333, -1.396,, -1.053, -1.195, -1.354, -1.511, -1.4,
 -1.422, -1.286, -1.293, -1.17, -1.4 (C-rich), 1.404, 1.178, 1.333, 1.381, 1.114, 1.37, 1.314, 1.396 (3G), 1.042, 1.372 (4G), 1.4, 1.4 (2G)]","PQS 128 (3G) of QGRS mapper and the PQS 3 (3G) of G4 hunter have similar G tracts.

PQS 3 (3G) from G4 hunter has a left frame-shift as compared to PQS 128 (3G) from QGRS mapper.

PQS 187 (3G) of QGRS mapper and the PQS 4 (3G) of G4 hunter have similar G tracts.

PQS 194 (3G) of QGRS mapper and the PQS 5 (3G) of G4 hunter have similar G tracts.

PQS 345 (3G) of QGRS mapper and the PQS 14 (3G) of G4 hunter have similar G tracts.

PQS 14 (3G) from G4 hunter has a left frame-shift as compared to PQS 345 (3G) from QGRS mapper.

PQS 381 (3G) of QGRS mapper and the PQS 15 (3G) of G4 hunter have similar G tracts.

PQS 15 (3G) from G4 hunter has a left frame-shift as compared to PQS 381 (3G) from QGRS mapper.

PQS 398 (3G) of QGRS mapper and the PQS 19 (3G) of G4 hunter have similar G tracts.

PQS 19 (3G) from G4 hunter has a left frame-shift as compared to PQS 398 (3G) from QGRS mapper.

PQS 398 (3G) of QGRS mapper and the PQS 20 (3G) of G4 hunter have similar G tracts.

PQS 480 (3G) of QGRS mapper and the PQS 21 (3G) of G4 hunter have similar G tracts.

PQS 577 (3G) of QGRS mapper and the PQS 22 (3G) of G4 hunter have similar G tracts.

By looking at PQS 19 and 20 (3G) in G4 hunter, it appears that at a time only 1 GQ can be formed as all PQS have a few common G-tracts due to overlap amongst all of these PQS. ",LIT1; Kncq1; KvDMR1; KCNQ10T1; KCNQ1-AS2; KvLQT1-AS; NCRNA00012
LBCS,prostate cancer,"qPCR, Western blot, RIP",down-regulated,31221168.0,Also Known As: LNC-LBCS,3,"NR_134649.1, NR_134650.1, NR_134651.1","4,4,3","4,4,3","0,0,0","0,0,0",VALIDATED,"2 (C-rich);
2 (C-rich);
0","[-0.843, -1.083 (C-rich)];
[-0.843, -1.083 (C-rich)];
0",No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,LBCS
LINC-PINT,prostate cancer,"Microarray, qPCR etc.",up-regulated,27556357.0,"Also Known As: PINT; MKLN1-AS1; LincRNA-Pint

Some (older-not checked for PQS) Linc-pint lncRNA ""lncRNA"" ncRNA (partial sequence - MG322760.1) was also there in result.",13,"NR_015431.2, NR_024153.2, NR_109850.1, NR_109851.1, NR_109852.1, NR_109853.1, NR_109854.1, NR_109855.1, NR_034120.1, NR_110472.1, NR_110473.1, NR_170175.1, NR_170176.1","19, 8, 21, 19, 19, 15, 15, 15, 9, 8, 3, 23, 21","16, 7, 18, 16, 16, 13, 13, 13, 9, 8, 3, 21, 19","3, 1, 3, 3, 3, 2, 2, 2, 0, 0, 0, 2, 2

PQS of 2nd variant is different from other variants.","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0",VALIDATED,"4 (2 - 2G, 2 - 3G);

1 (3G);

4 (2 - 2G, 2 - 3G);

4 (2 - 2G, 2 - 3G);

4 (2 - 2G, 2 - 3G);

4 (2 - 2G, 2 - 3G);

4 (2 - 2G, 2 - 3G);

4 (2 - 2G, 2 - 3G);

0;

0;

0;

4 (2 - 2G, 2 - 3G);

4 (2 - 2G, 2 - 3G)","[0.933, 0.935 (2G), 1.018, 0.794 (3G)];

[0.885 {3G)];

[0.933, 0.935 (2G), 1.018, 0.794 (3G)];

[0.933, 0.935 (2G), 1.018, 0.794 (3G)];

[0.933, 0.935 (2G), 1.018, 0.794 (3G)];

[0.933, 0.935 (2G), 1.018, 0.794 (3G)];

[0.933, 0.935 (2G), 1.018, 0.794 (3G)];

[0.933, 0.935 (2G), 1.018, 0.794 (3G)];

0;

0;

0;

[0.933, 0.935 (2G), 1.018, 0.794 (3G)];

[0.933, 0.935 (2G), 1.018, 0.794 (3G)]","In variant 1, 3, 4, 5, 6, 7, 8, 12 and 13, PQS 2 (3G) of QGRS mapper and the PQS 3 (3G) of G4 hunter have similar G tracts.

PQS 3 (3G) from G4 hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

In variant 1, 3, 4, 5, 6, 7, 8, 12 and 13 PQS 10 (3G) of QGRS mapper and the PQS 4 (3G) of G4 hunter have similar G tracts.

PQS 4 (3G) from G4 hunter has a left frame-shift as compared to PQS 10 (3G) from QGRS mapper.

In variant 2, PQS 3 (3G) of QGRS mapper and the PQS 1 (3G) of G4 hunter have similar G tracts.

PQS 1 (3G) from G4 hunter has a left frame-shift as compared to PQS 3 (3G) from QGRS mapper.","0;

0;

0;

0;

0;

0;

0;

0;

0;

0;

0;

0;

0","0

0

0

0

0

0

0

0

0

0

0

0

0",No PQS found in G4 hunter,PINT; MKLN1-AS1; LincRNA-Pint
LINC-ROR,prostate cancer,"qPCR, Microarray etc.",down-regulated,28843521.0,"Also Known As: ROR; lincRNA-RoR; lincRNA-ST8SIA3

Some (older) transcribed RNA, LINC-ROR variants (2-14; variant 1 not available in NCBI-NT) ""other"" ncRNA (complete sequence - _____, AB844430.1, AB844431.1, AB844432.1, AB844433.1, AB908956.1, AB932951.1, LC027885.1, LC027886.1, LC027887.1, LC027888.1, LC027889.1, LC027890.1 and LC027884.1 respectively) with PQS-___, 3, 1, 0, 0, 4, 1, 4, 13, 7, 8, 7, 2, 2 respectively were also there in result.

Sequence not available for 1st variant (older).",2,"NR_048536.2, NR_152602.1","15, 13","15, 13","0, 0","0, 0",REVIEWED,"3 (C-rich);

3 (C-rich)","[-0.933, -0.891, -0.911 (C-rich)];

[-0.933, -0.891, -0.911 (C-rich)]","No similarity to any PQS from QGRS mapper
",0,0,No PQS found in G4 hunter,ROR; lincRNA-RoR; lincRNA-ST8SIA3
LINC-ROR,prostate cancer,"qPCR, Western blot",up-regulated,30915739.0,"Also Known As: ROR; lincRNA-RoR; lincRNA-ST8SIA3

Some (older) transcribed RNA, LINC-ROR variants (2-14; variant 1 not available in NCBI-NT) ""other"" ncRNA (complete sequence - _____, AB844430.1, AB844431.1, AB844432.1, AB844433.1, AB908956.1, AB932951.1, LC027885.1, LC027886.1, LC027887.1, LC027888.1, LC027889.1, LC027890.1 and LC027884.1 respectively) with PQS-___, 3, 1, 0, 0, 4, 1, 4, 13, 7, 8, 7, 2, 2 respectively were also there in result.

Sequence not available for 1st variant (older).",2,"NR_048536.2, NR_152602.1","15, 13","15, 13","0, 0","0, 0",REVIEWED,"3 (C-rich);

3 (C-rich)","[-0.933, -0.891, -0.911 (C-rich)];

[-0.933, -0.891, -0.911 (C-rich)]","No similarity to any PQS from QGRS mapper
",0,0,No PQS found in G4 hunter,ROR; lincRNA-RoR; lincRNA-ST8SIA3
LINC00304,prostate cancer,"qRT-PCR , RNAi etc.",up-regulated,31012142.0,"Also Known As: C16orf81, NCRNA00304",1,NR_024347.2,26,25,1,0,VALIDATED,"13 (7-2G, 6- C-rich)","[0.803, 0.978, 0.913, 0.76, 0.939, 0.922, 0.911 (2G);
-0.891, -0.911, -0.978, -1.309, -0.911,  -0.85 (C-rich)]",No similarity to any PQS (2G) from QGRS mapper,1 (C-rich),[-1.447 (C-rich)],No similarity to PQS (3G) from QGRS mapper,C16orf81; NCRNA00304
LINC00308,prostate cancer,qPCR,up-regulated,29923546.0,Also known asPRED16; C21orf74; NCRNA00308,1,NR_038400.1,3,3,0,0,VALIDATED,0,0,No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,PRED16; C21orf74; NCRNA00308
LINC00355,prostate cancer,qPCR,up-regulated,29923546.0,,1,NR_145420.1,14,14,0,0,VALIDATED,1 (C-rich),[-0.933 (C-rich),,0,0,No PQS found in G4 hunter,long intergenic non-protein coding RNA 355;HSALNG0097622;NONHSAG013685.2;HSALNG0097626;NONHSAG013688.2;LINC00355;HSALNG0097627;NONHSAG013687.2
LINC00476,prostate cancer,RNA-seq,differential expression,30906477.0,"Also Known As: C9orf130, NAG11, NAG12",2,"NR_023390.1, NR_023389.1","46, 14","43, 14","3, 0","0, 0",VALIDATED,"11 (5-2G, 6-C-rich);
8 (5-2G, 3-C-rich)","[0.89, 0.942, 0.915, 0.896, 0.855 (2G); -1, -0.725, -0.918, -0.981, -0.939, -0.921] (C-rich);
[0.913,  0.933, 0.911, 0.911, 0.98 (2G); -0.961, -0.956, -0.911 (C-rich)]",No similarity to any PQS (2G) from QGRS mapper,2 (C-rich),"[-1.268, -1.4 (C-rich)]",No similarity to PQS (3G) from QGRS mapper,NAG11; NAG12; C9orf130; LINC00476
LINC00518,prostate cancer,"real-time PCR, Luciferase reporter assay, Western blot, other",up-regulated,30462844.0,Also known as: C6orf218,1,NR_027793.1,8,8,0,0,VALIDATED,2 (C-rich) ,"['-0.771, -0.814 (C-rich)]",No similarity to any PQS (2G)  from QGRS mapper,0,0,No PQS found in G4 Hunter,C6orf218
"LINC00617 
TUNAR",neuroendocrine prostate cancer,"RNA-seq, Microarray, qPCR etc.",up-regulated,29757368.0,Also Known As: HI-LNC78; TUNAR; TUNA; LINC00617,3 (TUNAR),"TUNAR (NR_132398.1, NR_038861.1, NR_132399.1)","26, 24, 19 (TUNAR)","26, 24, 19 (TUNAR)","0, 0, 0 (TUNAR)","0, 0, 0 (TUNAR)",REVIEWED (TUNAR),"8 (3-2G, 5-C-rich);
7 (3-2G, 4-C-rich);
14 ","[0.75, 0.915, 0.98 (2G); -0.882, -0.891, -0.793,  -0.87,  -0.742 (C-rich)];
[0.75, 0.915, 0.98 (2G); -0.882, -0.793,  -0.87,  -0.742 C-rich)];
[-1.07, -0.891, -0.911, -0.911, -0.911, -1.072, -0.891, -0.88, -0.793, 0.75, -0.87, 0.915, -0.742, 0.98 (C-rich)]",No similarity to any PQS (2G) from QGRS mapper,"0;
0;
0","0;
0;
0",No PQS found in G4 Hunter,TUNA; HI-LNC78; LINC00617
LINC00649,prostate cancer,RNA-seq,differential expression,30906477.0,"Also Known As: LINC00650, lnc-ITSN1-2",3,"NR_038883.2, NR_134558.1, NR_134559.1 ","18, 14, 4","18, 14, 4","0,0,0","0,0,0",VALIDATED,"3 (1-2G, 2-C-rich);
1 (2G);
2 (C-rich)
","[ 0.941 (2G); -0.936, -0.891 (C-rich)];
[0.941 (2G)];
[-0.936, -0.891 (C-rich)]",No similarity to any PQS (2G) from QGRS mapper,"0;
0;
0","0;
0;
0",No PQS found in G4 Hunter,LINC00650; lnc-ITSN1-2
LINC00662,prostate cancer,"qRT-PCR , Luciferase reporter assay , in vitro knockdown etc.",up-regulated,31114993.0,,1,NR_027301.1,6,5,1,0,VALIDATED,1 (C-rich),[-1 (C-rich)],"No similarity to any PQS from QGRS mapper
",0,0,No PQS found in G4 hunter,long intergenic non-protein coding RNA 662;CTC-459F4.2;LINC00662;HSALNG0125113;NONHSAG025376.2;NONHSAG025379.2
LINC00663,prostate cancer,qPCR etc.,down-regulated,26743782.0,,1,NR_026956.1,22,22,0,0,VALIDATED,"3 (2 - 2G, 1 - C-rich)","[0.885, 0.891 (2G), -0.759 (C-rich)]","No similarity to any PQS (2G) from QGRS mapper.
",0,0,No PQS found in G4 Hunter,long intergenic non-protein coding RNA 663;MGC39821;CTC-559E9.1;LINC00663;NONHSAG025200.2;HSALNG0124755
LINC00665,prostate cancer,"qPCR, Luciferase reporter assay etc.",up-regulated,32273723.0,,2,"NR_038278.1, NR_038279.1","16, 8","15, 7",2021-01-01 00:00:00,"0, 0",VALIDATED,"2 (C-rich);

3 (C-rich)","[-0.788, -0.911 (C-rich)];

[-0.797, -0.911, -0.913 (C-rich)]","No similarity to any PQS (2G) from QGRS mapper.
","0;

1 (C-rich)","0;

[-1.136 (C-rich)]","No similarity to any PQS (2G) from QGRS mapper.
",CIP2A-BP
LINC00673,prostate cancer,"RT-qPCR, Western blot analysis, Dual luciferase reporter gene assay, RIP",up-regulated,31881124.0,Also known asSLNCR; SLNCR1; ERRLR01; HILNC75; LUCAIR1; HI-LNC75,5,"NR_137281.2, NR_137280.2, NR_036488.1,  NR_152515.1, NR_152516.1 ","26, 25, 23, 23, 27","24 ,23, 22, 22, 25","2 ,2,1, 1, 2","0, 0, 0, 0, 0",VALIDATED,"9 (2 - 2G, 2 - 3G, 5 - C-rich);

9 (2 - 2G, 2 - 3G, 5 - C-rich);

7 (2 - 2G, 1 - 3G, 4 - C-rich);

7 (2 - 2G, 1 - 3G, 4 - C-rich);

9 (2 - 2G, 2 - 3G, 5 - C-rich)","[1, 0.911 (2G), 0.766, 0.935  (3G), -0.787, -0.88, -0.957, -0.936, -0.671 (C-rich)];

[1, 0.911 (2G), 0.766, 0.935  (3G), -0.787, -0.88, -0.957, -0.936, -0.671 (C-rich)];
 
(1, 0.911 (2G), 0.766 (3G), -0.787, -0.957, -0.936, -0.671 (C-rich)];

(1, 0.911 (2G), 0.766 (3G), -0.787, -0.957, -0.936, -0.671 (C-rich)];

[1, 0.911 (2G), 0.766, 0.935  (3G), -0.787, -0.88, -0.957, -0.936, -0.671 (C-rich)]","In variants 1, 2 and 5, PQS 9 (3G) of QGRS mapper and the PQS 4 (3G) of G4 hunter have similar G tracts.

PQS 15 (3G) of QGRS mapper and the PQS 5 (3G) of G4 hunter have similar G tracts.

In variants 3 and 4, PQS 9 (3G) of QGRS mapper and the PQS 4 (3G) of G4 hunter have similar G tracts.",0,0,No PQS found in G4 hunter,SLNCR; SLNCR1; ERRLR01; HILNC75; LUCAIR1; HI-LNC75
LINC00683,prostate cancer,RNA-seq,down-regulated,30963639.0,,1,NR_120419.1,18,14,4,0,VALIDATED,"4 (2-2G, 2-C-rich)","[1.052, 0.915 (2G); -1.116, -0.797 (C-rich)]",No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,long intergenic non-protein coding RNA 683;LINC00908;HSALNG0122571;HSALNG0122579;NONHSAG024201.2;LINC00683;NONHSAG024205.2;HSALNG0122581;HSALNG0122573
LINC00844,prostate cancer,"ChIP-seq, Microarray",down-regulated,30115758.0,,1,NR_108046.1,1,1,0,0,VALIDATED,0,0,No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,long intergenic non-protein coding RNA 844;HSALNG0078193;LINC00844;NONHSAG005962.2
LINC00908,prostate cancer,"Microarray, RT-qPCR, Western blot analysis, Dual luciferase reporter assay, RIP",down-regulated,31938018.0,Also Known As: ASRPS,1,NR_015417.1,19,19,0,0,VALIDATED,3 (C-rich),"[-0.878, -0.783, -0.911 (C-rich)]",No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,ASRPS
LINC00963,prostate cancer,"Microarray, qPCR, RNAi, Western blot etc.",up-regulated,24691949.0,Also Known As: MetaLnc9,1,NR_038955.1,21,20,1,0,VALIDATED,"3 (1-2G, 2-C-rich)","[0.776 (2G); -0.891, -0.731 (C-rich)]",No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,MetaLnc9
"LINC00969 
MIR570HG",prostate cancer,"Microarray, qPCR etc.",up-regulated,27556357.0,Also Known As: MIR570HG; LINC00969,1 (MIR570HG),MIR570HG (NR_122105.1),7 (MIR570HG),7 (MIR570HG),0 (MIR570HG),0 (MIR570HG),VALIDATED (MIR570HG),1 (C-rich),[0.667 (C-rich)],No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,LINC00969
"LINC00969 
MIR570HG",prostate cancer,"Microarray, qPCR etc.",down-regulated,27556357.0,Also Known As: MIR570HG; LINC00969,1 (MIR570HG),MIR570HG (NR_122105.1),7 (MIR570HG),7 (MIR570HG),0 (MIR570HG),0 (MIR570HG),VALIDATED (MIR570HG),1 (C-rich),[0.667 (C-rich)],No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,LINC00969
LINC01116,prostate cancer,"RNA-seq, qPCR, RNAi etc.",up-regulated,28131897.0,Also Known As: TALNEC2,1,NR_040001.2,2,2,0,0,VALIDATED,1 (C-rich),[-0.741 (C-rich)],No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter,TALNEC2
LINC01138,prostate cancer,"Microarray, qPCR etc.",down-regulated,27556357.0,Also Known As: LINC00875,2,"NR_027468.3, NR_104014.2","10,7","10,7","0,0","0,0",VALIDATED,"4 (1 - 2G, 3 - C-rich);
4 (1 - 2G, 3 - C-rich)","[0.613 (2G); -0.899, -0.875, -0.854 (C-rich)];
[0.613 (2G); -0.899, -0.875, -0.854 (C-rich)]",No similarity to any PQS (2G) from QGRS mapper,"0;
0","0;
0",No PQS found in G4 Hunter,LINC00875
LINC01138,prostate cancer,"Microarray, qPCR etc.",up-regulated,27556357.0,Also Known As: LINC00875,2,"NR_027468.3, NR_104014.2","10,7","10,7","0,0","0,0",VALIDATED,"4 (1 - 2G, 3 - C-rich);
4 (1 - 2G, 3 - C-rich)","[0.613 (2G); -0.899, -0.875, -0.854 (C-rich)];
[0.613 (2G); -0.899, -0.875, -0.854 (C-rich)]",No similarity to any PQS (2G) from QGRS mapper,"0;
0","0;
0",No PQS found in G4 Hunter,LINC00875
"LINC01296
DUXAP9",prostate cancer,"qPCR, Western blot",up-regulated,28392705.0,"Also Known As: DUXAP9; LNMAT1; LINC01296; LncRNA-CTD903 (Gene Cards)

Homo sapiens double homeobox A pseudogene 9 (DUXAP9), transcript variant 1 and 2, non-coding RNA (NR_122111.1 and NR_122112.1)

transcribed RNA-misc_RNA (mentioned as lncRNA in title of papers; PubMed - 31522796 and others) (NR_122111.1 and NR_122112.1)

Gene type - pseudo",2 (DUXAP9),"DUXAP9 (NR_122111.1, NR_122112.1)","19, 9 (DUXAP9)","19, 9 (DUXAP9)","0, 0 (DUXAP9)","0, 0 (DUXAP9)",VALIDATED (DUXAP9),"7 (1 - 2G, 6 - C-rich);
2 (C-rich)
","[0.613 (2G); -0.899, -0.875, -0.854, -0.944, -0.821, -0.782 (C-rich)];
[-0.821, -0.782 (C-rich)]",No similarity to any PQS (2G) from QGRS mapper,"0;
0","0;
0",No PQS found in G4 hunter,LNMAT1; LINC01296
LINP1,prostate cancer,"qPCR, Western blot",up-regulated,30058678.0,,1,NR_138480.1,7,5,2,0,VALIDATED,"4 (1 - 2G, 3 - C-rich)","[-0.915, -0.911, -0.847 (C-rich), 0.808 (2G)] 
","PQS 6 (3G) of QGRS mapper is similar to / a part of PQS 4 (3G) of G4 hunter 
",1 (3G),[1.4 (3G)],"PQS 6 (3G) of QGRS mapper is similar to / a part of PQS 1 (3G) of G4 hunter 
",lncRNA in non-homologous end joining pathway 1;lncRNA in nonhomologous end joining (NHEJ) pathway 1;lncRNA in nonhomologous end joining pathway 1;LINP1;NONHSAG005150.2;HSALNG0075977;HSALNG0075974
lncRNA-ATB,prostate cancer,"qPCR, Western blot etc.",up-regulated,27176634.0,,1,NR_160525.1,17,16,1,0,VALIDATED,"4 (1 - 2G, 3 - C-rich)","[-0.87, -0.913, -0.917 (C-rich), 0.729 (2G)]  
","No similarity to any PQS (2G) from QGRS mapper.
",0,0,No PQS found in G4 Hunter,
LOXL1-AS1,prostate cancer,"qRT-PCR , Microarray , Western blot etc.",down-regulated,31188543.0,,5,"NR_040066.1, NR_040067.1, NR_040068.1, NR_040069.1, NR_040070.1","15, 13, 11, 9, 11","12, 10, 11, 9, 10","3, 3, 0, 0, 1

PQS 1 of 5th variant is different from other variants.","0, 0, 0, 0, 0",VALIDATED,"5 (2 - 3G, 3 - C-rich);

5 (C-rich);

3 (C-rich);

3 (C-rich);

7 (3 - 2G, 4 - C-rich)","[0.851, 1.021 (3G), -0.786, -0.851, -0.976 (C-rich)]; 

[-0.956, -0.9, -0.789, -0.911, -0.936 (C-rich)]; 

[-0.786, -0.851, -0.976 (C-rich)]; 

[-0.786, -0.851, -0.976 (C-rich)]; 

[0.935, 0.765, 0.933 (2G), -0.933, -0.786, -0.851, -0.976 (C-rich)]","In variant 1, PQS 2 (3G) of QGRS mapper is similar to / a part of PQS 1 (3G) of G4 hunter 

PQS 5 (3G) of QGRS mapper is similar to / a part of PQS 2 (3G) of G4 hunter ",0,0,No PQS found in G4 Hunter,LOXL1 antisense RNA 1;LOXL1 antisense RNA 1 (non-protein coding);HSALNG0107133;LOXL1-AS1;NONHSAG017388.2;HSALNG0107136
LOXL1-AS1,prostate cancer,"qPCR, RNA-seq, Luciferase reporter assay, RNAi, other",down-regulated,30278884.0,,5,"NR_040066.1, NR_040067.1, NR_040068.1, NR_040069.1, NR_040070.1","15, 13, 11, 9, 11","12, 10, 11, 9, 10","3, 3, 0, 0, 1

PQS 1 of 5th variant is different from other variants.","0, 0, 0, 0, 0",VALIDATED,"5 (2 - 3G, 3 - C-rich);

5 (C-rich);

3 (C-rich);

3 (C-rich);

7 (3 - 2G, 4 - C-rich)","[0.851, 1.021 (3G), -0.786, -0.851, -0.976 (C-rich)]; 

[-0.956, -0.9, -0.789, -0.911, -0.936 (C-rich)]; 

[-0.786, -0.851, -0.976 (C-rich)]; 

[-0.786, -0.851, -0.976 (C-rich)]; 

[0.935, 0.765, 0.933 (2G), -0.933, -0.786, -0.851, -0.976 (C-rich)]","In variant 1, PQS 2 (3G) of QGRS mapper is similar to / a part of PQS 1 (3G) of G4 hunter 

PQS 5 (3G) of QGRS mapper is similar to / a part of PQS 2 (3G) of G4 hunter ",0,0,No PQS found in G4 Hunter,LOXL1 antisense RNA 1;LOXL1 antisense RNA 1 (non-protein coding);HSALNG0107133;LOXL1-AS1;NONHSAG017388.2;HSALNG0107136
LSAMP-AS1,prostate cancer,"RT-qPCR, Western blot",down-regulated,31727599.0,,1,NR_109998.1,4,4,0,0,VALIDATED,0,0,No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,LSAMP antisense RNA 1;LSAMP antisense RNA 1 (non-protein coding);HSALNG0028218;LSAMP-AS1;NONHSAG035803.2
LUCAT1,prostate cancer,"qRT-PCR , Western blot etc.",up-regulated,31081080.0,Also Known As: SCAL1; SCAT5,2,"NR_103548.1, NR_103549.1","3,2","3,2","0,0","0,0",VALIDATED,"0;
3 (2G)","0;
[0.876, 0.911, 0.911 (2G)]",No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,SCAL1; SCAT5
MALAT1,prostate cancer,qPCR etc.,down-regulated,32210615.0,"Also Known As: HCN; NEAT2; PRO2853; LINC00047; NCRNA00047

Some (older-not checked for PQS) scRNA mascRNA (MALAT1 gene) ""scRNA"" ncRNA (TPA: HG975416.1) was also there in result.

PQS 1 obtained in 1st variant was replaced by another PQS of same score (by shifting a G-Group within the same G-Group/Quartet frame) in 2nd and 3rd variants.",3,"NR_002819.4, NR_144567.1, NR_144568.1","53, 54, 53","46, 47, 47","7, 7, 6

PQS 1 obtained in 1st variant was replaced by another PQS of same score (by shifting a G-Group within the same G-Group/Quartet frame) in 2nd and 3rd variants.","0, 0, 0",REVIEWED,"31 (17 - 2G, 9 - 3G, 5 - C-rich);
30 (16 - 2G, 9 - 3G, 5 - C-rich);
31 (1- - 2G, 9 - 3G, 5 - C-rich)","[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];
[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];
[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891]",No similarity to PQS (2G) from QGRS mapper,"2 (3G);
2 (3G);
2 (3G)","[1.358, 1.354 (3G)];
[1.358, 1.354 (3G)];
[1.358, 1.354 (3G)]","For all three variants, 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
",HCN; NEAT2; PRO2853; LINC00047; NCRNA00047
MALAT1,prostate cancer,RNA-seq,differential expression,30906477.0,"Also Known As: HCN; NEAT2; PRO2853; LINC00047; NCRNA00047

Some (older-not checked for PQS) scRNA mascRNA (MALAT1 gene) ""scRNA"" ncRNA (TPA: HG975416.1) was also there in result.

PQS 1 obtained in 1st variant was replaced by another PQS of same score (by shifting a G-Group within the same G-Group/Quartet frame) in 2nd and 3rd variants.",3,"NR_002819.4, NR_144567.1, NR_144568.1","53, 54, 53","46, 47, 47","7, 7, 6

PQS 1 obtained in 1st variant was replaced by another PQS of same score (by shifting a G-Group within the same G-Group/Quartet frame) in 2nd and 3rd variants.","0, 0, 0",REVIEWED,"31 (17 - 2G, 9 - 3G, 5 - C-rich);
30 (16 - 2G, 9 - 3G, 5 - C-rich);
31 (1- - 2G, 9 - 3G, 5 - C-rich)","[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];
[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];
[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891]",No similarity to PQS (2G) from QGRS mapper,"2 (3G);
2 (3G);
2 (3G)","[1.358, 1.354 (3G)];
[1.358, 1.354 (3G)];
[1.358, 1.354 (3G)]","For all three variants, 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
",HCN; NEAT2; PRO2853; LINC00047; NCRNA00047
MALAT1,prostate cancer,"RT-qPCR, Western blot assay, Luciferase assay, RIP",up-regulated,31935634.0,"Also Known As: HCN; NEAT2; PRO2853; LINC00047; NCRNA00047

Some (older-not checked for PQS) scRNA mascRNA (MALAT1 gene) ""scRNA"" ncRNA (TPA: HG975416.1) was also there in result.

PQS 1 obtained in 1st variant was replaced by another PQS of same score (by shifting a G-Group within the same G-Group/Quartet frame) in 2nd and 3rd variants.",3,"NR_002819.4, NR_144567.1, NR_144568.1","53, 54, 53","46, 47, 47","7, 7, 6

PQS 1 obtained in 1st variant was replaced by another PQS of same score (by shifting a G-Group within the same G-Group/Quartet frame) in 2nd and 3rd variants.","0, 0, 0",REVIEWED,"31 (17 - 2G, 9 - 3G, 5 - C-rich);
30 (16 - 2G, 9 - 3G, 5 - C-rich);
31 (1- - 2G, 9 - 3G, 5 - C-rich)","[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];
[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];
[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891]",No similarity to PQS (2G) from QGRS mapper,"2 (3G);
2 (3G);
2 (3G)","[1.358, 1.354 (3G)];
[1.358, 1.354 (3G)];
[1.358, 1.354 (3G)]","For all three variants, 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
",HCN; NEAT2; PRO2853; LINC00047; NCRNA00047
MALAT1,prostate cancer,"qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, etc.",up-regulated,30642743.0,"Also Known As: HCN; NEAT2; PRO2853; LINC00047; NCRNA00047

Some (older-not checked for PQS) scRNA mascRNA (MALAT1 gene) ""scRNA"" ncRNA (TPA: HG975416.1) was also there in result.

PQS 1 obtained in 1st variant was replaced by another PQS of same score (by shifting a G-Group within the same G-Group/Quartet frame) in 2nd and 3rd variants.",3,"NR_002819.4, NR_144567.1, NR_144568.1","53, 54, 53","46, 47, 47","7, 7, 6

PQS 1 obtained in 1st variant was replaced by another PQS of same score (by shifting a G-Group within the same G-Group/Quartet frame) in 2nd and 3rd variants.","0, 0, 0",REVIEWED,"31 (17 - 2G, 9 - 3G, 5 - C-rich);
30 (16 - 2G, 9 - 3G, 5 - C-rich);
31 (1- - 2G, 9 - 3G, 5 - C-rich)","[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];
[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];
[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891]",No similarity to PQS (2G) from QGRS mapper,"2 (3G);
2 (3G);
2 (3G)","[1.358, 1.354 (3G)];
[1.358, 1.354 (3G)];
[1.358, 1.354 (3G)]","For all three variants, 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
",HCN; NEAT2; PRO2853; LINC00047; NCRNA00047
MALAT1,prostate cancer,"qPCR, Western blot, ChIP, Dot blot etc.",differential expression,27922078.0,"Also Known As: HCN; NEAT2; PRO2853; LINC00047; NCRNA00047

Some (older-not checked for PQS) scRNA mascRNA (MALAT1 gene) ""scRNA"" ncRNA (TPA: HG975416.1) was also there in result.

PQS 1 obtained in 1st variant was replaced by another PQS of same score (by shifting a G-Group within the same G-Group/Quartet frame) in 2nd and 3rd variants.",3,"NR_002819.4, NR_144567.1, NR_144568.1","53, 54, 53","46, 47, 47","7, 7, 6

PQS 1 obtained in 1st variant was replaced by another PQS of same score (by shifting a G-Group within the same G-Group/Quartet frame) in 2nd and 3rd variants.","0, 0, 0",REVIEWED,"31 (17 - 2G, 9 - 3G, 5 - C-rich);
30 (16 - 2G, 9 - 3G, 5 - C-rich);
31 (1- - 2G, 9 - 3G, 5 - C-rich)","[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];
[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];
[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891]",No similarity to PQS (2G) from QGRS mapper,"2 (3G);
2 (3G);
2 (3G)","[1.358, 1.354 (3G)];
[1.358, 1.354 (3G)];
[1.358, 1.354 (3G)]","For all three variants, 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
",HCN; NEAT2; PRO2853; LINC00047; NCRNA00047
MALAT1,prostate cancer,"Microarray, qPCR etc.",up-regulated,27600237.0,"Also Known As: HCN; NEAT2; PRO2853; LINC00047; NCRNA00047

Some (older-not checked for PQS) scRNA mascRNA (MALAT1 gene) ""scRNA"" ncRNA (TPA: HG975416.1) was also there in result.

PQS 1 obtained in 1st variant was replaced by another PQS of same score (by shifting a G-Group within the same G-Group/Quartet frame) in 2nd and 3rd variants.",3,"NR_002819.4, NR_144567.1, NR_144568.1","53, 54, 53","46, 47, 47","7, 7, 6

PQS 1 obtained in 1st variant was replaced by another PQS of same score (by shifting a G-Group within the same G-Group/Quartet frame) in 2nd and 3rd variants.","0, 0, 0",REVIEWED,"31 (17 - 2G, 9 - 3G, 5 - C-rich);
30 (16 - 2G, 9 - 3G, 5 - C-rich);
31 (1- - 2G, 9 - 3G, 5 - C-rich)","[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];
[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];
[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891]",No similarity to PQS (2G) from QGRS mapper,"2 (3G);
2 (3G);
2 (3G)","[1.358, 1.354 (3G)];
[1.358, 1.354 (3G)];
[1.358, 1.354 (3G)]","For all three variants, 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
",HCN; NEAT2; PRO2853; LINC00047; NCRNA00047
MALAT1,prostate cancer,"qPCR, RNAi, RIP, ChIP etc.",up-regulated,26516927.0,"Also Known As: HCN; NEAT2; PRO2853; LINC00047; NCRNA00047

Some (older-not checked for PQS) scRNA mascRNA (MALAT1 gene) ""scRNA"" ncRNA (TPA: HG975416.1) was also there in result.

PQS 1 obtained in 1st variant was replaced by another PQS of same score (by shifting a G-Group within the same G-Group/Quartet frame) in 2nd and 3rd variants.",3,"NR_002819.4, NR_144567.1, NR_144568.1","53, 54, 53","46, 47, 47","7, 7, 6

PQS 1 obtained in 1st variant was replaced by another PQS of same score (by shifting a G-Group within the same G-Group/Quartet frame) in 2nd and 3rd variants.","0, 0, 0",REVIEWED,"31 (17 - 2G, 9 - 3G, 5 - C-rich);
30 (16 - 2G, 9 - 3G, 5 - C-rich);
31 (1- - 2G, 9 - 3G, 5 - C-rich)","[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];
[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];
[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891]",No similarity to PQS (2G) from QGRS mapper,"2 (3G);
2 (3G);
2 (3G)","[1.358, 1.354 (3G)];
[1.358, 1.354 (3G)];
[1.358, 1.354 (3G)]","For all three variants, 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
",HCN; NEAT2; PRO2853; LINC00047; NCRNA00047
MALAT1,prostate cancer,"RNA-seq, qPCR etc.",up-regulated,22349460.0,"Also Known As: HCN; NEAT2; PRO2853; LINC00047; NCRNA00047

Some (older-not checked for PQS) scRNA mascRNA (MALAT1 gene) ""scRNA"" ncRNA (TPA: HG975416.1) was also there in result.

PQS 1 obtained in 1st variant was replaced by another PQS of same score (by shifting a G-Group within the same G-Group/Quartet frame) in 2nd and 3rd variants.",3,"NR_002819.4, NR_144567.1, NR_144568.1","53, 54, 53","46, 47, 47","7, 7, 6

PQS 1 obtained in 1st variant was replaced by another PQS of same score (by shifting a G-Group within the same G-Group/Quartet frame) in 2nd and 3rd variants.","0, 0, 0",REVIEWED,"31 (17 - 2G, 9 - 3G, 5 - C-rich);
30 (16 - 2G, 9 - 3G, 5 - C-rich);
31 (1- - 2G, 9 - 3G, 5 - C-rich)","[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];
[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];
[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891]",No similarity to PQS (2G) from QGRS mapper,"2 (3G);
2 (3G);
2 (3G)","[1.358, 1.354 (3G)];
[1.358, 1.354 (3G)];
[1.358, 1.354 (3G)]","For all three variants, 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
",HCN; NEAT2; PRO2853; LINC00047; NCRNA00047
MALAT1,prostate cancer,"qPCR, Western blot, Luciferase reporter assay etc.",up-regulated,29633510.0,"Also Known As: HCN; NEAT2; PRO2853; LINC00047; NCRNA00047

Some (older-not checked for PQS) scRNA mascRNA (MALAT1 gene) ""scRNA"" ncRNA (TPA: HG975416.1) was also there in result.

PQS 1 obtained in 1st variant was replaced by another PQS of same score (by shifting a G-Group within the same G-Group/Quartet frame) in 2nd and 3rd variants.",3,"NR_002819.4, NR_144567.1, NR_144568.1","53, 54, 53","46, 47, 47","7, 7, 6

PQS 1 obtained in 1st variant was replaced by another PQS of same score (by shifting a G-Group within the same G-Group/Quartet frame) in 2nd and 3rd variants.","0, 0, 0",REVIEWED,"31 (17 - 2G, 9 - 3G, 5 - C-rich);
30 (16 - 2G, 9 - 3G, 5 - C-rich);
31 (1- - 2G, 9 - 3G, 5 - C-rich)","[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];
[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];
[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891]",No similarity to PQS (2G) from QGRS mapper,"2 (3G);
2 (3G);
2 (3G)","[1.358, 1.354 (3G)];
[1.358, 1.354 (3G)];
[1.358, 1.354 (3G)]","For all three variants, 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
",HCN; NEAT2; PRO2853; LINC00047; NCRNA00047
MALAT1,prostate cancer,qPCR etc.,up-regulated,23845456.0,"Also Known As: HCN; NEAT2; PRO2853; LINC00047; NCRNA00047

Some (older-not checked for PQS) scRNA mascRNA (MALAT1 gene) ""scRNA"" ncRNA (TPA: HG975416.1) was also there in result.

PQS 1 obtained in 1st variant was replaced by another PQS of same score (by shifting a G-Group within the same G-Group/Quartet frame) in 2nd and 3rd variants.",3,"NR_002819.4, NR_144567.1, NR_144568.1","53, 54, 53","46, 47, 47","7, 7, 6

PQS 1 obtained in 1st variant was replaced by another PQS of same score (by shifting a G-Group within the same G-Group/Quartet frame) in 2nd and 3rd variants.","0, 0, 0",REVIEWED,"31 (17 - 2G, 9 - 3G, 5 - C-rich);
30 (16 - 2G, 9 - 3G, 5 - C-rich);
31 (1- - 2G, 9 - 3G, 5 - C-rich)","[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];
[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];
[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891]",No similarity to PQS (2G) from QGRS mapper,"2 (3G);
2 (3G);
2 (3G)","[1.358, 1.354 (3G)];
[1.358, 1.354 (3G)];
[1.358, 1.354 (3G)]","For all three variants, 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
",HCN; NEAT2; PRO2853; LINC00047; NCRNA00047
MALAT1,prostate cancer,"qPCR, Northern blot etc.",up-regulated,23726266.0,"Also Known As: HCN; NEAT2; PRO2853; LINC00047; NCRNA00047

Some (older-not checked for PQS) scRNA mascRNA (MALAT1 gene) ""scRNA"" ncRNA (TPA: HG975416.1) was also there in result.

PQS 1 obtained in 1st variant was replaced by another PQS of same score (by shifting a G-Group within the same G-Group/Quartet frame) in 2nd and 3rd variants.",3,"NR_002819.4, NR_144567.1, NR_144568.1","53, 54, 53","46, 47, 47","7, 7, 6

PQS 1 obtained in 1st variant was replaced by another PQS of same score (by shifting a G-Group within the same G-Group/Quartet frame) in 2nd and 3rd variants.","0, 0, 0",REVIEWED,"31 (17 - 2G, 9 - 3G, 5 - C-rich);
30 (16 - 2G, 9 - 3G, 5 - C-rich);
31 (1- - 2G, 9 - 3G, 5 - C-rich)","[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];
[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891];
[0.851, 0.898, 0.891, 0.852, 0.727, 1.019, 0.824, 0.854, 1.119, 0.816, -0.826, 0.857, 0.824, 0.872, 0.911, 0.731, 0.803, 0.698, 0.717, 0.681, 0.738, 0.793, 0.911, 0.65, 0.911, -0.911, -0.911, -0.808, -1, 0.913, 0.891]",No similarity to PQS (2G) from QGRS mapper,"2 (3G);
2 (3G);
2 (3G)","[1.358, 1.354 (3G)];
[1.358, 1.354 (3G)];
[1.358, 1.354 (3G)]","For all three variants, 
PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper.

PQS 2 (3G) from G4 Hunter has no similarity to PQS from QGRS mapper 
",HCN; NEAT2; PRO2853; LINC00047; NCRNA00047
MANCR,prostate cancer,"qPCR, RNA-seq etc",down-regulated,32199616.0,Also Known As: LINC00704,1,NR_024475.1,7,2,0,0,PREDICTED,,,,,,,LINC00704
MCM3AP-AS1,prostate cancer,"qPCR, Western blot, RIP etc",up-regulated,32193153.0,Also known as: C21orf85; MCM3APAS; MCM3AP-AS; MCM3APASB; NCRNA00031,4,"NR_110565.1, NR_002776.4,NR_110566.1,NR_110567.1","9,9,10,11","9,9,10,11","0,0,0,0","0,0,0,0",VALIDATED,"2 (C-rich);
1 (C-rich);
0;
3 (2G)","[-0.829, -0.911 (C-rich)];
[-0.911 (C-rich)];
0;
[0.865, 0.933, 0.911 (2G)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,C21orf85; MCM3APAS; MCM3AP-AS; MCM3APASB; NCRNA00031
MEG3,prostate cancer,"qPCR, Western blot, RIP etc",differential expressed,31790140.0,"Also Known As: GTL2; FP504; prebp1; PRO0518; PRO2160; LINC00023; NCRNA00023; onco-lncRNA-83

Sequence not available for 11th variant.

Some (older-not checked for PQS) Long non-coding RNA containing retained intron meg3 (MEG3 gene); and maternally expressed 3 transcript variant lncRNA (MEG3) ""lncRNA"" ncRNA (TPA: HG975417.1 and complete sequence - MH929320.1 respectively) were also there in result.

Some (older-not checked for PQS) MEG3 isoforms ncRNA ""other"" ncRNA (complete sequence, alternatively spliced) were also there in result.

PQS 7 and 9 obtained in 16th Variant when search parameter was set to Min G-Group Size: 2 was replaced by another PQSs of same scores (by shifting G-Group/Quartet frame) when search parameter was set to Min G-Group Size: 3.
For further consideration, PQS when search parameter was set to Min G-Group Size: 2 was taken.","15
(11th Variant not available)
(Total=16)","NR_002766.2, NR_003530.2, NR_003531.3, NR_033358.1, NR_033359.1, NR_033360.1, NR_046464.1, NR_046465.2, NR_046466.1, NR_046467.1, _____, NR_046469.1, NR_046470.2, NR_046471.1, NR_046472.1, NR_046473.1","16, 19, 18, 17, 17, 17, 17, 17, 17, 18, ___, 17, 19, 17, 18, 93","14, 17, 16, 15, 15, 15, 15, 15, 15, 16, ___, 15, 17, 15, 16, 81","2, 2, 2, 2, 2, 2, 2, 2, 2, 2, ___, 2, 2, 2, 2, 12

PQS 1 is same in all variants.
PQS 2 is absent in 16th variant.
PQS 2-12 of 16th variant is different from other variants.","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, ___, 0, 0, 0, 0, 0",REVIEWED,"4 (2 - 2G, 2 - C-rich);
4 (2 - 2G, 2 - C-rich);
9 (2 - 2G, 7 - C-rich);
4 (2 - 2G, 2 - C-rich);
9 (2 - 2G, 7 - C-rich);
4 (2 - 2G, 2 - C-rich);
9 (2 - 2G, 7 - C-rich);
4 (2 - 2G, 2 - C-rich);
4 (2 - 2G, 2 - C-rich);
4 (2 - 2G, 2 - C-rich);
____;
9 (2 - 2G, 7 - C-rich);
8 (2 - 2G, 6 - C-rich);
4 (2 - 2G, 2 - C-rich);
4 (2 - 2G, 2 - C-rich);
20 (19 - 2G, 1 - C-rich)","[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

_____;

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894, 0.915, -0.911, 0.87, 0.891, 0.829, 0.962, 0.877,  0.821, 0.911, 0.843, 0.851, 0.798, 0.917, 0.911, 0.911, 0.849, 0.842]",No similarity to PQS (2G) from QGRS mapper,"0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
___;
0;
0;
0;
0;
5 (3G)","0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
___;
0;
0;
0;
0;
[1.23, 1.396, 1.245, 1.422, 1.308 (3G)]","In Variant 16:

PQS 7 (3G) from QGRS mapper is similar to / a part of PQS 1, 2 (3G) from G4 hunter

PQS 2 (3G) from G4 Hunter has a left frame-shift as compared to PQS 7 (3G) from QGRS mapper.

PQS 8 (3G) from QGRS mapper is similar to / a part of PQS 3 (3G) from G4 hunter

PQS 3 (3G) from G4 Hunter has a left frame-shift as compared to PQS 8 (3G) from QGRS mapper.
 
By looking at  PQS 4, 5 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as both PQS have few common G-tracts due to overlap amongst all of these PQS.",GTL2; FP504; prebp1; PRO0518; PRO2160; LINC00023; NCRNA00023; onco-lncRNA-83
MEG3,prostate cancer,"qPCR, Western blot, Luciferase reporter assay, RIP, etc.",down-regulated,30565858.0,"Also Known As: GTL2; FP504; prebp1; PRO0518; PRO2160; LINC00023; NCRNA00023; onco-lncRNA-83

Sequence not available for 11th variant.

Some (older-not checked for PQS) Long non-coding RNA containing retained intron meg3 (MEG3 gene); and maternally expressed 3 transcript variant lncRNA (MEG3) ""lncRNA"" ncRNA (TPA: HG975417.1 and complete sequence - MH929320.1 respectively) were also there in result.

Some (older-not checked for PQS) MEG3 isoforms ncRNA ""other"" ncRNA (complete sequence, alternatively spliced) were also there in result.

PQS 7 and 9 obtained in 16th Variant when search parameter was set to Min G-Group Size: 2 was replaced by another PQSs of same scores (by shifting G-Group/Quartet frame) when search parameter was set to Min G-Group Size: 3.
For further consideration, PQS when search parameter was set to Min G-Group Size: 2 was taken.","15
(11th Variant not available)
(Total=16)","NR_002766.2, NR_003530.2, NR_003531.3, NR_033358.1, NR_033359.1, NR_033360.1, NR_046464.1, NR_046465.2, NR_046466.1, NR_046467.1, _____, NR_046469.1, NR_046470.2, NR_046471.1, NR_046472.1, NR_046473.1","16, 19, 18, 17, 17, 17, 17, 17, 17, 18, ___, 17, 19, 17, 18, 93","14, 17, 16, 15, 15, 15, 15, 15, 15, 16, ___, 15, 17, 15, 16, 81","2, 2, 2, 2, 2, 2, 2, 2, 2, 2, ___, 2, 2, 2, 2, 12

PQS 1 is same in all variants.
PQS 2 is absent in 16th variant.
PQS 2-12 of 16th variant is different from other variants.","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, ___, 0, 0, 0, 0, 0",REVIEWED,"4 (2 - 2G, 2 - C-rich);
4 (2 - 2G, 2 - C-rich);
9 (2 - 2G, 7 - C-rich);
4 (2 - 2G, 2 - C-rich);
9 (2 - 2G, 7 - C-rich);
4 (2 - 2G, 2 - C-rich);
9 (2 - 2G, 7 - C-rich);
4 (2 - 2G, 2 - C-rich);
4 (2 - 2G, 2 - C-rich);
4 (2 - 2G, 2 - C-rich);
____;
9 (2 - 2G, 7 - C-rich);
8 (2 - 2G, 6 - C-rich);
4 (2 - 2G, 2 - C-rich);
4 (2 - 2G, 2 - C-rich);
20 (19 - 2G, 1 - C-rich)","[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

_____;

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894, 0.915, -0.911, 0.87, 0.891, 0.829, 0.962, 0.877,  0.821, 0.911, 0.843, 0.851, 0.798, 0.917, 0.911, 0.911, 0.849, 0.842]",No similarity to PQS (2G) from QGRS mapper,"0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
___;
0;
0;
0;
0;
5 (3G)","0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
___;
0;
0;
0;
0;
[1.23, 1.396, 1.245, 1.422, 1.308 (3G)]","In Variant 16:

PQS 7 (3G) from QGRS mapper is similar to / a part of PQS 1, 2 (3G) from G4 hunter

PQS 2 (3G) from G4 Hunter has a left frame-shift as compared to PQS 7 (3G) from QGRS mapper.

PQS 8 (3G) from QGRS mapper is similar to / a part of PQS 3 (3G) from G4 hunter

PQS 3 (3G) from G4 Hunter has a left frame-shift as compared to PQS 8 (3G) from QGRS mapper.
 
By looking at  PQS 4, 5 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as both PQS have few common G-tracts due to overlap amongst all of these PQS.",GTL2; FP504; prebp1; PRO0518; PRO2160; LINC00023; NCRNA00023; onco-lncRNA-83
MEG3,prostate cancer,"qPCR, ISH etc.",down-regulated,14602737.0,"Also Known As: GTL2; FP504; prebp1; PRO0518; PRO2160; LINC00023; NCRNA00023; onco-lncRNA-83

Sequence not available for 11th variant.

Some (older-not checked for PQS) Long non-coding RNA containing retained intron meg3 (MEG3 gene); and maternally expressed 3 transcript variant lncRNA (MEG3) ""lncRNA"" ncRNA (TPA: HG975417.1 and complete sequence - MH929320.1 respectively) were also there in result.

Some (older-not checked for PQS) MEG3 isoforms ncRNA ""other"" ncRNA (complete sequence, alternatively spliced) were also there in result.

PQS 7 and 9 obtained in 16th Variant when search parameter was set to Min G-Group Size: 2 was replaced by another PQSs of same scores (by shifting G-Group/Quartet frame) when search parameter was set to Min G-Group Size: 3.
For further consideration, PQS when search parameter was set to Min G-Group Size: 2 was taken.","15
(11th Variant not available)
(Total=16)","NR_002766.2, NR_003530.2, NR_003531.3, NR_033358.1, NR_033359.1, NR_033360.1, NR_046464.1, NR_046465.2, NR_046466.1, NR_046467.1, _____, NR_046469.1, NR_046470.2, NR_046471.1, NR_046472.1, NR_046473.1","16, 19, 18, 17, 17, 17, 17, 17, 17, 18, ___, 17, 19, 17, 18, 93","14, 17, 16, 15, 15, 15, 15, 15, 15, 16, ___, 15, 17, 15, 16, 81","2, 2, 2, 2, 2, 2, 2, 2, 2, 2, ___, 2, 2, 2, 2, 12

PQS 1 is same in all variants.
PQS 2 is absent in 16th variant.
PQS 2-12 of 16th variant is different from other variants.","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, ___, 0, 0, 0, 0, 0",REVIEWED,"4 (2 - 2G, 2 - C-rich);
4 (2 - 2G, 2 - C-rich);
9 (2 - 2G, 7 - C-rich);
4 (2 - 2G, 2 - C-rich);
9 (2 - 2G, 7 - C-rich);
4 (2 - 2G, 2 - C-rich);
9 (2 - 2G, 7 - C-rich);
4 (2 - 2G, 2 - C-rich);
4 (2 - 2G, 2 - C-rich);
4 (2 - 2G, 2 - C-rich);
____;
9 (2 - 2G, 7 - C-rich);
8 (2 - 2G, 6 - C-rich);
4 (2 - 2G, 2 - C-rich);
4 (2 - 2G, 2 - C-rich);
20 (19 - 2G, 1 - C-rich)","[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

_____;

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894, 0.915, -0.911, 0.87, 0.891, 0.829, 0.962, 0.877,  0.821, 0.911, 0.843, 0.851, 0.798, 0.917, 0.911, 0.911, 0.849, 0.842]",No similarity to PQS (2G) from QGRS mapper,"0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
___;
0;
0;
0;
0;
5 (3G)","0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
___;
0;
0;
0;
0;
[1.23, 1.396, 1.245, 1.422, 1.308 (3G)]","In Variant 16:

PQS 7 (3G) from QGRS mapper is similar to / a part of PQS 1, 2 (3G) from G4 hunter

PQS 2 (3G) from G4 Hunter has a left frame-shift as compared to PQS 7 (3G) from QGRS mapper.

PQS 8 (3G) from QGRS mapper is similar to / a part of PQS 3 (3G) from G4 hunter

PQS 3 (3G) from G4 Hunter has a left frame-shift as compared to PQS 8 (3G) from QGRS mapper.
 
By looking at  PQS 4, 5 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as both PQS have few common G-tracts due to overlap amongst all of these PQS.",GTL2; FP504; prebp1; PRO0518; PRO2160; LINC00023; NCRNA00023; onco-lncRNA-83
MEG3,prostate cancer,"qPCR, RNAi, Western blot, Flow cytometry assay etc.",down-regulated,26610246.0,"Also Known As: GTL2; FP504; prebp1; PRO0518; PRO2160; LINC00023; NCRNA00023; onco-lncRNA-83

Sequence not available for 11th variant.

Some (older-not checked for PQS) Long non-coding RNA containing retained intron meg3 (MEG3 gene); and maternally expressed 3 transcript variant lncRNA (MEG3) ""lncRNA"" ncRNA (TPA: HG975417.1 and complete sequence - MH929320.1 respectively) were also there in result.

Some (older-not checked for PQS) MEG3 isoforms ncRNA ""other"" ncRNA (complete sequence, alternatively spliced) were also there in result.

PQS 7 and 9 obtained in 16th Variant when search parameter was set to Min G-Group Size: 2 was replaced by another PQSs of same scores (by shifting G-Group/Quartet frame) when search parameter was set to Min G-Group Size: 3.
For further consideration, PQS when search parameter was set to Min G-Group Size: 2 was taken.","15
(11th Variant not available)
(Total=16)","NR_002766.2, NR_003530.2, NR_003531.3, NR_033358.1, NR_033359.1, NR_033360.1, NR_046464.1, NR_046465.2, NR_046466.1, NR_046467.1, _____, NR_046469.1, NR_046470.2, NR_046471.1, NR_046472.1, NR_046473.1","16, 19, 18, 17, 17, 17, 17, 17, 17, 18, ___, 17, 19, 17, 18, 93","14, 17, 16, 15, 15, 15, 15, 15, 15, 16, ___, 15, 17, 15, 16, 81","2, 2, 2, 2, 2, 2, 2, 2, 2, 2, ___, 2, 2, 2, 2, 12

PQS 1 is same in all variants.
PQS 2 is absent in 16th variant.
PQS 2-12 of 16th variant is different from other variants.","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, ___, 0, 0, 0, 0, 0",REVIEWED,"4 (2 - 2G, 2 - C-rich);
4 (2 - 2G, 2 - C-rich);
9 (2 - 2G, 7 - C-rich);
4 (2 - 2G, 2 - C-rich);
9 (2 - 2G, 7 - C-rich);
4 (2 - 2G, 2 - C-rich);
9 (2 - 2G, 7 - C-rich);
4 (2 - 2G, 2 - C-rich);
4 (2 - 2G, 2 - C-rich);
4 (2 - 2G, 2 - C-rich);
____;
9 (2 - 2G, 7 - C-rich);
8 (2 - 2G, 6 - C-rich);
4 (2 - 2G, 2 - C-rich);
4 (2 - 2G, 2 - C-rich);
20 (19 - 2G, 1 - C-rich)","[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

_____;

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894, 0.915, -0.911, 0.87, 0.891, 0.829, 0.962, 0.877,  0.821, 0.911, 0.843, 0.851, 0.798, 0.917, 0.911, 0.911, 0.849, 0.842]",No similarity to PQS (2G) from QGRS mapper,"0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
___;
0;
0;
0;
0;
5 (3G)","0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
___;
0;
0;
0;
0;
[1.23, 1.396, 1.245, 1.422, 1.308 (3G)]","In Variant 16:

PQS 7 (3G) from QGRS mapper is similar to / a part of PQS 1, 2 (3G) from G4 hunter

PQS 2 (3G) from G4 Hunter has a left frame-shift as compared to PQS 7 (3G) from QGRS mapper.

PQS 8 (3G) from QGRS mapper is similar to / a part of PQS 3 (3G) from G4 hunter

PQS 3 (3G) from G4 Hunter has a left frame-shift as compared to PQS 8 (3G) from QGRS mapper.
 
By looking at  PQS 4, 5 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as both PQS have few common G-tracts due to overlap amongst all of these PQS.",GTL2; FP504; prebp1; PRO0518; PRO2160; LINC00023; NCRNA00023; onco-lncRNA-83
MEG3,prostate cancer,"RNA-seq, Microarray, qPCR, RNAi, Northern blot etc.",down-regulated,23728290.0,"Also Known As: GTL2; FP504; prebp1; PRO0518; PRO2160; LINC00023; NCRNA00023; onco-lncRNA-83

Sequence not available for 11th variant.

Some (older-not checked for PQS) Long non-coding RNA containing retained intron meg3 (MEG3 gene); and maternally expressed 3 transcript variant lncRNA (MEG3) ""lncRNA"" ncRNA (TPA: HG975417.1 and complete sequence - MH929320.1 respectively) were also there in result.

Some (older-not checked for PQS) MEG3 isoforms ncRNA ""other"" ncRNA (complete sequence, alternatively spliced) were also there in result.

PQS 7 and 9 obtained in 16th Variant when search parameter was set to Min G-Group Size: 2 was replaced by another PQSs of same scores (by shifting G-Group/Quartet frame) when search parameter was set to Min G-Group Size: 3.
For further consideration, PQS when search parameter was set to Min G-Group Size: 2 was taken.","15
(11th Variant not available)
(Total=16)","NR_002766.2, NR_003530.2, NR_003531.3, NR_033358.1, NR_033359.1, NR_033360.1, NR_046464.1, NR_046465.2, NR_046466.1, NR_046467.1, _____, NR_046469.1, NR_046470.2, NR_046471.1, NR_046472.1, NR_046473.1","16, 19, 18, 17, 17, 17, 17, 17, 17, 18, ___, 17, 19, 17, 18, 93","14, 17, 16, 15, 15, 15, 15, 15, 15, 16, ___, 15, 17, 15, 16, 81","2, 2, 2, 2, 2, 2, 2, 2, 2, 2, ___, 2, 2, 2, 2, 12

PQS 1 is same in all variants.
PQS 2 is absent in 16th variant.
PQS 2-12 of 16th variant is different from other variants.","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, ___, 0, 0, 0, 0, 0",REVIEWED,"4 (2 - 2G, 2 - C-rich);
4 (2 - 2G, 2 - C-rich);
9 (2 - 2G, 7 - C-rich);
4 (2 - 2G, 2 - C-rich);
9 (2 - 2G, 7 - C-rich);
4 (2 - 2G, 2 - C-rich);
9 (2 - 2G, 7 - C-rich);
4 (2 - 2G, 2 - C-rich);
4 (2 - 2G, 2 - C-rich);
4 (2 - 2G, 2 - C-rich);
____;
9 (2 - 2G, 7 - C-rich);
8 (2 - 2G, 6 - C-rich);
4 (2 - 2G, 2 - C-rich);
4 (2 - 2G, 2 - C-rich);
20 (19 - 2G, 1 - C-rich)","[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

_____;

[0.911, 0.894 (2G); -0.911, -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.885, -0.918, -0.848, -0.911, -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894 (2G); -0.915, -0.816 (C-rich)];

[0.911, 0.894, 0.915, -0.911, 0.87, 0.891, 0.829, 0.962, 0.877,  0.821, 0.911, 0.843, 0.851, 0.798, 0.917, 0.911, 0.911, 0.849, 0.842]",No similarity to PQS (2G) from QGRS mapper,"0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
___;
0;
0;
0;
0;
5 (3G)","0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
___;
0;
0;
0;
0;
[1.23, 1.396, 1.245, 1.422, 1.308 (3G)]","In Variant 16:

PQS 7 (3G) from QGRS mapper is similar to / a part of PQS 1, 2 (3G) from G4 hunter

PQS 2 (3G) from G4 Hunter has a left frame-shift as compared to PQS 7 (3G) from QGRS mapper.

PQS 8 (3G) from QGRS mapper is similar to / a part of PQS 3 (3G) from G4 hunter

PQS 3 (3G) from G4 Hunter has a left frame-shift as compared to PQS 8 (3G) from QGRS mapper.
 
By looking at  PQS 4, 5 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as both PQS have few common G-tracts due to overlap amongst all of these PQS.",GTL2; FP504; prebp1; PRO0518; PRO2160; LINC00023; NCRNA00023; onco-lncRNA-83
MIR17HG,prostate cancer,"Microarray, qPCR etc.",up-regulated,27556357.0,Also Known As: MIHG1; MIRH1; FGLDS2; MIRHG1; C13orf25; LINC00048; miR-17-92; NCRNA00048,2,"NR_027350.1, NR_027349.1","19, 4","18, 3","1, 1","0, 0",REVIEWED,"2 (1 - 2G, 1 - 3G);
2 (1 - 2G, 1 - 3G)","[0.755 (2G); 1 (3G)];
[0.755 (2G); 1 (3G)]",PQS 1  (3G) from QGRS mapper is similar to / a part of PQS 1  (3G) from G4 hunter for both transcript variants,"0;
0","0;
0",No PQS found in G4 Hunter,MIHG1; MIRH1; FGLDS2; MIRHG1; C13orf25; LINC00048; miR-17-92; NCRNA00048
MIR222HG,prostate cancer,"qPCR, luciferase reporter assay, RIP, in vitro knockdown etc.",up-regulated,29540675.0,Also Known As: Lnc-Ang362,1,NR_170290.1,89,84,3,2,VALIDATED,"27 (11 - 2G, 2 - 4G, 14- C-rich)",,"No similarity to PQS (2G) from QGRS mapper

PQS 1 (4G) from QGRS mapper is similar to / a part of PQS 1 (4G) from G4 hunter

PQS 2 (4G) from QGRS mapper is similar to / a part of PQS 2 (4G) from G4 hunter

PQS 1  (4G) from 0.9 threshold overlaps with PQS 1  (4G) from 1.4 threshold, can be considered as one.

PQS 2  (4G) from 0.9 threshold overlaps with PQS 2 (4G) from 1.4 threshold, can be considered as one.","5 (2-4G, 3 - C-rich)","[1.116, 1.167 (4G);
-1.422, -1.422, -1.36 (C-rich)]","PQS 1 (4G) from QGRS mapper is similar to / a part of PQS 1 (4G) from G4 hunter

PQS 2 (4G) from QGRS mapper is similar to / a part of PQS 2 (4G) from G4 hunter

PQS 1  (4G) from 0.9 threshold overlaps with PQS 1  (4G) from 1.4 threshold, can be considered as one.

PQS 2  (4G) from 0.9 threshold overlaps with PQS 2 (4G) from 1.4 threshold, can be considered as one.",Lnc-Ang362
MNX1-AS1,prostate cancer,"qPCR, Western blot",up-regulated,30980513.0,Also Known As: MAYA; CCAT5,1,NR_038835.1,12,10,2,0,VALIDATED,4 (C-rich),"[-0.963, -0.913, -0.978, -0.683 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,1 (C-rich),[-1.362 (C-rich)],No similarity to PQS from QGRS mapper,MAYA; CCAT5
"MYCLo-5
LPP-AS2",prostate cancer,"qPCR, Flow cytometry assay, Cell proliferation assay etc.",down-regulated,26003165.0,"Also Known As: LPP-AS2; MYCLo-5; MYCLo-6

Some (older) MYCLo-5_v1 and v2 long non-coding RNA ""other"" ncRNA (complete sequence-JX046913.1 and JX046914.1 respectively) with PQS-10, 5 respectively were also there in result.

Aliases for LPP-AS2 Gene (From GeneCards database - GCID:GC03M188151)
LPP Antisense RNA 2
LPP-AS2
LPP Antisense RNA 2 (Non-Protein Coding) 2
MYCLo-5
MYCLo-6
NONHSAG036948.2
HSALNG0031463

Alias symbols for LPP-AS2 (From HGNC databse - HGNC ID - HGNC:27952)
MYCLo-5
MYCLo-6
LPP antisense RNA 2 (non-protein coding)

Gene Synonyms for LPP-AS2 (From Ensembl database - Ensembl version - ENSG00000270959.1)
MYCLo-5, MYCLo-6",1 (LPP-AS2),LPP-AS2 (NR_036497.1),18 (LPP-AS2),18 (LPP-AS2),0 (LPP-AS2),0 (LPP-AS2),VALIDATED (LPP-AS2),"10 (2- 2G, 8 - C-rich)","[ 0.936, 0.894 (2G); -1.04, -0.958, -1.011, -0.868, -0.942, -0.915, -0.788, -0.883 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,MYCLo-5; MYCLo-6
"MYCLo-6
LPP-AS2",prostate cancer,"qPCR, Flow cytometry assay, Cell proliferation assay etc.",down-regulated,26003165.0,"Also Known As: LPP-AS2; MYCLo-5; MYCLo-6

Some (older) MYCLo-5_v1 and v2 long non-coding RNA ""other"" ncRNA (complete sequence-JX046913.1 and JX046914.1 respectively) with PQS-10, 5 respectively were also there in result.

Aliases for LPP-AS2 Gene (From GeneCards database - GCID:GC03M188151)
LPP Antisense RNA 2
LPP-AS2
LPP Antisense RNA 2 (Non-Protein Coding) 2
MYCLo-5
MYCLo-6
NONHSAG036948.2
HSALNG0031463

Alias symbols for LPP-AS2 (From HGNC databse - HGNC ID - HGNC:27952)
MYCLo-5
MYCLo-6
LPP antisense RNA 2 (non-protein coding)

Gene Synonyms for LPP-AS2 (From Ensembl database - Ensembl version - ENSG00000270959.1)
MYCLo-5, MYCLo-6",1 (LPP-AS2),LPP-AS2 (NR_036497.1),18 (LPP-AS2),18 (LPP-AS2),0 (LPP-AS2),0 (LPP-AS2),VALIDATED (LPP-AS2),"10 (2- 2G, 8 - C-rich)","[ 0.936, 0.894 (2G); -1.04, -0.958, -1.011, -0.868, -0.942, -0.915, -0.788, -0.883 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,MYCLo-5; MYCLo-6
"MYU 
(VPS9D1-AS1)",prostate cancer,"qPCR, ChIP, Dual luciferase activity assay, Western blot",up-regulated,30132573.0,Also Known As: VPS9D1-AS1; MY,1 (VPS9D1-AS1),VPS9D1-AS1 (NR_036480.1),20 (VPS9D1-AS1),16 (VPS9D1-AS1),4 (VPS9D1-AS1),0 (VPS9D1-AS1),VALIDATED (VPS9D1-AS1),"28 (8 - 2G, 2 - 3G, 18 - C-rich)","[1, 0.894 (3G), 0.87, 0.911, 0.911, 0.933, 0.911, 0.911, 0.957, 0.891 (2G), -0.946, -0.916, -0.956, -1.111, -0.936, -0.885, -0.957, -0.911, -0.878, -0.947, -0.958, -0.898, -0.947, -0.958,  -0.898, -0.833, -0.815, -0.939 (C-rich)]","PQS 7 (3G) of QGRS mapper is similar to / a part of PQS 1 (3G) of G4 hunter 

PQS 16 (3G) of QGRS mapper is similar to / a part of PQS 10 (3G) of G4 hunter ",2 (C-rich),"[-1.333, -1.366 (C-rich)]",No similarity to any PQS (3G) from QGRS mapper.,MYU
"NCK1-AS1
NCK1-DT",prostate cancer,"RT-qPCR, Western blotting",up-regulated,31807161.0,Also Known As: NCK1-DT; NCK1-AS1; SLC35G2-AS1,3 (NCK1-DT),"NCK1-DT (NR_110175.1, NR_110176.1, NR_110177.1)","9, 8, 7 (NCK1-DT)","9, 8, 7 (NCK1-DT)","0, 0, 0 (NCK1-DT)","0, 0, 0 (NCK1-DT)",VALIDATED (NCK1-DT),"3 (2-C-rich, 1-2G);
3 (2-C-rich, 1-2G);
3 (2-C-rich, 1-2G)","[-0.78, -0.94 (C-rich);
0.891 (2G)];

[-0.78, -0.94 (C-rich);
0.891 (2G)];

[-0.78, -0.94 (C-rich);
0.891 (2G)]",,0,0,"No PQS found in
G4 Hunter",NCK1-AS1; SLC35G2-AS1
NEAT1,prostate cancer,"qRT-PCR, Western blot, RIP, Dual luciferase reporter assay",up-regulated,31672604.0,"Also Known As: VINC; TncRNA; LINC00084; NCRNA00084

Some (older, not checked for PQS) NEAT1 lncRNA ""lncRNA"" ncRNA (complete sequence-MK562403.1; experiment-RACE) was also there in result.",2 (NEAT1_MENbeta and MENepsilon),"NEAT1_MENbeta and MENepsilon (NR_131012.1,NR_028272.1 respectively)","150, 41 (NEAT1_MENbeta and MENepsilon)","134, 33 (NEAT1_MENbeta and MENepsilon)","16, 8 (NEAT1_MENbeta and MENepsilon)","0, 0 (NEAT1_MENbeta and MENepsilon)",REVIEWED,"64 (39 - 2G, 25 - C-rich);
25 (23 - 2G, 2 - C-rich )",,No similarity to PQS (2G) from QGRS mapper,"11 (9 - 3G, 2 - C-rich);
8 (3G)","[1.4, 1.37, 1.306, 1.231, 1.38, 1.391, 1.404, 1.153, 1.377 (3G); -1.296, -1.316 (C-rich)];
[1.4, 1.37, 1.306, 1.231, 1.38, 1.391, 1.404, 1.153 (3G)]
","PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter.

PQS 4 (3G) from QGRS mapper is similar to / a part of PQS 2 (3G) from G4 hunter

PQS 6 (3G) from QGRS mapper is similar to / a part of PQS 6 (3G) from G4 hunter

PQS 5, 7, 8, 9, 10, 11 from G4 Hunter has no similarity to PQS from QGRS mapper

PQS 3, 4 (3G) from G4 Hunter has a left frame-shift as compared to PQS 5 (3G) from QGRS mapper. PQS 6 (3G) from G4 Hunter has a left frame-shift as compared to PQS 6 (3G)  from QGRS mapper.

By looking at  PQS 3, 4 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as both PQS have few common G-tracts due to overlap amongst all of these PQS.",VINC; TncRNA; LINC00084; NCRNA00084
NEAT1,prostate cancer,"qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP, etc.",up-regulated,31481527.0,"Also Known As: VINC; TncRNA; LINC00084; NCRNA00084

Some (older, not checked for PQS) NEAT1 lncRNA ""lncRNA"" ncRNA (complete sequence-MK562403.1; experiment-RACE) was also there in result.",2 (NEAT1_MENbeta and MENepsilon),"NEAT1_MENbeta and MENepsilon (NR_131012.1,NR_028272.1 respectively)","150, 41 (NEAT1_MENbeta and MENepsilon)","134, 33 (NEAT1_MENbeta and MENepsilon)","16, 8 (NEAT1_MENbeta and MENepsilon)","0, 0 (NEAT1_MENbeta and MENepsilon)",REVIEWED,"64 (39 - 2G, 25 - C-rich);
25 (23 - 2G, 2 - C-rich )",,No similarity to PQS (2G) from QGRS mapper,"11 (9 - 3G, 2 - C-rich);
8 (3G)","[1.4, 1.37, 1.306, 1.231, 1.38, 1.391, 1.404, 1.153, 1.377 (3G); -1.296, -1.316 (C-rich)];
[1.4, 1.37, 1.306, 1.231, 1.38, 1.391, 1.404, 1.153 (3G)]
","PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter.

PQS 4 (3G) from QGRS mapper is similar to / a part of PQS 2 (3G) from G4 hunter

PQS 6 (3G) from QGRS mapper is similar to / a part of PQS 6 (3G) from G4 hunter

PQS 5, 7, 8, 9, 10, 11 from G4 Hunter has no similarity to PQS from QGRS mapper

PQS 3, 4 (3G) from G4 Hunter has a left frame-shift as compared to PQS 5 (3G) from QGRS mapper. PQS 6 (3G) from G4 Hunter has a left frame-shift as compared to PQS 6 (3G)  from QGRS mapper.

By looking at  PQS 3, 4 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as both PQS have few common G-tracts due to overlap amongst all of these PQS.",VINC; TncRNA; LINC00084; NCRNA00084
NEAT1,prostate cancer,"RNA-seq, qPCR, ChIP etc.",up-regulated,25415230.0,"Also Known As: VINC; TncRNA; LINC00084; NCRNA00084

Some (older, not checked for PQS) NEAT1 lncRNA ""lncRNA"" ncRNA (complete sequence-MK562403.1; experiment-RACE) was also there in result.",2 (NEAT1_MENbeta and MENepsilon),"NEAT1_MENbeta and MENepsilon (NR_131012.1,NR_028272.1 respectively)","150, 41 (NEAT1_MENbeta and MENepsilon)","134, 33 (NEAT1_MENbeta and MENepsilon)","16, 8 (NEAT1_MENbeta and MENepsilon)","0, 0 (NEAT1_MENbeta and MENepsilon)",REVIEWED,"64 (39 - 2G, 25 - C-rich);
25 (23 - 2G, 2 - C-rich )",,No similarity to PQS (2G) from QGRS mapper,"11 (9 - 3G, 2 - C-rich);
8 (3G)","[1.4, 1.37, 1.306, 1.231, 1.38, 1.391, 1.404, 1.153, 1.377 (3G); -1.296, -1.316 (C-rich)];
[1.4, 1.37, 1.306, 1.231, 1.38, 1.391, 1.404, 1.153 (3G)]
","PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter.

PQS 4 (3G) from QGRS mapper is similar to / a part of PQS 2 (3G) from G4 hunter

PQS 6 (3G) from QGRS mapper is similar to / a part of PQS 6 (3G) from G4 hunter

PQS 5, 7, 8, 9, 10, 11 from G4 Hunter has no similarity to PQS from QGRS mapper

PQS 3, 4 (3G) from G4 Hunter has a left frame-shift as compared to PQS 5 (3G) from QGRS mapper. PQS 6 (3G) from G4 Hunter has a left frame-shift as compared to PQS 6 (3G)  from QGRS mapper.

By looking at  PQS 3, 4 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as both PQS have few common G-tracts due to overlap amongst all of these PQS.",VINC; TncRNA; LINC00084; NCRNA00084
NEAT1,prostate cancer,"RNA-seq, Microarray, qPCR, RNAi, Northern blot etc.",up-regulated,23728290.0,"Also Known As: VINC; TncRNA; LINC00084; NCRNA00084

Some (older, not checked for PQS) NEAT1 lncRNA ""lncRNA"" ncRNA (complete sequence-MK562403.1; experiment-RACE) was also there in result.",2 (NEAT1_MENbeta and MENepsilon),"NEAT1_MENbeta and MENepsilon (NR_131012.1,NR_028272.1 respectively)","150, 41 (NEAT1_MENbeta and MENepsilon)","134, 33 (NEAT1_MENbeta and MENepsilon)","16, 8 (NEAT1_MENbeta and MENepsilon)","0, 0 (NEAT1_MENbeta and MENepsilon)",REVIEWED,"64 (39 - 2G, 25 - C-rich);
25 (23 - 2G, 2 - C-rich )",,No similarity to PQS (2G) from QGRS mapper,"11 (9 - 3G, 2 - C-rich);
8 (3G)","[1.4, 1.37, 1.306, 1.231, 1.38, 1.391, 1.404, 1.153, 1.377 (3G); -1.296, -1.316 (C-rich)];
[1.4, 1.37, 1.306, 1.231, 1.38, 1.391, 1.404, 1.153 (3G)]
","PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter.

PQS 4 (3G) from QGRS mapper is similar to / a part of PQS 2 (3G) from G4 hunter

PQS 6 (3G) from QGRS mapper is similar to / a part of PQS 6 (3G) from G4 hunter

PQS 5, 7, 8, 9, 10, 11 from G4 Hunter has no similarity to PQS from QGRS mapper

PQS 3, 4 (3G) from G4 Hunter has a left frame-shift as compared to PQS 5 (3G) from QGRS mapper. PQS 6 (3G) from G4 Hunter has a left frame-shift as compared to PQS 6 (3G)  from QGRS mapper.

By looking at  PQS 3, 4 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as both PQS have few common G-tracts due to overlap amongst all of these PQS.",VINC; TncRNA; LINC00084; NCRNA00084
NORAD,prostate cancer,"qPCR, Western blot",up-regulated,31342822.0,Also Known As: LINC00657,1,NR_027451.1,30,25,5,0,VALIDATED,"12 (6 - 2G, 1 - 3G, 5 - C-rich)","[0.894, 0.778, 0.681, 0.911, 0.75,  0.824 (2G); 1.167 (3G);  -0.911, -0.882, -0.825, -1.118, -0.938 (C-rich)]","PQS 1 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter
",2 (3G),"[1.337, 1.354 (3G)]","PQS 1 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 1 from 0.9 threshold overlaps with PQS 1 from 1.4 threshold, can be considered as one.

PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 2 from G4 Hunter",LINC00657
NR2F2-AS1,prostate cancer,"qPCR , Western blot etc.",up-regulated,31566058.0,,3,"NR_102743.1, NR_102744.1, NR_125738.1","9, 4, 3","9, 4, 3","0, 0, 0","0, 0, 0",VALIDATED,"2 (2G);
0;
2 (c-rich)","[1, 0.891 (2G)];
0;
[-0.911, -0.821 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,NR2F2 antisense RNA 1;NR2F2 antisense RNA 1 (non-protein coding);HSALNG0108391;NR2F2-AS1;NONHSAG017999.2;HSALNG0108393;NONHSAG018003.2;HSALNG0108400;HSALNG0108394;HSALNG0108392;HSALNG0108404;HSALNG0108399
OSTN-AS1,prostate cancer,qPCR,up-regulated,29923546.0,,1,NR_133663.1,1,1,0,0,VALIDATED,0,0,No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,OSTN antisense RNA 1;OSTN antisense RNA 1 (non-protein coding);HSALNG0031592;NONHSAG036974.2;OSTN-AS1
PART1,prostate cancer,"qPCR, Western blotting, Microarray etc.",up-regulated,29261512.0,Also Known As: NCRNA00206,3,"NR_024617.1, NR_028508.1, NR_028509.1","18, 11, 21","18, 11, 20","0, 0, 1","0, 0, 0",VALIDATED,"8 (6 - 2G, 2 - C-rich);
1  (2G);
14 (4 - 2G, 10 - C-rich)","[0.872, -0.86, -0.875, 0.872, 0.913, 0.913, 0.911, 0.911];
[0.872];
[0.872, -0.865, -0.804, 0.72, 0.788, 0.911, -0.843, -0.767, -0.83, -0.96, -0.837, -0.911, -0.911, -0.797]",No similarity to PQS (2G) from QGRS mapper,"0;
0;
1 (3G)","0; 
0; 
[-1.014 (3G)]",PQS (3G) from QGRS mapper is similar to / a part of PQS (3G) from G4 hunter for Variant 3,NCRNA00206
PCA3,prostate cancer,"qPCR, Western blot, etc.",up-regulated,30569456.0,Also known asDD3; PCAT3; NCRNA00019; PRUNE2-AS1,3,"NR_132312.1, NR_015342.2 , NR_132313.1 ",2011-12-11 00:00:00,"11,10,10","1,1,1","0,0,0",REVIEWED,"8 (4- 2G, 4 - C-rich);
8 (4- 2G, 4 - C-rich);
8 (4- 2G, 4 - C-rich)","[0.863, 0.911, 0.813, 0.789 (2G); -1.013, -0.911, -0.911, -0.891 (C-rich)];
[0.863, 0.911, 0.813, 0.789 (2G); -1.013, -0.911, -0.911, -0.891 (C-rich)];
[0.863, 0.911, 0.813, 0.789 (2G); -1.013, -0.911, -0.911, -0.891 (C-rich)]",,"2 (C-rich);
2 (C-rich);
2 (C-rich)","[-1.391, 1.313 (C-rich)];
[-1.391, 1.313 (C-rich)];
[-1.391, 1.313 (C-rich)]",No similarity to PQS from QGRS Mapper,DD3; PCAT3; NCRNA00019; PRUNE2-AS1
PCA3,prostate cancer,PROGENSA PCA3 assay etc.,up-regulated,21883822.0,Also known asDD3; PCAT3; NCRNA00019; PRUNE2-AS1,3,"NR_132312.1, NR_015342.2 , NR_132313.1 ",2011-12-11 00:00:00,"11,10,10","1,1,1","0,0,0",REVIEWED,"8 (4- 2G, 4 - C-rich);
8 (4- 2G, 4 - C-rich);
8 (4- 2G, 4 - C-rich)","[0.863, 0.911, 0.813, 0.789 (2G); -1.013, -0.911, -0.911, -0.891 (C-rich)];
[0.863, 0.911, 0.813, 0.789 (2G); -1.013, -0.911, -0.911, -0.891 (C-rich)];
[0.863, 0.911, 0.813, 0.789 (2G); -1.013, -0.911, -0.911, -0.891 (C-rich)]",,"2 (C-rich);
2 (C-rich);
2 (C-rich)","[-1.391, 1.313 (C-rich)];
[-1.391, 1.313 (C-rich)];
[-1.391, 1.313 (C-rich)]",No similarity to PQS from QGRS Mapper,DD3; PCAT3; NCRNA00019; PRUNE2-AS1
PCA3,prostate cancer,qPCR etc.,differential expression,21655300.0,Also known asDD3; PCAT3; NCRNA00019; PRUNE2-AS1,3,"NR_132312.1, NR_015342.2 , NR_132313.1 ",2011-12-11 00:00:00,"11,10,10","1,1,1","0,0,0",REVIEWED,"8 (4- 2G, 4 - C-rich);
8 (4- 2G, 4 - C-rich);
8 (4- 2G, 4 - C-rich)","[0.863, 0.911, 0.813, 0.789 (2G); -1.013, -0.911, -0.911, -0.891 (C-rich)];
[0.863, 0.911, 0.813, 0.789 (2G); -1.013, -0.911, -0.911, -0.891 (C-rich)];
[0.863, 0.911, 0.813, 0.789 (2G); -1.013, -0.911, -0.911, -0.891 (C-rich)]",,"2 (C-rich);
2 (C-rich);
2 (C-rich)","[-1.391, 1.313 (C-rich)];
[-1.391, 1.313 (C-rich)];
[-1.391, 1.313 (C-rich)]",No similarity to PQS from QGRS Mapper,DD3; PCAT3; NCRNA00019; PRUNE2-AS1
PCA3,prostate cancer,qPCR,up-regulated,28938580.0,Also known asDD3; PCAT3; NCRNA00019; PRUNE2-AS1,3,"NR_132312.1, NR_015342.2 , NR_132313.1 ",2011-12-11 00:00:00,"11,10,10","1,1,1","0,0,0",REVIEWED,"8 (4- 2G, 4 - C-rich);
8 (4- 2G, 4 - C-rich);
8 (4- 2G, 4 - C-rich)","[0.863, 0.911, 0.813, 0.789 (2G); -1.013, -0.911, -0.911, -0.891 (C-rich)];
[0.863, 0.911, 0.813, 0.789 (2G); -1.013, -0.911, -0.911, -0.891 (C-rich)];
[0.863, 0.911, 0.813, 0.789 (2G); -1.013, -0.911, -0.911, -0.891 (C-rich)]",,"2 (C-rich);
2 (C-rich);
2 (C-rich)","[-1.391, 1.313 (C-rich)];
[-1.391, 1.313 (C-rich)];
[-1.391, 1.313 (C-rich)]",No similarity to PQS from QGRS Mapper,DD3; PCAT3; NCRNA00019; PRUNE2-AS1
PCA3,prostate cancer,"qPCR, western blot etc.",differential expression,28739722.0,Also known asDD3; PCAT3; NCRNA00019; PRUNE2-AS1,3,"NR_132312.1, NR_015342.2 , NR_132313.1 ",2011-12-11 00:00:00,"11,10,10","1,1,1","0,0,0",REVIEWED,"8 (4- 2G, 4 - C-rich);
8 (4- 2G, 4 - C-rich);
8 (4- 2G, 4 - C-rich)","[0.863, 0.911, 0.813, 0.789 (2G); -1.013, -0.911, -0.911, -0.891 (C-rich)];
[0.863, 0.911, 0.813, 0.789 (2G); -1.013, -0.911, -0.911, -0.891 (C-rich)];
[0.863, 0.911, 0.813, 0.789 (2G); -1.013, -0.911, -0.911, -0.891 (C-rich)]",,"2 (C-rich);
2 (C-rich);
2 (C-rich)","[-1.391, 1.313 (C-rich)];
[-1.391, 1.313 (C-rich)];
[-1.391, 1.313 (C-rich)]",No similarity to PQS from QGRS Mapper,DD3; PCAT3; NCRNA00019; PRUNE2-AS1
PCA3,prostate cancer,qPCR etc.,down-regulated,26960690.0,Also known asDD3; PCAT3; NCRNA00019; PRUNE2-AS1,3,"NR_132312.1, NR_015342.2 , NR_132313.1 ",2011-12-11 00:00:00,"11,10,10","1,1,1","0,0,0",REVIEWED,"8 (4- 2G, 4 - C-rich);
8 (4- 2G, 4 - C-rich);
8 (4- 2G, 4 - C-rich)","[0.863, 0.911, 0.813, 0.789 (2G); -1.013, -0.911, -0.911, -0.891 (C-rich)];
[0.863, 0.911, 0.813, 0.789 (2G); -1.013, -0.911, -0.911, -0.891 (C-rich)];
[0.863, 0.911, 0.813, 0.789 (2G); -1.013, -0.911, -0.911, -0.891 (C-rich)]",,"2 (C-rich);
2 (C-rich);
2 (C-rich)","[-1.391, 1.313 (C-rich)];
[-1.391, 1.313 (C-rich)];
[-1.391, 1.313 (C-rich)]",No similarity to PQS from QGRS Mapper,DD3; PCAT3; NCRNA00019; PRUNE2-AS1
PCA3,prostate cancer,"qPCR, RNAi, Northern blot, Cell apoptosis assay etc.",up-regulated,26080435.0,Also known asDD3; PCAT3; NCRNA00019; PRUNE2-AS1,3,"NR_132312.1, NR_015342.2 , NR_132313.1 ",2011-12-11 00:00:00,"11,10,10","1,1,1","0,0,0",REVIEWED,"8 (4- 2G, 4 - C-rich);
8 (4- 2G, 4 - C-rich);
8 (4- 2G, 4 - C-rich)","[0.863, 0.911, 0.813, 0.789 (2G); -1.013, -0.911, -0.911, -0.891 (C-rich)];
[0.863, 0.911, 0.813, 0.789 (2G); -1.013, -0.911, -0.911, -0.891 (C-rich)];
[0.863, 0.911, 0.813, 0.789 (2G); -1.013, -0.911, -0.911, -0.891 (C-rich)]",,"2 (C-rich);
2 (C-rich);
2 (C-rich)","[-1.391, 1.313 (C-rich)];
[-1.391, 1.313 (C-rich)];
[-1.391, 1.313 (C-rich)]",No similarity to PQS from QGRS Mapper,DD3; PCAT3; NCRNA00019; PRUNE2-AS1
PCA3,prostate cancer,PCR etc.,up-regulated,25445501.0,Also known asDD3; PCAT3; NCRNA00019; PRUNE2-AS1,3,"NR_132312.1, NR_015342.2 , NR_132313.1 ",2011-12-11 00:00:00,"11,10,10","1,1,1","0,0,0",REVIEWED,"8 (4- 2G, 4 - C-rich);
8 (4- 2G, 4 - C-rich);
8 (4- 2G, 4 - C-rich)","[0.863, 0.911, 0.813, 0.789 (2G); -1.013, -0.911, -0.911, -0.891 (C-rich)];
[0.863, 0.911, 0.813, 0.789 (2G); -1.013, -0.911, -0.911, -0.891 (C-rich)];
[0.863, 0.911, 0.813, 0.789 (2G); -1.013, -0.911, -0.911, -0.891 (C-rich)]",,"2 (C-rich);
2 (C-rich);
2 (C-rich)","[-1.391, 1.313 (C-rich)];
[-1.391, 1.313 (C-rich)];
[-1.391, 1.313 (C-rich)]",No similarity to PQS from QGRS Mapper,DD3; PCAT3; NCRNA00019; PRUNE2-AS1
PCA3,prostate cancer,"qPCR, in vitro knockdown etc.",up-regulated,23130941.0,Also known asDD3; PCAT3; NCRNA00019; PRUNE2-AS1,3,"NR_132312.1, NR_015342.2 , NR_132313.1 ",2011-12-11 00:00:00,"11,10,10","1,1,1","0,0,0",REVIEWED,"8 (4- 2G, 4 - C-rich);
8 (4- 2G, 4 - C-rich);
8 (4- 2G, 4 - C-rich)","[0.863, 0.911, 0.813, 0.789 (2G); -1.013, -0.911, -0.911, -0.891 (C-rich)];
[0.863, 0.911, 0.813, 0.789 (2G); -1.013, -0.911, -0.911, -0.891 (C-rich)];
[0.863, 0.911, 0.813, 0.789 (2G); -1.013, -0.911, -0.911, -0.891 (C-rich)]",,"2 (C-rich);
2 (C-rich);
2 (C-rich)","[-1.391, 1.313 (C-rich)];
[-1.391, 1.313 (C-rich)];
[-1.391, 1.313 (C-rich)]",No similarity to PQS from QGRS Mapper,DD3; PCAT3; NCRNA00019; PRUNE2-AS1
PCA3,prostate cancer,"RNA-seq, qPCR etc.",up-regulated,22349460.0,Also known asDD3; PCAT3; NCRNA00019; PRUNE2-AS1,3,"NR_132312.1, NR_015342.2 , NR_132313.1 ",2011-12-11 00:00:00,"11,10,10","1,1,1","0,0,0",REVIEWED,"8 (4- 2G, 4 - C-rich);
8 (4- 2G, 4 - C-rich);
8 (4- 2G, 4 - C-rich)","[0.863, 0.911, 0.813, 0.789 (2G); -1.013, -0.911, -0.911, -0.891 (C-rich)];
[0.863, 0.911, 0.813, 0.789 (2G); -1.013, -0.911, -0.911, -0.891 (C-rich)];
[0.863, 0.911, 0.813, 0.789 (2G); -1.013, -0.911, -0.911, -0.891 (C-rich)]",,"2 (C-rich);
2 (C-rich);
2 (C-rich)","[-1.391, 1.313 (C-rich)];
[-1.391, 1.313 (C-rich)];
[-1.391, 1.313 (C-rich)]",No similarity to PQS from QGRS Mapper,DD3; PCAT3; NCRNA00019; PRUNE2-AS1
PCA3,prostate cancer,qPCR etc.,up-regulated,20114043.0,Also known asDD3; PCAT3; NCRNA00019; PRUNE2-AS1,3,"NR_132312.1, NR_015342.2 , NR_132313.1 ",2011-12-11 00:00:00,"11,10,10","1,1,1","0,0,0",REVIEWED,"8 (4- 2G, 4 - C-rich);
8 (4- 2G, 4 - C-rich);
8 (4- 2G, 4 - C-rich)","[0.863, 0.911, 0.813, 0.789 (2G); -1.013, -0.911, -0.911, -0.891 (C-rich)];
[0.863, 0.911, 0.813, 0.789 (2G); -1.013, -0.911, -0.911, -0.891 (C-rich)];
[0.863, 0.911, 0.813, 0.789 (2G); -1.013, -0.911, -0.911, -0.891 (C-rich)]",,"2 (C-rich);
2 (C-rich);
2 (C-rich)","[-1.391, 1.313 (C-rich)];
[-1.391, 1.313 (C-rich)];
[-1.391, 1.313 (C-rich)]",No similarity to PQS from QGRS Mapper,DD3; PCAT3; NCRNA00019; PRUNE2-AS1
PCA3,prostate cancer,qPCR etc.,up-regulated,20332487.0,Also known asDD3; PCAT3; NCRNA00019; PRUNE2-AS1,3,"NR_132312.1, NR_015342.2 , NR_132313.1 ",2011-12-11 00:00:00,"11,10,10","1,1,1","0,0,0",REVIEWED,"8 (4- 2G, 4 - C-rich);
8 (4- 2G, 4 - C-rich);
8 (4- 2G, 4 - C-rich)","[0.863, 0.911, 0.813, 0.789 (2G); -1.013, -0.911, -0.911, -0.891 (C-rich)];
[0.863, 0.911, 0.813, 0.789 (2G); -1.013, -0.911, -0.911, -0.891 (C-rich)];
[0.863, 0.911, 0.813, 0.789 (2G); -1.013, -0.911, -0.911, -0.891 (C-rich)]",,"2 (C-rich);
2 (C-rich);
2 (C-rich)","[-1.391, 1.313 (C-rich)];
[-1.391, 1.313 (C-rich)];
[-1.391, 1.313 (C-rich)]",No similarity to PQS from QGRS Mapper,DD3; PCAT3; NCRNA00019; PRUNE2-AS1
PCA3,prostate cancer,qPCR etc.,up-regulated,19319183.0,Also known asDD3; PCAT3; NCRNA00019; PRUNE2-AS1,3,"NR_132312.1, NR_015342.2 , NR_132313.1 ",2011-12-11 00:00:00,"11,10,10","1,1,1","0,0,0",REVIEWED,"8 (4- 2G, 4 - C-rich);
8 (4- 2G, 4 - C-rich);
8 (4- 2G, 4 - C-rich)","[0.863, 0.911, 0.813, 0.789 (2G); -1.013, -0.911, -0.911, -0.891 (C-rich)];
[0.863, 0.911, 0.813, 0.789 (2G); -1.013, -0.911, -0.911, -0.891 (C-rich)];
[0.863, 0.911, 0.813, 0.789 (2G); -1.013, -0.911, -0.911, -0.891 (C-rich)]",,"2 (C-rich);
2 (C-rich);
2 (C-rich)","[-1.391, 1.313 (C-rich)];
[-1.391, 1.313 (C-rich)];
[-1.391, 1.313 (C-rich)]",No similarity to PQS from QGRS Mapper,DD3; PCAT3; NCRNA00019; PRUNE2-AS1
PCA3,prostate cancer,Northern blot etc.,up-regulated,14607216.0,Also known asDD3; PCAT3; NCRNA00019; PRUNE2-AS1,3,"NR_132312.1, NR_015342.2 , NR_132313.1 ",2011-12-11 00:00:00,"11,10,10","1,1,1","0,0,0",REVIEWED,"8 (4- 2G, 4 - C-rich);
8 (4- 2G, 4 - C-rich);
8 (4- 2G, 4 - C-rich)","[0.863, 0.911, 0.813, 0.789 (2G); -1.013, -0.911, -0.911, -0.891 (C-rich)];
[0.863, 0.911, 0.813, 0.789 (2G); -1.013, -0.911, -0.911, -0.891 (C-rich)];
[0.863, 0.911, 0.813, 0.789 (2G); -1.013, -0.911, -0.911, -0.891 (C-rich)]",,"2 (C-rich);
2 (C-rich);
2 (C-rich)","[-1.391, 1.313 (C-rich)];
[-1.391, 1.313 (C-rich)];
[-1.391, 1.313 (C-rich)]",No similarity to PQS from QGRS Mapper,DD3; PCAT3; NCRNA00019; PRUNE2-AS1
PCA3,prostate cancer,qPCR etc.,up-regulated,11980670.0,Also known asDD3; PCAT3; NCRNA00019; PRUNE2-AS1,3,"NR_132312.1, NR_015342.2 , NR_132313.1 ",2011-12-11 00:00:00,"11,10,10","1,1,1","0,0,0",REVIEWED,"8 (4- 2G, 4 - C-rich);
8 (4- 2G, 4 - C-rich);
8 (4- 2G, 4 - C-rich)","[0.863, 0.911, 0.813, 0.789 (2G); -1.013, -0.911, -0.911, -0.891 (C-rich)];
[0.863, 0.911, 0.813, 0.789 (2G); -1.013, -0.911, -0.911, -0.891 (C-rich)];
[0.863, 0.911, 0.813, 0.789 (2G); -1.013, -0.911, -0.911, -0.891 (C-rich)]",,"2 (C-rich);
2 (C-rich);
2 (C-rich)","[-1.391, 1.313 (C-rich)];
[-1.391, 1.313 (C-rich)];
[-1.391, 1.313 (C-rich)]",No similarity to PQS from QGRS Mapper,DD3; PCAT3; NCRNA00019; PRUNE2-AS1
PCA3,prostate cancer,"qPCR, Northern blot etc.",up-regulated,10606244.0,Also known asDD3; PCAT3; NCRNA00019; PRUNE2-AS1,3,"NR_132312.1, NR_015342.2 , NR_132313.1 ",2011-12-11 00:00:00,"11,10,10","1,1,1","0,0,0",REVIEWED,"8 (4- 2G, 4 - C-rich);
8 (4- 2G, 4 - C-rich);
8 (4- 2G, 4 - C-rich)","[0.863, 0.911, 0.813, 0.789 (2G); -1.013, -0.911, -0.911, -0.891 (C-rich)];
[0.863, 0.911, 0.813, 0.789 (2G); -1.013, -0.911, -0.911, -0.891 (C-rich)];
[0.863, 0.911, 0.813, 0.789 (2G); -1.013, -0.911, -0.911, -0.891 (C-rich)]",,"2 (C-rich);
2 (C-rich);
2 (C-rich)","[-1.391, 1.313 (C-rich)];
[-1.391, 1.313 (C-rich)];
[-1.391, 1.313 (C-rich)]",No similarity to PQS from QGRS Mapper,DD3; PCAT3; NCRNA00019; PRUNE2-AS1
PCA3,prostate cancer,"qPCR, RNAi, Western blot, ChIP, Luciferase reporter assay, Cell proliferation assay etc.",differential expression,27743381.0,Also known asDD3; PCAT3; NCRNA00019; PRUNE2-AS1,3,"NR_132312.1, NR_015342.2 , NR_132313.1 ",2011-12-11 00:00:00,"11,10,10","1,1,1","0,0,0",REVIEWED,"8 (4- 2G, 4 - C-rich);
8 (4- 2G, 4 - C-rich);
8 (4- 2G, 4 - C-rich)","[0.863, 0.911, 0.813, 0.789 (2G); -1.013, -0.911, -0.911, -0.891 (C-rich)];
[0.863, 0.911, 0.813, 0.789 (2G); -1.013, -0.911, -0.911, -0.891 (C-rich)];
[0.863, 0.911, 0.813, 0.789 (2G); -1.013, -0.911, -0.911, -0.891 (C-rich)]",,"2 (C-rich);
2 (C-rich);
2 (C-rich)","[-1.391, 1.313 (C-rich)];
[-1.391, 1.313 (C-rich)];
[-1.391, 1.313 (C-rich)]",No similarity to PQS from QGRS Mapper,DD3; PCAT3; NCRNA00019; PRUNE2-AS1
PCA3,prostate cancer,"RNA-seq, Microarray, qPCR, RNAi, Northern blot etc.",up-regulated,23728290.0,Also known asDD3; PCAT3; NCRNA00019; PRUNE2-AS1,3,"NR_132312.1, NR_015342.2 , NR_132313.1 ",2011-12-11 00:00:00,"11,10,10","1,1,1","0,0,0",REVIEWED,"8 (4- 2G, 4 - C-rich);
8 (4- 2G, 4 - C-rich);
8 (4- 2G, 4 - C-rich)","[0.863, 0.911, 0.813, 0.789 (2G); -1.013, -0.911, -0.911, -0.891 (C-rich)];
[0.863, 0.911, 0.813, 0.789 (2G); -1.013, -0.911, -0.911, -0.891 (C-rich)];
[0.863, 0.911, 0.813, 0.789 (2G); -1.013, -0.911, -0.911, -0.891 (C-rich)]",,"2 (C-rich);
2 (C-rich);
2 (C-rich)","[-1.391, 1.313 (C-rich)];
[-1.391, 1.313 (C-rich)];
[-1.391, 1.313 (C-rich)]",No similarity to PQS from QGRS Mapper,DD3; PCAT3; NCRNA00019; PRUNE2-AS1
PCA3,prostate cancer,"qPCR, Northern blot etc.",up-regulated,23726266.0,Also known asDD3; PCAT3; NCRNA00019; PRUNE2-AS1,3,"NR_132312.1, NR_015342.2 , NR_132313.1 ",2011-12-11 00:00:00,"11,10,10","1,1,1","0,0,0",REVIEWED,"8 (4- 2G, 4 - C-rich);
8 (4- 2G, 4 - C-rich);
8 (4- 2G, 4 - C-rich)","[0.863, 0.911, 0.813, 0.789 (2G); -1.013, -0.911, -0.911, -0.891 (C-rich)];
[0.863, 0.911, 0.813, 0.789 (2G); -1.013, -0.911, -0.911, -0.891 (C-rich)];
[0.863, 0.911, 0.813, 0.789 (2G); -1.013, -0.911, -0.911, -0.891 (C-rich)]",,"2 (C-rich);
2 (C-rich);
2 (C-rich)","[-1.391, 1.313 (C-rich)];
[-1.391, 1.313 (C-rich)];
[-1.391, 1.313 (C-rich)]",No similarity to PQS from QGRS Mapper,DD3; PCAT3; NCRNA00019; PRUNE2-AS1
PCAN-R1,prostate cancer,"RNA-seq, Microarray, qPCR, RNAi, Northern blot etc.",up-regulated,23728290.0,Also Known As: PCAT6; KDM5BAS1; ncRNA-a2; KDM5B-AS1; onco-lncRNA-96,2,"NR_046325.1, NR_046326.1",2021-04-03 00:00:00,2021-03-02 00:00:00,2021-01-01 00:00:00,"0, 0",VALIDATED,"12 (2 - 2G; 10 - C-rich);
10( 2 - 2G; 8 - C-rich)","[0.935, 0.804 (2G); -0.862, -0.957, -0.915, -0.918, -0.865, -0.911, -0.896, -0.914, -0.945, -0.915 (C-rich)];
[0.935, 0.804 (2G); -0.862, -0.957, -0.915, -0.918, -0.865, -0.911, -0.896, -0.914 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,"2 (C-rich);
1 (C-rich)","[ 1.417 (3G); -1.3 (C-rich)];
[-1.3 (C-rich)]",No similarity to PQS from QGRS Mapper,PCAN-R1; KDM5BAS1; ncRNA-a2; KDM5B-AS1; onco-lncRNA-96
"PCAN-R2 
PCAT7",prostate cancer,"RNA-seq, Microarray, qPCR, RNAi, Northern blot etc.",up-regulated,23728290.0,Also Known as: PCAT7; PCAN-R2,4 (PCAT7),"PCAT7 (NR_121566.2, NR_121567.2 , NR_121568.2, NR_121569.2)","16, 15, 11, 15 (PCAT7)","15, 14, 10, 14 (PCAT7)","1, 1, 1, 1 (PCAT7)","0, 0, 0 ,0 (PCAT7)",VALIDATED  (PCAT7),"5 (2G);
5 (2G);
2 (2G);
5 (2G)","[0.879, 0.891, 0.904, 0.746, 0.872 (2G)];
[0.879, 0.891, 0.904, 0.746, 0.872 (2G)];
[0.746, 0.872 (2G)];
[0.879, 0.891, 0.904, 0.746, 0.872 (2G)]",No similarity to PQS (2G) from QGRS mapper,"0, 0, 0, 0","0, 0, 0, 0",No PQS found in G4 Hunter,PCAN-R2
PCAT1,prostate cancer,"qPCR, RNA-seq, RIP",up-regulated,30773595.0,"Also Known As: PCA1; PiHL; PCAT-1

Some (older, not checked for PQS) PCAT1 long non-coding RNA ""other"" ncRNA (complete sequence-HQ605084.1) was also there in result.",1,NR_045262.2,14,14,0,0,REVIEWED,0,0,No PQS found in G4 hunter,0,0,No PQS found in G4 hunter,PCA1; PiHL; PCAT-1
PCAT1,prostate cancer,qPCR etc.,up-regulated,28945760.0,"Also Known As: PCA1; PiHL; PCAT-1

Some (older, not checked for PQS) PCAT1 long non-coding RNA ""other"" ncRNA (complete sequence-HQ605084.1) was also there in result.",1,NR_045262.2,14,14,0,0,REVIEWED,0,0,No PQS found in G4 hunter,0,0,No PQS found in G4 hunter,PCA1; PiHL; PCAT-1
PCAT1,prostate cancer,"qPCR, RNAi, Luciferase reporter assay etc.",up-regulated,25425964.0,"Also Known As: PCA1; PiHL; PCAT-1

Some (older, not checked for PQS) PCAT1 long non-coding RNA ""other"" ncRNA (complete sequence-HQ605084.1) was also there in result.",1,NR_045262.2,14,14,0,0,REVIEWED,0,0,No PQS found in G4 hunter,0,0,No PQS found in G4 hunter,PCA1; PiHL; PCAT-1
PCAT1,prostate cancer,qPCR etc.,up-regulated,29378170.0,"Also Known As: PCA1; PiHL; PCAT-1

Some (older, not checked for PQS) PCAT1 long non-coding RNA ""other"" ncRNA (complete sequence-HQ605084.1) was also there in result.",1,NR_045262.2,14,14,0,0,REVIEWED,0,0,No PQS found in G4 hunter,0,0,No PQS found in G4 hunter,PCA1; PiHL; PCAT-1
PCAT1,prostate cancer,"qPCR, in vitro knockdown, Western blot",up-regulated,28884413.0,"Also Known As: PCA1; PiHL; PCAT-1

Some (older, not checked for PQS) PCAT1 long non-coding RNA ""other"" ncRNA (complete sequence-HQ605084.1) was also there in result.",1,NR_045262.2,14,14,0,0,REVIEWED,0,0,No PQS found in G4 hunter,0,0,No PQS found in G4 hunter,PCA1; PiHL; PCAT-1
PCAT1,prostate cancer,"qPCR, luciferase reporter assays, Western blot etc.",up-regulated,28922730.0,"Also Known As: PCA1; PiHL; PCAT-1

Some (older, not checked for PQS) PCAT1 long non-coding RNA ""other"" ncRNA (complete sequence-HQ605084.1) was also there in result.",1,NR_045262.2,14,14,0,0,REVIEWED,0,0,No PQS found in G4 hunter,0,0,No PQS found in G4 hunter,PCA1; PiHL; PCAT-1
PCAT1,prostate cancer,"Microarray, qPCR, RNAi, Western blot, Luciferase reporter assay etc.",up-regulated,24473064.0,"Also Known As: PCA1; PiHL; PCAT-1

Some (older, not checked for PQS) PCAT1 long non-coding RNA ""other"" ncRNA (complete sequence-HQ605084.1) was also there in result.",1,NR_045262.2,14,14,0,0,REVIEWED,0,0,No PQS found in G4 hunter,0,0,No PQS found in G4 hunter,PCA1; PiHL; PCAT-1
PCAT1,prostate cancer,"RNA-seq, Microarray, qPCR, RNAi, Northern blot etc.",up-regulated,23728290.0,"Also Known As: PCA1; PiHL; PCAT-1

Some (older, not checked for PQS) PCAT1 long non-coding RNA ""other"" ncRNA (complete sequence-HQ605084.1) was also there in result.",1,NR_045262.2,14,14,0,0,REVIEWED,0,0,No PQS found in G4 hunter,0,0,No PQS found in G4 hunter,PCA1; PiHL; PCAT-1
PCAT1,prostate cancer,"RNA-seq, qPCR, Western blot etc.",up-regulated,21804560.0,"Also Known As: PCA1; PiHL; PCAT-1

Some (older, not checked for PQS) PCAT1 long non-coding RNA ""other"" ncRNA (complete sequence-HQ605084.1) was also there in result.",1,NR_045262.2,14,14,0,0,REVIEWED,0,0,No PQS found in G4 hunter,0,0,No PQS found in G4 hunter,PCA1; PiHL; PCAT-1
PCAT14,prostate cancer,"RNA-seq, qPCR, RNAi, ISH etc.",up-regulated,27566105.0,,1,NR_109832.1,7,7,0,0,VALIDATED,3 (2G),"[0.957, 0.849, 0.911 (2G)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter,prostate cancer associated transcript 14;prostate cancer associated transcript 14 (non-protein coding);HSALNG0134403;PCAT14
PCAT18,prostate cancer,"Microarray, qPCR, RNAi etc.",up-regulated,24519926.0,Also Known As: LINC01092,1,NR_024259.1 ,8,7,1,0,VALIDATED,1 (3G),[0.833 (3G)],"
PQS 10 (3G) of QGRS mapper is similar to / a part of PQS 1 (3G) of G4 hunter ",0,0,No PQS found in G4 Hunter,LINC01092
PCAT19,prostate cancer,"qPCR, Western blot, luciferase reporter assay",,30033362.0,"Also Known As: LINC01190

Variant X1,X2,X3: PREDICTED Sequence,",5,"NR_040109.2, NR_136334.1 (Variant 1 and 2)
+
XR_001756399.1 , XR_001756400.1 , XR_002958911.1 (Variant X1, X2 and X3)","18, 15 (Variant 1 and 2)
+
5, 4, 7","18, 15 (Variant 1 and 2)
+
5, 4,7","0, 0 (Variant 1 and 2)
+
0, 0,0","0, 0 (Variant 1 and 2)
+
0, 0,0","VALIDATED (Variant 1 and 2)
+
PREDICTED (Variant X1, X2, X3)","1 (C-rich);
1 (C-rich)","[-0.766 (C-rich)];
[-0.766 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter,LINC01190
PCAT29,prostate cancer,"qPCR, Western blot etc.",down-regulated,28467474.0,,2," NR_126437.1, NR_126438.1",2021-07-04 00:00:00,2021-07-04 00:00:00,"0, 0","0, 0",REVIEWED,"2 (2G);
0","[0.911, 0.917 (2G)];
0",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter,"prostate cancer associated transcript 29;prostate cancer associated transcript 29 (non-protein coding);DRAIC;downregulated RNA in cancer, inhibitor of cell invasion and migration;NONHSAG017290.2;lnc-RPLP1-12;HSALNG0106856;NONHSAG017288.2;HSALNG0106873;HSALNG0106864;HSALNG0106875;HSALNG0106861;HSALNG0106865;HSALNG0106878;NONHSAG017294.2;HSALNG0106871"
PCAT29,prostate cancer,"Microarray, qPCR etc.",down-regulated,25030374.0,,2," NR_126437.1, NR_126438.1",2021-07-04 00:00:00,2021-07-04 00:00:00,"0, 0","0, 0",REVIEWED,"2 (2G);
0","[0.911, 0.917 (2G)];
0",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter,"prostate cancer associated transcript 29;prostate cancer associated transcript 29 (non-protein coding);DRAIC;downregulated RNA in cancer, inhibitor of cell invasion and migration;NONHSAG017290.2;lnc-RPLP1-12;HSALNG0106856;NONHSAG017288.2;HSALNG0106873;HSALNG0106864;HSALNG0106875;HSALNG0106861;HSALNG0106865;HSALNG0106878;NONHSAG017294.2;HSALNG0106871"
PCAT3,prostate cancer,"qRT-PCR, Western blot, Luciferase reporter assay, in vitro knockdown",up-regulated,29552304.0,Also known asDD3; PCA3; NCRNA00019; PRUNE2-AS1,3,"NR_132312.1, NR_015342.2 , NR_132313.1 ",2011-12-11 00:00:00,"11,10,10","1,1,1","0,0,0",REVIEWED,"8 (4- 2G, 4 - C-rich);
8 (4- 2G, 4 - C-rich);
8 (4- 2G, 4 - C-rich)","[0.863, 0.911, 0.813, 0.789 (2G); -1.013, -0.911, -0.911, -0.891 (C-rich)];
[0.863, 0.911, 0.813, 0.789 (2G); -1.013, -0.911, -0.911, -0.891 (C-rich)];
[0.863, 0.911, 0.813, 0.789 (2G); -1.013, -0.911, -0.911, -0.891 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,"2 (C-rich);
2 (C-rich);
2 (C-rich)","[-1.391, 1.313 (C-rich)];
[-1.391, 1.313 (C-rich)];
[-1.391, 1.313 (C-rich)]",,DD3; PCAT3; NCRNA00019; PRUNE2-AS1
PCAT5,prostate cancer,"RNA-seq, qPCR, RNAi etc.",up-regulated,26282172.0,"Also Known As: LINC01452, TPCAT-10-36067",1,NR_110138.1,25,25,0,0,VALIDATED,10,"[0.961, 0.913, 0.857 (2G); -0.845, -0.854, -0.872, -0.891, -0.911, -0.913 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,LINC01452; TPCAT-10-36067
PCAT7,prostate cancer,"qRT-PCR, Western blotting, Luciferase reporter assay, RIP",up-regulated,31925912.0,Also Known As: PCAN-R2,4,"NR_121566.2, NR_121567.2 , NR_121568.2, NR_121569.2","16, 15, 11, 15","15, 14, 10, 14","1, 1, 1, 1 ","0, 0, 0 ,0 ",VALIDATED ,"5 (2G);
5 (2G);
2 (2G);
5 (2G)","[0.879, 0.891, 0.904, 0.746, 0.872 (2G)];
[0.879, 0.891, 0.904, 0.746, 0.872 (2G)];
[0.746, 0.872 (2G)];
[0.879, 0.891, 0.904, 0.746, 0.872 (2G)]",No similarity to PQS (2G) from QGRS mapper,"0, 0, 0, 0","0, 0, 0, 0",No PQS found in G4 Hunter,PCAN-R2
PCAT9,prostate cancer,"qPCR, Western blot, Luciferase reporter assay, in vitro knockdown",up-regulated,29552304.0,"Also Known As: PCGEM1 ; LINC00071; NCRNA00071
 
 Some (older-not checked for PQS) Long non-coding RNA pcgem1 (pcgem1 gene) ""antisense RNA"" ncRNA (TPA: HG975429.1) was also there in result.",2,"NR_002769.1, NR_152587.1",2021-07-08 00:00:00,2021-07-08 00:00:00,"0, 0","0, 0",REVIEWED,0,0,No PQS found in G4 Hunter,0,0,No PQS found in G4 Hunter,PCAT9; LINC00071; NCRNA00071
PCGEM1,prostate cancer,"qPCR, RNAi, Western blot, ChIP, Luciferase reporter assay, MTT assay etc.",up-regulated,27682980.0,,Refer PCAT9,,,,,,REVIEWED,0,0,No PQS found in G4 Hunter,0,0,No PQS found in G4 Hunter,"PCGEM1 prostate-specific transcript;NCRNA00071;LINC00071;PCAT9;non-protein coding RNA 71;long intergenic non-protein coding RNA 71;prostate cancer associated transcript 9;prostate cancer gene expression marker 1;prostate-specific transcript 1 (non-protein coding);PCGEM1, prostate-specific transcript (non-protein coding);PCGEM1, prostate-specific transcript;HSALNG0021209;HSALNG0021208;PCGEM1;NONHSAG030128.2;NONHSAG030129.2"
PCGEM1,prostate cancer,"qPCR, Flow cytometry assay etc.",down-regulated,25619388.0,,Refer PCAT9,,,,,,REVIEWED,0,0,No PQS found in G4 Hunter,0,0,No PQS found in G4 Hunter,"PCGEM1 prostate-specific transcript;NCRNA00071;LINC00071;PCAT9;non-protein coding RNA 71;long intergenic non-protein coding RNA 71;prostate cancer associated transcript 9;prostate cancer gene expression marker 1;prostate-specific transcript 1 (non-protein coding);PCGEM1, prostate-specific transcript (non-protein coding);PCGEM1, prostate-specific transcript;HSALNG0021209;HSALNG0021208;PCGEM1;NONHSAG030128.2;NONHSAG030129.2"
PCGEM1,prostate cancer,qPCR etc.,up-regulated,25512540.0,,Refer PCAT9,,,,,,REVIEWED,0,0,No PQS found in G4 Hunter,0,0,No PQS found in G4 Hunter,"PCGEM1 prostate-specific transcript;NCRNA00071;LINC00071;PCAT9;non-protein coding RNA 71;long intergenic non-protein coding RNA 71;prostate cancer associated transcript 9;prostate cancer gene expression marker 1;prostate-specific transcript 1 (non-protein coding);PCGEM1, prostate-specific transcript (non-protein coding);PCGEM1, prostate-specific transcript;HSALNG0021209;HSALNG0021208;PCGEM1;NONHSAG030128.2;NONHSAG030129.2"
PCGEM1,prostate cancer,qPCR etc.,differential expression,23459097.0,,Refer PCAT9,,,,,,REVIEWED,0,0,No PQS found in G4 Hunter,0,0,No PQS found in G4 Hunter,"PCGEM1 prostate-specific transcript;NCRNA00071;LINC00071;PCAT9;non-protein coding RNA 71;long intergenic non-protein coding RNA 71;prostate cancer associated transcript 9;prostate cancer gene expression marker 1;prostate-specific transcript 1 (non-protein coding);PCGEM1, prostate-specific transcript (non-protein coding);PCGEM1, prostate-specific transcript;HSALNG0021209;HSALNG0021208;PCGEM1;NONHSAG030128.2;NONHSAG030129.2"
PCGEM1,prostate cancer,qPCR etc.,up-regulated,20868494.0,,Refer PCAT9,,,,,,REVIEWED,0,0,No PQS found in G4 Hunter,0,0,No PQS found in G4 Hunter,"PCGEM1 prostate-specific transcript;NCRNA00071;LINC00071;PCAT9;non-protein coding RNA 71;long intergenic non-protein coding RNA 71;prostate cancer associated transcript 9;prostate cancer gene expression marker 1;prostate-specific transcript 1 (non-protein coding);PCGEM1, prostate-specific transcript (non-protein coding);PCGEM1, prostate-specific transcript;HSALNG0021209;HSALNG0021208;PCGEM1;NONHSAG030128.2;NONHSAG030129.2"
PCGEM1,prostate cancer,qPCR etc.,up-regulated,19186008.0,,Refer PCAT9,,,,,,REVIEWED,0,0,No PQS found in G4 Hunter,0,0,No PQS found in G4 Hunter,"PCGEM1 prostate-specific transcript;NCRNA00071;LINC00071;PCAT9;non-protein coding RNA 71;long intergenic non-protein coding RNA 71;prostate cancer associated transcript 9;prostate cancer gene expression marker 1;prostate-specific transcript 1 (non-protein coding);PCGEM1, prostate-specific transcript (non-protein coding);PCGEM1, prostate-specific transcript;HSALNG0021209;HSALNG0021208;PCGEM1;NONHSAG030128.2;NONHSAG030129.2"
PCGEM1,prostate cancer,Northern blot etc.,up-regulated,16569192.0,,Refer PCAT9,,,,,,REVIEWED,0,0,No PQS found in G4 Hunter,0,0,No PQS found in G4 Hunter,"PCGEM1 prostate-specific transcript;NCRNA00071;LINC00071;PCAT9;non-protein coding RNA 71;long intergenic non-protein coding RNA 71;prostate cancer associated transcript 9;prostate cancer gene expression marker 1;prostate-specific transcript 1 (non-protein coding);PCGEM1, prostate-specific transcript (non-protein coding);PCGEM1, prostate-specific transcript;HSALNG0021209;HSALNG0021208;PCGEM1;NONHSAG030128.2;NONHSAG030129.2"
PCGEM1,prostate cancer,qPCR etc.,up-regulated,16515751.0,,Refer PCAT9,,,,,,REVIEWED,0,0,No PQS found in G4 Hunter,0,0,No PQS found in G4 Hunter,"PCGEM1 prostate-specific transcript;NCRNA00071;LINC00071;PCAT9;non-protein coding RNA 71;long intergenic non-protein coding RNA 71;prostate cancer associated transcript 9;prostate cancer gene expression marker 1;prostate-specific transcript 1 (non-protein coding);PCGEM1, prostate-specific transcript (non-protein coding);PCGEM1, prostate-specific transcript;HSALNG0021209;HSALNG0021208;PCGEM1;NONHSAG030128.2;NONHSAG030129.2"
PCGEM1,prostate cancer,qPCR etc.,up-regulated,14724589.0,,Refer PCAT9,,,,,,REVIEWED,0,0,No PQS found in G4 Hunter,0,0,No PQS found in G4 Hunter,"PCGEM1 prostate-specific transcript;NCRNA00071;LINC00071;PCAT9;non-protein coding RNA 71;long intergenic non-protein coding RNA 71;prostate cancer associated transcript 9;prostate cancer gene expression marker 1;prostate-specific transcript 1 (non-protein coding);PCGEM1, prostate-specific transcript (non-protein coding);PCGEM1, prostate-specific transcript;HSALNG0021209;HSALNG0021208;PCGEM1;NONHSAG030128.2;NONHSAG030129.2"
PCGEM1,prostate cancer,"RNA-seq, qPCR etc.",up-regulated,25744782.0,,Refer PCAT9,,,,,,REVIEWED,0,0,No PQS found in G4 Hunter,0,0,No PQS found in G4 Hunter,"PCGEM1 prostate-specific transcript;NCRNA00071;LINC00071;PCAT9;non-protein coding RNA 71;long intergenic non-protein coding RNA 71;prostate cancer associated transcript 9;prostate cancer gene expression marker 1;prostate-specific transcript 1 (non-protein coding);PCGEM1, prostate-specific transcript (non-protein coding);PCGEM1, prostate-specific transcript;HSALNG0021209;HSALNG0021208;PCGEM1;NONHSAG030128.2;NONHSAG030129.2"
PCGEM1,prostate cancer,"qPCR, Western blot, RIP etc.",up-regulated,24727738.0,,Refer PCAT9,,,,,,REVIEWED,0,0,No PQS found in G4 Hunter,0,0,No PQS found in G4 Hunter,"PCGEM1 prostate-specific transcript;NCRNA00071;LINC00071;PCAT9;non-protein coding RNA 71;long intergenic non-protein coding RNA 71;prostate cancer associated transcript 9;prostate cancer gene expression marker 1;prostate-specific transcript 1 (non-protein coding);PCGEM1, prostate-specific transcript (non-protein coding);PCGEM1, prostate-specific transcript;HSALNG0021209;HSALNG0021208;PCGEM1;NONHSAG030128.2;NONHSAG030129.2"
PCGEM1,prostate cancer,"RNA-seq, Microarray, qPCR, RNAi, Northern blot etc.",up-regulated,23728290.0,,Refer PCAT9,,,,,,REVIEWED,0,0,No PQS found in G4 Hunter,0,0,No PQS found in G4 Hunter,"PCGEM1 prostate-specific transcript;NCRNA00071;LINC00071;PCAT9;non-protein coding RNA 71;long intergenic non-protein coding RNA 71;prostate cancer associated transcript 9;prostate cancer gene expression marker 1;prostate-specific transcript 1 (non-protein coding);PCGEM1, prostate-specific transcript (non-protein coding);PCGEM1, prostate-specific transcript;HSALNG0021209;HSALNG0021208;PCGEM1;NONHSAG030128.2;NONHSAG030129.2"
PCGEM1,prostate cancer,"qPCR, RIP etc.",up-regulated,23945587.0,,Refer PCAT9,,,,,,REVIEWED,0,0,No PQS found in G4 Hunter,0,0,No PQS found in G4 Hunter,"PCGEM1 prostate-specific transcript;NCRNA00071;LINC00071;PCAT9;non-protein coding RNA 71;long intergenic non-protein coding RNA 71;prostate cancer associated transcript 9;prostate cancer gene expression marker 1;prostate-specific transcript 1 (non-protein coding);PCGEM1, prostate-specific transcript (non-protein coding);PCGEM1, prostate-specific transcript;HSALNG0021209;HSALNG0021208;PCGEM1;NONHSAG030128.2;NONHSAG030129.2"
PCGEM1,prostate cancer,"qPCR, Northern blot, FISH, ISH etc.",up-regulated,11050243.0,,Refer PCAT9,,,,,,REVIEWED,0,0,No PQS found in G4 Hunter,0,0,No PQS found in G4 Hunter,"PCGEM1 prostate-specific transcript;NCRNA00071;LINC00071;PCAT9;non-protein coding RNA 71;long intergenic non-protein coding RNA 71;prostate cancer associated transcript 9;prostate cancer gene expression marker 1;prostate-specific transcript 1 (non-protein coding);PCGEM1, prostate-specific transcript (non-protein coding);PCGEM1, prostate-specific transcript;HSALNG0021209;HSALNG0021208;PCGEM1;NONHSAG030128.2;NONHSAG030129.2"
PCSEAT,prostate cancer,"qPCR, Western blot, Luciferase reporter assay, in vitro knockdown",up-regulated,29803673.0,Also Known As: PRCAT38,1,NR_164474.1,25,23,2,0,VALIDATED,13,"[0.935, 0.818, 0.842, 0.933, 0.933, 0.885, 0.839, 0.911 (2G) -0.792, -0.918, -0.894, -0.776, -0.882 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,PRCAT38
PCSEAT,prostate cancer,"qPCR, Western blot etc.",up-regulated,29803673.0,Also Known As: PRCAT38,1,NR_164474.1,25,23,2,0,VALIDATED,13,"[0.935, 0.818, 0.842, 0.933, 0.933, 0.885, 0.839, 0.911 (2G) -0.792, -0.918, -0.894, -0.776, -0.882 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,PRCAT38
"PlncRNA-1
CBR3-AS1",prostate cancer,"qPCR, Western blot etc.",up-regulated,22264502.0,Also Known As: CBR3-AS1; PlncRNA1; PlncRNA-1,3 (CBR3-AS1),"CBR3-AS1 (NR_038892.1, NR_038893.1, NR_038894.1)","10, 9, 6 (CBR3-AS1)","10, 9, 6 (CBR3-AS1)","0, 0, 0 (CBR3-AS1)","0, 0, 0 (CBR3-AS1)",VALIDATED (CBR3-AS1),"1 (C-rich);
1 (C-rich);
1 (C-rich)","[-0.882 (C-rich)];
[-0.882 (C-rich)];
[-0.936 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter,PlncRNA1; PlncRNA-1
"PlncRNA-1
CBR3-AS1",prostate cancer,"qPCR, Western blot, Northern blot, RIP, ChIP, Flow cytometry assay etc.",up-regulated,26808578.0,Also Known As: CBR3-AS1; PlncRNA1; PlncRNA-1,3 (CBR3-AS1),"CBR3-AS1 (NR_038892.1, NR_038893.1, NR_038894.1)","10, 9, 6 (CBR3-AS1)","10, 9, 6 (CBR3-AS1)","0, 0, 0 (CBR3-AS1)","0, 0, 0 (CBR3-AS1)",VALIDATED (CBR3-AS1),"1 (C-rich);
1 (C-rich);
1 (C-rich)","[-0.882 (C-rich)];
[-0.882 (C-rich)];
[-0.936 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter,PlncRNA1; PlncRNA-1
"PlncRNA-1
CBR3-AS1",prostate cancer,"qPCR, RNAi, Western blot, Flow cytometry assay etc.",up-regulated,28212533.0,Also Known As: CBR3-AS1; PlncRNA1; PlncRNA-1,3 (CBR3-AS1),"CBR3-AS1 (NR_038892.1, NR_038893.1, NR_038894.1)","10, 9, 6 (CBR3-AS1)","10, 9, 6 (CBR3-AS1)","0, 0, 0 (CBR3-AS1)","0, 0, 0 (CBR3-AS1)",VALIDATED (CBR3-AS1),"1 (C-rich);
1 (C-rich);
1 (C-rich)","[-0.882 (C-rich)];
[-0.882 (C-rich)];
[-0.936 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter,PlncRNA1; PlncRNA-1
PRCAT38,prostate cancer,"qPCR, Western blot, Luciferase reporter assay, RNAi, other",up-regulated,31405024.0,Also Known As: PRCAT38,1,NR_164474.1,25,23,2,0,VALIDATED,"13 (8 - 2G, 5 - C-rich)","[0.935, 0.818, 0.842, 0.933, 0.933, 0.885, 0.839, 0.911 (2G) -0.792, -0.918, -0.894, -0.776, -0.882 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,PRCAT38
PRCAT38,prostate cancer,qPCR etc.,up-regulated,29671889.0,Also Known As: PRCAT38,1,NR_164474.1,25,23,2,0,VALIDATED,"13 (8 - 2G, 5 - C-rich)","[0.935, 0.818, 0.842, 0.933, 0.933, 0.885, 0.839, 0.911 (2G) -0.792, -0.918, -0.894, -0.776, -0.882 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,PRCAT38
PRNCR1,prostate cancer,"qPCR, Northern blot etc.",up-regulated,20874843.0,Also Known As: PCAT8; CARLo-3,1,NR_109833.1,61,60,1,0,VALIDATED,"28 (9 - 2G, 19 - C-rich)
","[-0.875, -0.936, -0.894, -0.911, -0.911, -0.875, -0.911, -0.891, -0.911, -0.641, -0.981, -0.939, -1.061, -0.803, -0.957, -0.891, -0.961, -0.885, -0.854 (C-rich), 0.808, 0.926, 0.9, 0.98, 1, 1.103,  0.703, 0.839, 0.871 (2G)]","No similarity to any PQS (2G) from QGRS mapper.
",0,0,No PQS found in G4 Hunter,PCAT8; CARLo-3
PRNCR1,prostate cancer,"qPCR, RIP etc.",up-regulated,23945587.0,Also Known As: PCAT8; CARLo-3,1,NR_109833.1,61,60,1,0,VALIDATED,"28 (9 - 2G, 19 - C-rich)
","[-0.875, -0.936, -0.894, -0.911, -0.911, -0.875, -0.911, -0.891, -0.911, -0.641, -0.981, -0.939, -1.061, -0.803, -0.957, -0.891, -0.961, -0.885, -0.854 (C-rich), 0.808, 0.926, 0.9, 0.98, 1, 1.103,  0.703, 0.839, 0.871 (2G)]","No similarity to any PQS (2G) from QGRS mapper.
",0,0,No PQS found in G4 Hunter,PCAT8; CARLo-3
PROX1-AS1,prostate cancer,"qPCR, Luciferase reporter assay etc",up-regulated,32271411.0,,1,NR_037850.2,30,30,0,0,VALIDATED,"10 (5 - 2G, 5 - C-rich)","[0.942, 0.846, 0.891, 0.915, 0.945, 0.7 (2G); -0.891, -0.712, -0.915, -0.764 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,PROX1 antisense RNA 1;PROX1 antisense RNA 1 (non-protein coding);PROX1-AS1;HSALNG0010460;NONHSAG004261.2
PRRT3-AS1,prostate cancer,"RT-qPCR, Western blot, Microarray",up-regulated,32086850.0,,1,NR_046734.1,3,3,0,0,VALIDATED,0,0,No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,PRRT3 antisense RNA 1;PRRT3 antisense RNA 1 (non-protein coding);HSALNG0024078;NONHSAG034409.2
PSLNR,Prostate cancer,"qPCR, Western blot, RNAi",down-regulated,31269242.0,Also Known As: LA16c-83F12.6,1,NR_132385.2,6,6,0,0,VALIDATED,0,0,No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,LA16c-83F12.6
PTENP1,prostate cancer,"qPCR, Western blot, Dual luciferase reporter assay, Cell proliferation assay etc.",down-regulated,20577206.0,"Processed pseudogene;
Also known as
PTH2; PTEN2; PTEN-rs; PTENpg1; psiPTEN;
Search Results for PTENP1-AS also displayed",1,HG975434.1,20,18,2,0,REVIEWED,"11 (5 - 2G, 6 - C-rich)","[0.942, 0.933, 0.911, 1, 0.754 (2G); -0.933, -0.911,  -0.933, -1, -0.933, -0.891 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter,"phosphatase and tensin homolog pseudogene 1;PTEN2;psiPTEN;PTH2;PTEN-rs;PTENpg1;phosphatase and tensin homolog pseudogene 1 (functional);PTEN/MMAC1 pseudogene;phosphatase and tensin homolog (mutated in multiple advanced cancers 1), pseudogene 1"
PVT1,prostate cancer,"qPCR, Western blot, RNAi, other",down-regulated,30250582.0,"Also Known As: LINC00079; MIR1204HG; NCRNA00079; onco-lncRNA-100

Some (older) PVT1 splice variant 1, 2, 3, 4, 5 and 6 lncRNA ""lncRNA"" ncRNA (complete sequence-MG562504.1, MG562505.1, MG562506.1, MG562507.1, MG562508.1 and MG562509.1 respectively; note=""alternatively spliced) with PQS-10, 8, 9, 8, 8, 7 (2G) respectively were also there in result.

Some (older, not checked for PQS) PVT1 lncRNA ""lncRNA"" ncRNA (partial sequence-KY887488.1) was also there in result.",1, PVT1,14,13,1,0,REVIEWED,"4 (2 - 2G, 2 - C-rich)","[0.933, 0.82 (2G); -0.959, -1.083 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter,"Pvt1 oncogene;NCRNA00079;LINC00079;onco-lncRNA-100;MIR1204HG;non-protein coding RNA 79;long intergenic non-protein coding RNA 79;MIR1204, MIR1205, MIR1206 and MIR1207 host gene;plasmacytoma variant translocation 1;pvt-1 (murine) oncogene homolog, MYC activator;Pvt1 oncogene homolog (mouse);Pvt1 oncogene (non-protein coding);CXCR4/PVT1 fusion;HIST1H2BD/PVT1 fusion;MIR1204, MIR1205, MIR1206 and MIR1207 host;Oncogene PVT-1 (MYC activator);PVT1/CASC8 fusion;PVT1/CCDC26 fusion;PVT1/IFRD1 fusion;PVT1/IRF2BP2 fusion;PVT1/LINC00824 fusion;PVT1/MYC fusion;PVT1/NFIL3 fusion;PVT1/NSMCE2 fusion;PVT1/SPRY2 fusion;PVT1/UBB fusion;RP11-89K10/PVT1 fusion;PVT1;HSALNG0068494;HSALNG0068477;NONHSAG051258.2;HSALNG0068505;HSALNG0068503;HSALNG0068496;HSALNG0068488"
PVT1,prostate cancer,"qPCR, ChIP etc.",differential expression,21814516.0,"Also Known As: LINC00079; MIR1204HG; NCRNA00079; onco-lncRNA-100

Some (older) PVT1 splice variant 1, 2, 3, 4, 5 and 6 lncRNA ""lncRNA"" ncRNA (complete sequence-MG562504.1, MG562505.1, MG562506.1, MG562507.1, MG562508.1 and MG562509.1 respectively; note=""alternatively spliced) with PQS-10, 8, 9, 8, 8, 7 (2G) respectively were also there in result.

Some (older, not checked for PQS) PVT1 lncRNA ""lncRNA"" ncRNA (partial sequence-KY887488.1) was also there in result.",1, PVT1,14,13,1,0,REVIEWED,"4 (2 - 2G, 2 - C-rich)","[0.933, 0.82 (2G); -0.959, -1.083 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter,"Pvt1 oncogene;NCRNA00079;LINC00079;onco-lncRNA-100;MIR1204HG;non-protein coding RNA 79;long intergenic non-protein coding RNA 79;MIR1204, MIR1205, MIR1206 and MIR1207 host gene;plasmacytoma variant translocation 1;pvt-1 (murine) oncogene homolog, MYC activator;Pvt1 oncogene homolog (mouse);Pvt1 oncogene (non-protein coding);CXCR4/PVT1 fusion;HIST1H2BD/PVT1 fusion;MIR1204, MIR1205, MIR1206 and MIR1207 host;Oncogene PVT-1 (MYC activator);PVT1/CASC8 fusion;PVT1/CCDC26 fusion;PVT1/IFRD1 fusion;PVT1/IRF2BP2 fusion;PVT1/LINC00824 fusion;PVT1/MYC fusion;PVT1/NFIL3 fusion;PVT1/NSMCE2 fusion;PVT1/SPRY2 fusion;PVT1/UBB fusion;RP11-89K10/PVT1 fusion;PVT1;HSALNG0068494;HSALNG0068477;NONHSAG051258.2;HSALNG0068505;HSALNG0068503;HSALNG0068496;HSALNG0068488"
PVT1,prostate cancer,"RNA-seq, qPCR, Western blot etc.",up-regulated,29452232.0,"Also Known As: LINC00079; MIR1204HG; NCRNA00079; onco-lncRNA-100

Some (older) PVT1 splice variant 1, 2, 3, 4, 5 and 6 lncRNA ""lncRNA"" ncRNA (complete sequence-MG562504.1, MG562505.1, MG562506.1, MG562507.1, MG562508.1 and MG562509.1 respectively; note=""alternatively spliced) with PQS-10, 8, 9, 8, 8, 7 (2G) respectively were also there in result.

Some (older, not checked for PQS) PVT1 lncRNA ""lncRNA"" ncRNA (partial sequence-KY887488.1) was also there in result.",1, PVT1,14,13,1,0,REVIEWED,"4 (2 - 2G, 2 - C-rich)","[0.933, 0.82 (2G); -0.959, -1.083 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter,"Pvt1 oncogene;NCRNA00079;LINC00079;onco-lncRNA-100;MIR1204HG;non-protein coding RNA 79;long intergenic non-protein coding RNA 79;MIR1204, MIR1205, MIR1206 and MIR1207 host gene;plasmacytoma variant translocation 1;pvt-1 (murine) oncogene homolog, MYC activator;Pvt1 oncogene homolog (mouse);Pvt1 oncogene (non-protein coding);CXCR4/PVT1 fusion;HIST1H2BD/PVT1 fusion;MIR1204, MIR1205, MIR1206 and MIR1207 host;Oncogene PVT-1 (MYC activator);PVT1/CASC8 fusion;PVT1/CCDC26 fusion;PVT1/IFRD1 fusion;PVT1/IRF2BP2 fusion;PVT1/LINC00824 fusion;PVT1/MYC fusion;PVT1/NFIL3 fusion;PVT1/NSMCE2 fusion;PVT1/SPRY2 fusion;PVT1/UBB fusion;RP11-89K10/PVT1 fusion;PVT1;HSALNG0068494;HSALNG0068477;NONHSAG051258.2;HSALNG0068505;HSALNG0068503;HSALNG0068496;HSALNG0068488"
PVT1,prostate cancer,"qPCR, MSP-PCR, RNAi etc.",up-regulated,27794184.0,"Also Known As: LINC00079; MIR1204HG; NCRNA00079; onco-lncRNA-100

Some (older) PVT1 splice variant 1, 2, 3, 4, 5 and 6 lncRNA ""lncRNA"" ncRNA (complete sequence-MG562504.1, MG562505.1, MG562506.1, MG562507.1, MG562508.1 and MG562509.1 respectively; note=""alternatively spliced) with PQS-10, 8, 9, 8, 8, 7 (2G) respectively were also there in result.

Some (older, not checked for PQS) PVT1 lncRNA ""lncRNA"" ncRNA (partial sequence-KY887488.1) was also there in result.",1, PVT1,14,13,1,0,REVIEWED,"4 (2 - 2G, 2 - C-rich)","[0.933, 0.82 (2G); -0.959, -1.083 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter,"Pvt1 oncogene;NCRNA00079;LINC00079;onco-lncRNA-100;MIR1204HG;non-protein coding RNA 79;long intergenic non-protein coding RNA 79;MIR1204, MIR1205, MIR1206 and MIR1207 host gene;plasmacytoma variant translocation 1;pvt-1 (murine) oncogene homolog, MYC activator;Pvt1 oncogene homolog (mouse);Pvt1 oncogene (non-protein coding);CXCR4/PVT1 fusion;HIST1H2BD/PVT1 fusion;MIR1204, MIR1205, MIR1206 and MIR1207 host;Oncogene PVT-1 (MYC activator);PVT1/CASC8 fusion;PVT1/CCDC26 fusion;PVT1/IFRD1 fusion;PVT1/IRF2BP2 fusion;PVT1/LINC00824 fusion;PVT1/MYC fusion;PVT1/NFIL3 fusion;PVT1/NSMCE2 fusion;PVT1/SPRY2 fusion;PVT1/UBB fusion;RP11-89K10/PVT1 fusion;PVT1;HSALNG0068494;HSALNG0068477;NONHSAG051258.2;HSALNG0068505;HSALNG0068503;HSALNG0068496;HSALNG0068488"
PVT1,prostate cancer,"qPCR, RNAi",up-regulated,29050519.0,"Also Known As: LINC00079; MIR1204HG; NCRNA00079; onco-lncRNA-100

Some (older) PVT1 splice variant 1, 2, 3, 4, 5 and 6 lncRNA ""lncRNA"" ncRNA (complete sequence-MG562504.1, MG562505.1, MG562506.1, MG562507.1, MG562508.1 and MG562509.1 respectively; note=""alternatively spliced) with PQS-10, 8, 9, 8, 8, 7 (2G) respectively were also there in result.

Some (older, not checked for PQS) PVT1 lncRNA ""lncRNA"" ncRNA (partial sequence-KY887488.1) was also there in result.",1, PVT1,14,13,1,0,REVIEWED,"4 (2 - 2G, 2 - C-rich)","[0.933, 0.82 (2G); -0.959, -1.083 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter,"Pvt1 oncogene;NCRNA00079;LINC00079;onco-lncRNA-100;MIR1204HG;non-protein coding RNA 79;long intergenic non-protein coding RNA 79;MIR1204, MIR1205, MIR1206 and MIR1207 host gene;plasmacytoma variant translocation 1;pvt-1 (murine) oncogene homolog, MYC activator;Pvt1 oncogene homolog (mouse);Pvt1 oncogene (non-protein coding);CXCR4/PVT1 fusion;HIST1H2BD/PVT1 fusion;MIR1204, MIR1205, MIR1206 and MIR1207 host;Oncogene PVT-1 (MYC activator);PVT1/CASC8 fusion;PVT1/CCDC26 fusion;PVT1/IFRD1 fusion;PVT1/IRF2BP2 fusion;PVT1/LINC00824 fusion;PVT1/MYC fusion;PVT1/NFIL3 fusion;PVT1/NSMCE2 fusion;PVT1/SPRY2 fusion;PVT1/UBB fusion;RP11-89K10/PVT1 fusion;PVT1;HSALNG0068494;HSALNG0068477;NONHSAG051258.2;HSALNG0068505;HSALNG0068503;HSALNG0068496;HSALNG0068488"
PVT1,prostate cancer,"RNA-seq, Microarray, qPCR, RNAi, Northern blot etc.",up-regulated,23728290.0,"Also Known As: LINC00079; MIR1204HG; NCRNA00079; onco-lncRNA-100

Some (older) PVT1 splice variant 1, 2, 3, 4, 5 and 6 lncRNA ""lncRNA"" ncRNA (complete sequence-MG562504.1, MG562505.1, MG562506.1, MG562507.1, MG562508.1 and MG562509.1 respectively; note=""alternatively spliced) with PQS-10, 8, 9, 8, 8, 7 (2G) respectively were also there in result.

Some (older, not checked for PQS) PVT1 lncRNA ""lncRNA"" ncRNA (partial sequence-KY887488.1) was also there in result.",1, PVT1,14,13,1,0,REVIEWED,"4 (2 - 2G, 2 - C-rich)","[0.933, 0.82 (2G); -0.959, -1.083 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter,"Pvt1 oncogene;NCRNA00079;LINC00079;onco-lncRNA-100;MIR1204HG;non-protein coding RNA 79;long intergenic non-protein coding RNA 79;MIR1204, MIR1205, MIR1206 and MIR1207 host gene;plasmacytoma variant translocation 1;pvt-1 (murine) oncogene homolog, MYC activator;Pvt1 oncogene homolog (mouse);Pvt1 oncogene (non-protein coding);CXCR4/PVT1 fusion;HIST1H2BD/PVT1 fusion;MIR1204, MIR1205, MIR1206 and MIR1207 host;Oncogene PVT-1 (MYC activator);PVT1/CASC8 fusion;PVT1/CCDC26 fusion;PVT1/IFRD1 fusion;PVT1/IRF2BP2 fusion;PVT1/LINC00824 fusion;PVT1/MYC fusion;PVT1/NFIL3 fusion;PVT1/NSMCE2 fusion;PVT1/SPRY2 fusion;PVT1/UBB fusion;RP11-89K10/PVT1 fusion;PVT1;HSALNG0068494;HSALNG0068477;NONHSAG051258.2;HSALNG0068505;HSALNG0068503;HSALNG0068496;HSALNG0068488"
RBMS3-AS3,prostate cancer,"RT-qPCR, Western blot, RIP",down-regulated,31712637.0,,1,NR_109804.1,5,5,0,0,VALIDATED,0,0,No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,RBMS3 antisense RNA 3;RBMS3 antisense RNA 3 (non-protein coding);HSALNG0024874;NONHSAG034659.2;RBMS3-AS3;HSALNG0024869
"RNCR3
MIR124-1HG",prostate cancer,"qPCR, Western blot, Luciferase reporter assay, in vitro knockdown",up-regulated,29887969.0,Also Known As: MIR124-1HG; Rncr3; neuroLNC; LINC00599,1 (MIR124-1HG),MIR124-1HG (NR_024281.1),25 (MIR124-1HG),23 (MIR124-1HG),2 (MIR124-1HG),0 (MIR124-1HG),VALIDATED (MIR124-1HG),"17 (7 - 2G, 1 - 3G, 9 - C-rich)",,No similarity to PQS (2G) from QGRS mapper,1 (3G),[1.293 (3G)],"PQS 1 from QGRS mapper is similar to / a part of PQS (3G) from G4 hunter

",Rncr3; neuroLNC; LINC00599
"RNCR3
MIR124-1HG",prostate cancer,"qPCR, Luciferase reporter assay, Western blot, etc.",up-regulated,29887969.0,Also Known As: MIR124-1HG; Rncr3; neuroLNC; LINC00599,1 (MIR124-1HG),MIR124-1HG (NR_024281.1),25 (MIR124-1HG),23 (MIR124-1HG),2 (MIR124-1HG),0 (MIR124-1HG),VALIDATED (MIR124-1HG),"17 (7 - 2G, 1 - 3G, 9 - C-rich)",,No similarity to PQS (2G) from QGRS mapper,1 (3G),[1.293 (3G)],"PQS 1 from QGRS mapper is similar to / a part of PQS (3G) from G4 hunter

",Rncr3; neuroLNC; LINC00599
SAP30L-AS1,prostate cancer,"qPCR, Western blot, in vitro knockdown, etc.",up-regulated,30599235.0,Also Known As: GALNT10-AS1,1,NR_037897.1,27,25,2,0,VALIDATED,"5 (3 -2G, 2 -C-rich)","[0.84, 0.891, 0.774 (2G); -0.891, -0.679 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,GALNT10-AS1
SAP30L-AS1,prostate cancer,"qPCR, Western blot",up-regulated,29614511.0,Also Known As: GALNT10-AS1,1,NR_037897.1,27,25,2,0,VALIDATED,"5 (3 -2G, 2 -C-rich)","[0.84, 0.891, 0.774 (2G); -0.891, -0.679 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,GALNT10-AS1
SChLAP1,prostate cancer,"qPCR, Western blot",up-regulated,29614511.0,Also known asPCAT11; PCAT114; LINC00913,7,"NR_104319.1, NR_104320.1, NR_104321.1 , NR_104322.1, NR_104323.1 , NR_104324.1, NR_104325.1","5, 4, 2, 6, 6, 4, 5","4, 3, 1, 5, 5, 3, 4","1, 1, 1, 1, 1, 1, 1","0, 0, 0, 0 , 0, 0, 0",VALIDATED,"2 (1- 2G, 1 - C-rich);
2 (1- 2G, 1 - C-rich);
2 (1- 2G, 1 - C-rich);
2 (1- 2G, 1 - C-rich);
2 (1- 2G, 1 - C-rich);
2 (1- 2G, 1 - C-rich);","[0.865 (2G); -0.915 (C-rich)];
[0.865 (2G); -0.915 (C-rich)];
[0.865 (2G); -0.915 (C-rich)];
[0.865 (2G); -0.915 (C-rich)];
[0.865 (2G); -0.915 (C-rich)];
[0.865 (2G); -0.915 (C-rich)];
[0.865 (2G); -0.915 (C-rich)];",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,PCAT11; PCAT114; LINC00913
SChLAP1,prostate cancer,ISH etc.,up-regulated,26724257.0,Also known asPCAT11; PCAT114; LINC00913,7,"NR_104319.1, NR_104320.1, NR_104321.1 , NR_104322.1, NR_104323.1 , NR_104324.1, NR_104325.1","5, 4, 2, 6, 6, 4, 5","4, 3, 1, 5, 5, 3, 4","1, 1, 1, 1, 1, 1, 1","0, 0, 0, 0 , 0, 0, 0",VALIDATED,"2 (1- 2G, 1 - C-rich);
2 (1- 2G, 1 - C-rich);
2 (1- 2G, 1 - C-rich);
2 (1- 2G, 1 - C-rich);
2 (1- 2G, 1 - C-rich);
2 (1- 2G, 1 - C-rich);","[0.865 (2G); -0.915 (C-rich)];
[0.865 (2G); -0.915 (C-rich)];
[0.865 (2G); -0.915 (C-rich)];
[0.865 (2G); -0.915 (C-rich)];
[0.865 (2G); -0.915 (C-rich)];
[0.865 (2G); -0.915 (C-rich)];
[0.865 (2G); -0.915 (C-rich)];",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,PCAT11; PCAT114; LINC00913
SChLAP1,prostate cancer,"Microarray, ISH etc.",up-regulated,25499224.0,Also known asPCAT11; PCAT114; LINC00913,7,"NR_104319.1, NR_104320.1, NR_104321.1 , NR_104322.1, NR_104323.1 , NR_104324.1, NR_104325.1","5, 4, 2, 6, 6, 4, 5","4, 3, 1, 5, 5, 3, 4","1, 1, 1, 1, 1, 1, 1","0, 0, 0, 0 , 0, 0, 0",VALIDATED,"2 (1- 2G, 1 - C-rich);
2 (1- 2G, 1 - C-rich);
2 (1- 2G, 1 - C-rich);
2 (1- 2G, 1 - C-rich);
2 (1- 2G, 1 - C-rich);
2 (1- 2G, 1 - C-rich);","[0.865 (2G); -0.915 (C-rich)];
[0.865 (2G); -0.915 (C-rich)];
[0.865 (2G); -0.915 (C-rich)];
[0.865 (2G); -0.915 (C-rich)];
[0.865 (2G); -0.915 (C-rich)];
[0.865 (2G); -0.915 (C-rich)];
[0.865 (2G); -0.915 (C-rich)];",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,PCAT11; PCAT114; LINC00913
SChLAP1,prostate cancer,"Microarray, qPCR etc.",up-regulated,25456366.0,Also known asPCAT11; PCAT114; LINC00913,7,"NR_104319.1, NR_104320.1, NR_104321.1 , NR_104322.1, NR_104323.1 , NR_104324.1, NR_104325.1","5, 4, 2, 6, 6, 4, 5","4, 3, 1, 5, 5, 3, 4","1, 1, 1, 1, 1, 1, 1","0, 0, 0, 0 , 0, 0, 0",VALIDATED,"2 (1- 2G, 1 - C-rich);
2 (1- 2G, 1 - C-rich);
2 (1- 2G, 1 - C-rich);
2 (1- 2G, 1 - C-rich);
2 (1- 2G, 1 - C-rich);
2 (1- 2G, 1 - C-rich);","[0.865 (2G); -0.915 (C-rich)];
[0.865 (2G); -0.915 (C-rich)];
[0.865 (2G); -0.915 (C-rich)];
[0.865 (2G); -0.915 (C-rich)];
[0.865 (2G); -0.915 (C-rich)];
[0.865 (2G); -0.915 (C-rich)];
[0.865 (2G); -0.915 (C-rich)];",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,PCAT11; PCAT114; LINC00913
SChLAP1,prostate cancer,"RNA-seq, qPCR, in vitro knockdown etc.",up-regulated,24076601.0,Also known asPCAT11; PCAT114; LINC00913,7,"NR_104319.1, NR_104320.1, NR_104321.1 , NR_104322.1, NR_104323.1 , NR_104324.1, NR_104325.1","5, 4, 2, 6, 6, 4, 5","4, 3, 1, 5, 5, 3, 4","1, 1, 1, 1, 1, 1, 1","0, 0, 0, 0 , 0, 0, 0",VALIDATED,"2 (1- 2G, 1 - C-rich);
2 (1- 2G, 1 - C-rich);
2 (1- 2G, 1 - C-rich);
2 (1- 2G, 1 - C-rich);
2 (1- 2G, 1 - C-rich);
2 (1- 2G, 1 - C-rich);","[0.865 (2G); -0.915 (C-rich)];
[0.865 (2G); -0.915 (C-rich)];
[0.865 (2G); -0.915 (C-rich)];
[0.865 (2G); -0.915 (C-rich)];
[0.865 (2G); -0.915 (C-rich)];
[0.865 (2G); -0.915 (C-rich)];
[0.865 (2G); -0.915 (C-rich)];",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,PCAT11; PCAT114; LINC00913
SNHG1,prostate cancer,"qPCR, Western blot, Luciferase Reporter Assays",up-regulated,28400279.0,Also Known As: UHG; U22HG; lncRNA16; LINC00057; NCRNA00057,12,"NR_003098.2, NR_152575.1, NR_152576.1, NR_152577.1, NR_152578.1, NR_152579.1, NR_152580.1, NR_152581.1, NR_152582.1, NR_152583.1, NR_152584.1, NR_152585.1","5, 9, 9, 4, 4, 4, 4, 4, 5, 3, 7, 7","5, 9, 9, 4, 4, 4, 4, 4, 5, 3, 7, 7","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0",REVIEWED,"0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0","0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0",No PQS found in G4 Hunter,"0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0","0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0",No PQS found in G4 Hunter,UHG; U22HG; lncRNA16; LINC00057; NCRNA00057
SNHG1,prostate cancer,"Microarray, qPCR etc.",down-regulated,27556357.0,Also Known As: UHG; U22HG; lncRNA16; LINC00057; NCRNA00057,12,"NR_003098.2, NR_152575.1, NR_152576.1, NR_152577.1, NR_152578.1, NR_152579.1, NR_152580.1, NR_152581.1, NR_152582.1, NR_152583.1, NR_152584.1, NR_152585.1","5, 9, 9, 4, 4, 4, 4, 4, 5, 3, 7, 7","5, 9, 9, 4, 4, 4, 4, 4, 5, 3, 7, 7","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0",REVIEWED,"0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0","0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0",No PQS found in G4 Hunter,"0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0","0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0",No PQS found in G4 Hunter,UHG; U22HG; lncRNA16; LINC00057; NCRNA00057
SNHG1,prostate cancer,"Microarray, qPCR etc.",up-regulated,27556357.0,Also Known As: UHG; U22HG; lncRNA16; LINC00057; NCRNA00057,12,"NR_003098.2, NR_152575.1, NR_152576.1, NR_152577.1, NR_152578.1, NR_152579.1, NR_152580.1, NR_152581.1, NR_152582.1, NR_152583.1, NR_152584.1, NR_152585.1","5, 9, 9, 4, 4, 4, 4, 4, 5, 3, 7, 7","5, 9, 9, 4, 4, 4, 4, 4, 5, 3, 7, 7","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0",REVIEWED,"0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0","0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0",No PQS found in G4 Hunter,"0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0","0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0;
0",No PQS found in G4 Hunter,UHG; U22HG; lncRNA16; LINC00057; NCRNA00057
SNHG11,prostate cancer,RNA-seq,differential expression,30906477.0,Also Known As: C20orf198; LINC00101; NCRNA00101,1,NR_003239.1,12,10,2,0,VALIDATED,"5 (1  - 2G, 4 - C-rich)","[-0.905, -0.896, -0.911, -0.96, 0.894]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter,C20orf198; LINC00101; NCRNA00101
SNHG12,prostate cancer,"qPCR, Luciferase reporter assay, Western blot",down-regulated,30945357.0,Also Known As: C1orf79; PNAS-123; LINC00100; ASLNC04080; NCRNA00100,8,"NR_024127.2, NR_146381.1, NR_146382.1, NR_146383.1, NR_146384.1, NR_146385.1, NR_146386.1, NR_146387.1","8, 13, 9, 8, 13, 8, 8, 11","8, 13, 9, 8, 13, 8, 8, 11","0, 0, 0, 0, 0, 0, 0, 0","0, 0, 0, 0, 0, 0, 0, 0",REVIEWED,"0;
0;
1 (C-rich);
0;
0;
1 (2G);
0;
0
","
0;
0;
[-0.945 (C-rich)];
0;
0;
[0.875 (2G)];
0;
0",No similarity to PQS (2G) from QGRS mapper,"0;
0;
0;
0;
0;
0;
0;
0","0;
0;
0;
0;
0;
0;
0;
0",No PQS found in G4 Hunter,C1orf79; PNAS-123; LINC00100; ASLNC04080; NCRNA00100
SNHG12,prostate cancer,"RT-qPCR, Dual luciferase reporter assay and RNA binding protein immunoprecipitation (RIP), Western blot",up-regulated,31933941.0,Also Known As: C1orf79; PNAS-123; LINC00100; ASLNC04080; NCRNA00100,8,"NR_024127.2, NR_146381.1, NR_146382.1, NR_146383.1, NR_146384.1, NR_146385.1, NR_146386.1, NR_146387.1","8, 13, 9, 8, 13, 8, 8, 11","8, 13, 9, 8, 13, 8, 8, 11","0, 0, 0, 0, 0, 0, 0, 0","0, 0, 0, 0, 0, 0, 0, 0",REVIEWED,"0;
0;
1 (C-rich);
0;
0;
1 (2G);
0;
0
","
0;
0;
[-0.945 (C-rich)];
0;
0;
[0.875 (2G)];
0;
0",No similarity to PQS (2G) from QGRS mapper,"0;
0;
0;
0;
0;
0;
0;
0","0;
0;
0;
0;
0;
0;
0;
0",No PQS found in G4 Hunter,C1orf79; PNAS-123; LINC00100; ASLNC04080; NCRNA00100
SNHG12,prostate cancer,qPCR,up-regulated,31267540.0,Also Known As: C1orf79; PNAS-123; LINC00100; ASLNC04080; NCRNA00100,8,"NR_024127.2, NR_146381.1, NR_146382.1, NR_146383.1, NR_146384.1, NR_146385.1, NR_146386.1, NR_146387.1","8, 13, 9, 8, 13, 8, 8, 11","8, 13, 9, 8, 13, 8, 8, 11","0, 0, 0, 0, 0, 0, 0, 0","0, 0, 0, 0, 0, 0, 0, 0",REVIEWED,"0;
0;
1 (C-rich);
0;
0;
1 (2G);
0;
0
","
0;
0;
[-0.945 (C-rich)];
0;
0;
[0.875 (2G)];
0;
0",No similarity to PQS (2G) from QGRS mapper,"0;
0;
0;
0;
0;
0;
0;
0","0;
0;
0;
0;
0;
0;
0;
0",No PQS found in G4 Hunter,C1orf79; PNAS-123; LINC00100; ASLNC04080; NCRNA00100
SNHG14,prostate cancer,"RT-qPCR, RIP",up-regulated,32016964.0,Also Known As: 115HG; LNCAT; UBE3A-AS; UBE3AATS; UBE3A-AS1; UBE3A-ATS; NCRNA00214; U-UBE3A-ATS; IC-SNURF-SNRPN,1,NR_146177.1,176,175,1,0,REVIEWED,"20 (4 - 2G, 16 - C-rich)","[0.84, 0.84, 0.911, -0.915, -0.764, -0.741, 0.911, -0.852, -0.979, -0.894, -0.882, -0.978, -0.912, -0.911, -0.891, -0.911, -1.146, -0.872, -0.911, -1.146] ",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter,115HG; LNCAT; UBE3A-AS; UBE3AATS; UBE3A-AS1; UBE3A-ATS; NCRNA00214; U-UBE3A-ATS; IC-SNURF-SNRPN
SNHG15,prostate cancer,qPCR,up-regulated,30981837.0,Also Known As: C7orf40; MYO1GUT; Linc-Myo1g,5,"NR_003697.2, NR_152594.1, NR_152595.1, NR_152596.1, NR_152597.1","8, 7, 7, 8, 6","8, 7, 7, 8, 6","0, 0, 0, 0, 0","0, 0, 0, 0, 0",REVIEWED,"0;
0;
0;
0;
0","0;
0;
0;
0;
0",No PQS found in G4 hunter,0,0,No PQS found in G4 hunter,C7orf40; MYO1GUT; Linc-Myo1g
SNHG16,prostate cancer,qPCR etc.,up-regulated,32210616.0,,Refer (Nbla12061),,,,,,VALIDATED,"1  (C-rich);
1  (C-rich);
1  (C-rich);
1  (C-rich)","[-0.819 (C-rich)];
[-0.819 (C-rich)];
[-0.819 (C-rich)];
[-0.819 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter,small nucleolar RNA host gene 16;ncRAN;Nbla12061;Nbla10727;non-coding RNA expressed in aggressive neuroblastoma;small nucleolar RNA host gene 16 (non-protein coding);HSALNG0118855;SNHG16;NONHSAG022825.2
SNHG17,prostate cancer,qPCR etc.,up-regulated,32351538.0,,14,"NR_015366.5, NR_027241.3, NR_152753.1, NR_152754.1, NR_152755.1, NR_152756.1, NR_152757.1, NR_152758.1, NR_152759.1, NR_152760.1, NR_152761.1, NR_152762.1, NR_152763.1, NR_152764.1","12, 12, 9, 14, 10, 10, 8, 12, 11, 11, 10, 8, 11, 10","12, 12, 9, 14, 10, 10, 8, 12, 11, 11, 10, 8, 11, 10","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0","0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0",VALIDATED,"4 (2 - 2G, 2 - C-rich);
4 (2 - 2G, 2 - C-rich);
3 (1 - 2G, 2 - C-rich);
4 (2 - 2G, 2 - C-rich);
4 (2 - 2G, 2 - C-rich);
4 (2 - 2G, 2 - C-rich);
3 (1 - 2G, 2 - C-rich);
4 (2 - 2G, 2 - C-rich);
3 (1 - 2G, 2 - C-rich);
3 (1 - 2G, 2 - C-rich);
3 (1 - 2G, 2 - C-rich);
3 (1 - 2G, 2 - C-rich)","[0.878, 0.865 (2G); -0.929, -0.933 (C-rich)];
[0.878, 0.865 (2G); -0.929, -0.933 (C-rich)];
[0.865 (2G); -0.929, -0.933 (C-rich)];
[0.878, 0.865 (2G); -0.929, -0.933 (C-rich)];
[0.878, 0.865 (2G); -0.929, -0.933 (C-rich)];
[0.878, 0.865 (2G); -0.929, -0.933 (C-rich)];
[0.865 (2G); -0.929, -0.933 (C-rich)];
[0.878, 0.865 (2G); -0.929, -0.933 (C-rich)];
[0.865 (2G); -0.929, -0.933 (C-rich)];
[0.865 (2G); -0.929, -0.933 (C-rich)];
[0.865 (2G); -0.929, -0.933 (C-rich)];
[0.865 (2G); -0.929, -0.933 (C-rich)]

",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,small nucleolar RNA host gene 17;small nucleolar RNA host gene 17 (non-protein coding);NONHSAG031749.2;HSALNG0129982;SNHG17;HSALNG0129980;NONHSAG031748.2
SNHG20,prostate cancer,"qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, etc.",up-regulated,31497231.0,Also Known As: C17orf86; LINC00338; NCRNA00338; SCARNA16HG,1,NR_027058.1,18,17,1,0,VALIDATED,3 (2G),"[1.104, 0.753, 0.774]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter,C17orf86; LINC00338; NCRNA00338; SCARNA16HG
SNHG3,prostate cancer,"qPCR, Western blot, Luciferase reporter assay, RIP etc.",up-regulated,32248648.0,Also Known As: U17HG; RNU17C; RNU17D; U17HG-A; U17HG-AB; NCRNA00014,2,"NR_036473.1, NR_002909.2","18, 16","18, 16","0, 0","0, 0",VALIDATED,"3 (2G);
3 (2G)","[0.933, 0.894, 0.828 (2G)];
[0.933, 0.894, 0.828 (2G)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter,U17HG; RNU17C; RNU17D; U17HG-A; U17HG-AB; NCRNA00014
SNHG4,prostate cancer,"qRT-PCR , Luciferase reporter assay , Western blot , in vitro knockdown etc.",up-regulated,31608997.0,"Also Known As: NCRNA00059, U19H",2,"NR_003141.3, NR_036536.1 ",2021-10-08 00:00:00,2021-10-08 00:00:00,"0, 0","0, 0",VALIDATED,"4 (2 - 2G, 2 - C-rich);
2 (C-rich)","[0.911 ,  0.891 (2G), -0.754, -0.8 (C-rich)];
[-0.754, -0.8 (C-rich)]
",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter,U19H; NCRNA00059
SNHG5,prostate cancer,"Microarray, qPCR etc.",down-regulated,27556357.0,Also Known As: U50HG; C6orf160; LINC00044; NCRNA00044,1,NR_003038.2,2,2,0,0,REVIEWED,0,0,No PQS found in G4 hunter,0,0,No PQS found in G4 hunter,U50HG; C6orf160; LINC00044; NCRNA00044
SNHG5,prostate cancer,"Microarray, qPCR etc.",up-regulated,27556357.0,Also Known As: U50HG; C6orf160; LINC00044; NCRNA00044,1,NR_003038.2,2,2,0,0,REVIEWED,0,0,No PQS found in G4 hunter,0,0,No PQS found in G4 hunter,U50HG; C6orf160; LINC00044; NCRNA00044
SNHG6,prostate cancer,RNA-seq,up-regulated,30911973.0,Also Known As: U87HG; HBII-276HG; NCRNA00058,4,"NR_002599.2, NR_152598.1, NR_152599.1, NR_152600.1","4, 5, 3, 5","4, 5, 3, 5","0, 0, 0, 0","0, 0, 0, 0",VALIDATED,"0, 0, 0, 0","0, 0, 0, 0",No PQS found in G4 hunter,"0;
0;
0;
0","0;
0;
0;
0",No PQS found in G4 hunter,U87HG; HBII-276HG; NCRNA00058
SNHG7,prostate cancer,qRT-PCR,up-regulated,32049793.0,Also Known As: NCRNA00061,3,"NR_003672.2, NR_024542.1, NR_024543.1","28, 13, 12","23, 10, 9","5, 3, 3

PQS 1 and 2 are same in all variants.
PQS 3, 4 and 5 of 1st variant is different from other variants.
PQS 3 of 2nd and 3rd variants are same.","0, 0, 0",VALIDATED,"8 (2G)
3 (1 - 2G, 2 - C-rich)
2 (2G)","[0.826, 0.891, 0.904, 0.806, 0.891, 0.911, 0.854, 0.809 (2G)];
[0.826 (2G); -0.957,  -0.911 (C-rich)] ;
[0.826, 0.8 (2G)] 
",No similarity to PQS (2G) from QGRS mapper,"3 (3G);
2 (3G);
2 (3G)","[1.348, 1.292, 1.444 (3G)];
[1.348, 1.292 (3G)];
[1.348, 1.292 (3G)]","PQS 1, 2 from QGRS mapper is similar to / a part of PQS 1, 2 (3G) from G4 hunter

",NCRNA00061
SNHG7,prostate cancer,"qPCR, Western blot, Luciferase reporter assay, in vitro knockdown",up-regulated,31324390.0,Also Known As: NCRNA00061,3,"NR_003672.2, NR_024542.1, NR_024543.1","28, 13, 12","23, 10, 9","5, 3, 3

PQS 1 and 2 are same in all variants.
PQS 3, 4 and 5 of 1st variant is different from other variants.
PQS 3 of 2nd and 3rd variants are same.","0, 0, 0",VALIDATED,"8 (2G)
3 (1 - 2G, 2 - C-rich)
2 (2G)","[0.826, 0.891, 0.904, 0.806, 0.891, 0.911, 0.854, 0.809 (2G)];
[0.826 (2G); -0.957,  -0.911 (C-rich)] ;
[0.826, 0.8 (2G)] 
",No similarity to PQS (2G) from QGRS mapper,"3 (3G);
2 (3G);
2 (3G)","[1.348, 1.292, 1.444 (3G)];
[1.348, 1.292 (3G)];
[1.348, 1.292 (3G)]","PQS 1, 2 from QGRS mapper is similar to / a part of PQS 1, 2 (3G) from G4 hunter

",NCRNA00061
SNHG7,prostate cancer,"qPCR, Western blot etc.",up-regulated,29571017.0,Also Known As: NCRNA00061,3,"NR_003672.2, NR_024542.1, NR_024543.1","28, 13, 12","23, 10, 9","5, 3, 3

PQS 1 and 2 are same in all variants.
PQS 3, 4 and 5 of 1st variant is different from other variants.
PQS 3 of 2nd and 3rd variants are same.","0, 0, 0",VALIDATED,"8 (2G)
3 (1 - 2G, 2 - C-rich)
2 (2G)","[0.826, 0.891, 0.904, 0.806, 0.891, 0.911, 0.854, 0.809 (2G)];
[0.826 (2G); -0.957,  -0.911 (C-rich)] ;
[0.826, 0.8 (2G)] 
",No similarity to PQS (2G) from QGRS mapper,"3 (3G);
2 (3G);
2 (3G)","[1.348, 1.292, 1.444 (3G)];
[1.348, 1.292 (3G)];
[1.348, 1.292 (3G)]","PQS 1, 2 from QGRS mapper is similar to / a part of PQS 1, 2 (3G) from G4 hunter

",NCRNA00061
SOCS2-AS1,prostate cancer,"RNA-seq, qPCR, RIP, ChIP etc.",up-regulated,27342777.0,,1,NR_038263.1,5,5,0,0,VALIDATED,5 (C-rich),"[-0.966, -0.923, -0.911, -0.918, -0.957 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,SOCS2 antisense RNA 1;SOCS2 antisense RNA 1 (non-protein coding);NONHSAG011928.2;HSALNG0093119;SOCS2-AS1
SPRY4-IT1,prostate cancer,"Microarray, qPCR, RNA-FISH etc.",up-regulated,25307116.0,Also Known As: SPRIGHTLY,1,NR_131221.1,5,5,0,0,REVIEWED,0,0,No PQS found in G4 hunter,0,0,No PQS found in G4 hunter,SPRIGHTLY
TINCR,prostate cancer,"qPCR, Western blot",down-regulated,30154672.0,Also Known As: PLAC2; LINC00036; NCRNA00036; onco-lncRNA-16,1,NR_027064.3,40,30,10,0,REVIEWED,"24 ( 10- 2G, 5 - 3G, 9 - C-rich)","[1.184, 1.04, 0.936, 0.884, 0.877, 0.87, -0.836, -0.978, -1, 0.766, 1.136, 0.885, 0.865, 0.655, 0.542, -0.847, -0.833, -0.774, -0.956, 1, 0.911, 0.745, -1.075, -0.891]",No similarity to PQS (2G) from QGRS mapper,"10 (2 - 3G, 8 - C-rich)","[1.373, 1.604 (3G); -1.391, -1.422, -1.354, 1.347, -1.4, -1.5, -1.489, -1.375 (C-rich)]",No similarity to PQS (3G) from QGRS Mapper,TINCR ubiquitin domain containing;FLJ90734;NCRNA00036;LINC00036;onco-lncRNA-16;non-protein coding RNA 36;long intergenic non-protein coding RNA 36;terminal differentiation-induced ncRNA;placenta-specific 2;placenta-specific 2 (non-protein coding);tissue differentiation-inducing non-protein coding RNA;PLAC2;NONHSAG024566.2;lnc-TINCR-1;HSALNG0123467;HSALNG0123468;Ubiquitin domain-containing protein TINCR;Placenta-specific protein 2;Terminal differentiation-induced cornification regulator
TMPO-AS1,prostate cancer,"qPCR, ChIP",up-regulated,30105831.0,,1,NR_027157.1,18,17,1,0,VALIDATED,"6 (1-3G, 5-C-rich)","[0.774 (3G); -0.778, -0.911, -0.695, -0.82, -0.911 (C-rich)]","The PQS 1 (3G) of QGRS
Mapper is similar to / a part of PQS 1 (4G)
of G4 hunter",0,0,No PQS found in G4 Hunter,TMPO antisense RNA 1;TMPO antisense RNA 1 (non-protein coding);NONHSAG012025.2;HSALNG0093383;TMPO-AS1
TRPM2-AS,prostate cancer,"Microarray, qPCR etc.",differential expression,26484139.0,Also Known As: TRPM2-AS1,1,NR_109964.1,10,9,1,0,VALIDATED,2 (C-rich),"[-0.923, -0.898 [C-rich]]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter,TRPM2-AS1
TRPM2-AS,prostate cancer,"Microarray, qPCR, RNAi etc.",up-regulated,24931166.0,Also Known As: TRPM2-AS1,1,NR_109964.1,10,9,1,0,VALIDATED,2 (C-rich),"[-0.923, -0.898 [C-rich]]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter,TRPM2-AS1
TTN-AS1,prostate cancer,"RT-qPCR, Dual Luciferase Reporter Gene Assay",up-regulated,31858535.0,,2,"NR_038272.1, NR_038271.1","32,13","32,13","0,0","0,0",VALIDATED,"5 (2G)
3 (2-2G, 1-C-rich)","[0.911, 0.8, 0.658, 
0.958, 0.911 (2G)];

[0.922, 0.894 (2G); 
-0.915 (C-rich)]",No similarity to PQS (2G) from QGRS mapper,0,0,No PQS found on G4 Hunter,TTN antisense RNA 1;TTN antisense RNA 1 (non-protein coding);HSALNG0020713;NONHSAG029956.2
TTTY15,prostate cancer,"qPCR, Luciferase reporter assay, in vitro knockdown, etc.",up-regulated,30527798.0,,2,"NR_038272.1, NR_038271.1","32, 13","32, 13","0, 0","0, 0",VALIDATED,"5 (2G);
3 (2 - 2G, 1 - C-rich)","[0.911, 0.8, 0.658, 0.958, 0.911 (2G)];
[0.922, 0.894 (2G); -0.915 (C-rich)]
",,,,,"testis-specific transcript, Y-linked 15;DKFZP434I143;NCRNA00138;non-protein coding RNA 138;testis-specific transcript, Y-linked 15 (non-protein coding);USP9Y;ubiquitin specific peptidase 9 Y-linked;AZFA;DFFRY;NONHSAG055784.2;TTTY15;HSALNG0141211"
"TUC338 
PCBP2-OT1",prostate cancer,qRT-PCR etc.,up-regulated,31085276.0,"Also Known As: TUC.338, TUC338, uc.338 (PCBP2-OT1)",1 (PCBP2-OT1),PCBP2-OT1 (NR_109828.1),5 (PCBP2-OT1),5 (PCBP2-OT1),0 (PCBP2-OT1),0 (PCBP2-OT1),VALIDATED (PCBP2-OT1),3 (C-rich),"[-0.872, -0.641, -0.845 (C-rich)] ",No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter,TUC338; uc.338; TUC.338
TUG1,prostate cancer,"qRT-PCR, Western blot",up-regulated,32057513.0,Also Known As: TI-227H; LINC00080; NCRNA00080,8,"NR_110492.1, NR_110493.1, NR_002323.2, NR_152867.1, NR_152868.1, NR_152869.1, NR_152870.1, NR_152871.1","35, 34, 34, 12, 12, 34, 34, 35","31, 30, 30, 12, 12, 30, 30, 31","4, 4, 4, 0, 0, 4, 4, 4","0, 0, 0, 0, 0, 0, 0, 0",REVIEWED,"8 (7 - 2G, 1 - C-rich), 
8 (7 - 2G, 1 - C-rich), 
8 (7 - 2G, 1 - C-rich), 
3 (1 - 2G, 2 - C-rich), 
3 (1 - 2G, 2 - C-rich),
8 (7 - 2G, 1 - C-rich), 
8 (7 - 2G, 1 - C-rich), 
8 (7 - 2G, 1 - C-rich)","[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933 (2G);  -0.875, -0.918 (C-rich)];
[0.933 (2G);  -0.875, -0.918 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)]",Some PQS from QGRS mapper is similar to / a part of PQS (2G) from G4 hunter,"5 (3G);
5 (3G);
5 (3G);
0;
0;
5 (3G);
5 (3G);
5 (3G)  ","[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
0; 
0; 
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)]
","PQS 1 (3G) from QGRS mapper is similar to / a part of PQS 1, 2, 3 (3G) from G4 hunter

PQS 1  and 2 (3G) from G4 Hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper. PQS 3 (3G) from G4 Hunter has a right frame-shift as compared to PQS 1  from QGRS mapper.

PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 4, 5 (3G) from G4 hunter

PQS 4 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper. PQS 5 (3G) from G4 Hunter has a right frame-shift as compared to PQS 2  from QGRS mapper.

By looking at  PQS 1, 2, 3 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as all three PQS have few common G-tracts due to overlap amongst all of these PQS.

By looking at  PQS 4, 5 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as both PQS have few common G-tracts due to overlap amongst both of these PQS.",taurine up-regulated 1;FLJ20618;NCRNA00080;LINC00080;non-protein coding RNA 80;long intergenic non-protein coding RNA 80;taurine upregulated 1 (non-protein coding);taurine up-regulated 1 (non-protein coding);TI-227H;taurine upregulated gene 1;TUG1;HSALNG0134930;NONHSAG033691.2;Taurine up-regulated 1
TUG1,prostate cancer,"qRT-PCR, Western blot",up-regulated,32016963.0,Also Known As: TI-227H; LINC00080; NCRNA00080,8,"NR_110492.1, NR_110493.1, NR_002323.2, NR_152867.1, NR_152868.1, NR_152869.1, NR_152870.1, NR_152871.1","35, 34, 34, 12, 12, 34, 34, 35","31, 30, 30, 12, 12, 30, 30, 31","4, 4, 4, 0, 0, 4, 4, 4","0, 0, 0, 0, 0, 0, 0, 0",REVIEWED,"8 (7 - 2G, 1 - C-rich), 
8 (7 - 2G, 1 - C-rich), 
8 (7 - 2G, 1 - C-rich), 
3 (1 - 2G, 2 - C-rich), 
3 (1 - 2G, 2 - C-rich),
8 (7 - 2G, 1 - C-rich), 
8 (7 - 2G, 1 - C-rich), 
8 (7 - 2G, 1 - C-rich)","[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933 (2G);  -0.875, -0.918 (C-rich)];
[0.933 (2G);  -0.875, -0.918 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)]",Some PQS from QGRS mapper is similar to / a part of PQS (2G) from G4 hunter,"5 (3G);
5 (3G);
5 (3G);
0;
0;
5 (3G);
5 (3G);
5 (3G)  ","[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
0; 
0; 
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)]
","PQS 1 (3G) from QGRS mapper is similar to / a part of PQS 1, 2, 3 (3G) from G4 hunter

PQS 1  and 2 (3G) from G4 Hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper. PQS 3 (3G) from G4 Hunter has a right frame-shift as compared to PQS 1  from QGRS mapper.

PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 4, 5 (3G) from G4 hunter

PQS 4 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper. PQS 5 (3G) from G4 Hunter has a right frame-shift as compared to PQS 2  from QGRS mapper.

By looking at  PQS 1, 2, 3 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as all three PQS have few common G-tracts due to overlap amongst all of these PQS.

By looking at  PQS 4, 5 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as both PQS have few common G-tracts due to overlap amongst both of these PQS.",taurine up-regulated 1;FLJ20618;NCRNA00080;LINC00080;non-protein coding RNA 80;long intergenic non-protein coding RNA 80;taurine upregulated 1 (non-protein coding);taurine up-regulated 1 (non-protein coding);TI-227H;taurine upregulated gene 1;TUG1;HSALNG0134930;NONHSAG033691.2;Taurine up-regulated 1
TUG1,prostate cancer,"qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RNAi",down-regulated,29967294.0,Also Known As: TI-227H; LINC00080; NCRNA00080,8,"NR_110492.1, NR_110493.1, NR_002323.2, NR_152867.1, NR_152868.1, NR_152869.1, NR_152870.1, NR_152871.1","35, 34, 34, 12, 12, 34, 34, 35","31, 30, 30, 12, 12, 30, 30, 31","4, 4, 4, 0, 0, 4, 4, 4","0, 0, 0, 0, 0, 0, 0, 0",REVIEWED,"8 (7 - 2G, 1 - C-rich), 
8 (7 - 2G, 1 - C-rich), 
8 (7 - 2G, 1 - C-rich), 
3 (1 - 2G, 2 - C-rich), 
3 (1 - 2G, 2 - C-rich),
8 (7 - 2G, 1 - C-rich), 
8 (7 - 2G, 1 - C-rich), 
8 (7 - 2G, 1 - C-rich)","[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933 (2G);  -0.875, -0.918 (C-rich)];
[0.933 (2G);  -0.875, -0.918 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)]",Some PQS from QGRS mapper is similar to / a part of PQS (2G) from G4 hunter,"5 (3G);
5 (3G);
5 (3G);
0;
0;
5 (3G);
5 (3G);
5 (3G)  ","[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
0; 
0; 
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)]
","PQS 1 (3G) from QGRS mapper is similar to / a part of PQS 1, 2, 3 (3G) from G4 hunter

PQS 1  and 2 (3G) from G4 Hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper. PQS 3 (3G) from G4 Hunter has a right frame-shift as compared to PQS 1  from QGRS mapper.

PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 4, 5 (3G) from G4 hunter

PQS 4 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper. PQS 5 (3G) from G4 Hunter has a right frame-shift as compared to PQS 2  from QGRS mapper.

By looking at  PQS 1, 2, 3 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as all three PQS have few common G-tracts due to overlap amongst all of these PQS.

By looking at  PQS 4, 5 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as both PQS have few common G-tracts due to overlap amongst both of these PQS.",taurine up-regulated 1;FLJ20618;NCRNA00080;LINC00080;non-protein coding RNA 80;long intergenic non-protein coding RNA 80;taurine upregulated 1 (non-protein coding);taurine up-regulated 1 (non-protein coding);TI-227H;taurine upregulated gene 1;TUG1;HSALNG0134930;NONHSAG033691.2;Taurine up-regulated 1
TUG1,prostate cancer,"qPCR, Western blot etc.",up-regulated,32256083.0,Also Known As: TI-227H; LINC00080; NCRNA00080,8,"NR_110492.1, NR_110493.1, NR_002323.2, NR_152867.1, NR_152868.1, NR_152869.1, NR_152870.1, NR_152871.1","35, 34, 34, 12, 12, 34, 34, 35","31, 30, 30, 12, 12, 30, 30, 31","4, 4, 4, 0, 0, 4, 4, 4","0, 0, 0, 0, 0, 0, 0, 0",REVIEWED,"8 (7 - 2G, 1 - C-rich), 
8 (7 - 2G, 1 - C-rich), 
8 (7 - 2G, 1 - C-rich), 
3 (1 - 2G, 2 - C-rich), 
3 (1 - 2G, 2 - C-rich),
8 (7 - 2G, 1 - C-rich), 
8 (7 - 2G, 1 - C-rich), 
8 (7 - 2G, 1 - C-rich)","[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933 (2G);  -0.875, -0.918 (C-rich)];
[0.933 (2G);  -0.875, -0.918 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)]",Some PQS from QGRS mapper is similar to / a part of PQS (2G) from G4 hunter,"5 (3G);
5 (3G);
5 (3G);
0;
0;
5 (3G);
5 (3G);
5 (3G)  ","[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
0; 
0; 
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)]
","PQS 1 (3G) from QGRS mapper is similar to / a part of PQS 1, 2, 3 (3G) from G4 hunter

PQS 1  and 2 (3G) from G4 Hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper. PQS 3 (3G) from G4 Hunter has a right frame-shift as compared to PQS 1  from QGRS mapper.

PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 4, 5 (3G) from G4 hunter

PQS 4 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper. PQS 5 (3G) from G4 Hunter has a right frame-shift as compared to PQS 2  from QGRS mapper.

By looking at  PQS 1, 2, 3 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as all three PQS have few common G-tracts due to overlap amongst all of these PQS.

By looking at  PQS 4, 5 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as both PQS have few common G-tracts due to overlap amongst both of these PQS.",taurine up-regulated 1;FLJ20618;NCRNA00080;LINC00080;non-protein coding RNA 80;long intergenic non-protein coding RNA 80;taurine upregulated 1 (non-protein coding);taurine up-regulated 1 (non-protein coding);TI-227H;taurine upregulated gene 1;TUG1;HSALNG0134930;NONHSAG033691.2;Taurine up-regulated 1
TUG1,prostate cancer,"qPCR, Western blot",up-regulated,30964164.0,Also Known As: TI-227H; LINC00080; NCRNA00080,8,"NR_110492.1, NR_110493.1, NR_002323.2, NR_152867.1, NR_152868.1, NR_152869.1, NR_152870.1, NR_152871.1","35, 34, 34, 12, 12, 34, 34, 35","31, 30, 30, 12, 12, 30, 30, 31","4, 4, 4, 0, 0, 4, 4, 4","0, 0, 0, 0, 0, 0, 0, 0",REVIEWED,"8 (7 - 2G, 1 - C-rich), 
8 (7 - 2G, 1 - C-rich), 
8 (7 - 2G, 1 - C-rich), 
3 (1 - 2G, 2 - C-rich), 
3 (1 - 2G, 2 - C-rich),
8 (7 - 2G, 1 - C-rich), 
8 (7 - 2G, 1 - C-rich), 
8 (7 - 2G, 1 - C-rich)","[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933 (2G);  -0.875, -0.918 (C-rich)];
[0.933 (2G);  -0.875, -0.918 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)]",Some PQS from QGRS mapper is similar to / a part of PQS (2G) from G4 hunter,"5 (3G);
5 (3G);
5 (3G);
0;
0;
5 (3G);
5 (3G);
5 (3G)  ","[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
0; 
0; 
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)]
","PQS 1 (3G) from QGRS mapper is similar to / a part of PQS 1, 2, 3 (3G) from G4 hunter

PQS 1  and 2 (3G) from G4 Hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper. PQS 3 (3G) from G4 Hunter has a right frame-shift as compared to PQS 1  from QGRS mapper.

PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 4, 5 (3G) from G4 hunter

PQS 4 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper. PQS 5 (3G) from G4 Hunter has a right frame-shift as compared to PQS 2  from QGRS mapper.

By looking at  PQS 1, 2, 3 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as all three PQS have few common G-tracts due to overlap amongst all of these PQS.

By looking at  PQS 4, 5 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as both PQS have few common G-tracts due to overlap amongst both of these PQS.",taurine up-regulated 1;FLJ20618;NCRNA00080;LINC00080;non-protein coding RNA 80;long intergenic non-protein coding RNA 80;taurine upregulated 1 (non-protein coding);taurine up-regulated 1 (non-protein coding);TI-227H;taurine upregulated gene 1;TUG1;HSALNG0134930;NONHSAG033691.2;Taurine up-regulated 1
TUG1,prostate cancer,qPCR,up-regulated,31210308.0,Also Known As: TI-227H; LINC00080; NCRNA00080,8,"NR_110492.1, NR_110493.1, NR_002323.2, NR_152867.1, NR_152868.1, NR_152869.1, NR_152870.1, NR_152871.1","35, 34, 34, 12, 12, 34, 34, 35","31, 30, 30, 12, 12, 30, 30, 31","4, 4, 4, 0, 0, 4, 4, 4","0, 0, 0, 0, 0, 0, 0, 0",REVIEWED,"8 (7 - 2G, 1 - C-rich), 
8 (7 - 2G, 1 - C-rich), 
8 (7 - 2G, 1 - C-rich), 
3 (1 - 2G, 2 - C-rich), 
3 (1 - 2G, 2 - C-rich),
8 (7 - 2G, 1 - C-rich), 
8 (7 - 2G, 1 - C-rich), 
8 (7 - 2G, 1 - C-rich)","[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933 (2G);  -0.875, -0.918 (C-rich)];
[0.933 (2G);  -0.875, -0.918 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)]",Some PQS from QGRS mapper is similar to / a part of PQS (2G) from G4 hunter,"5 (3G);
5 (3G);
5 (3G);
0;
0;
5 (3G);
5 (3G);
5 (3G)  ","[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
0; 
0; 
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)]
","PQS 1 (3G) from QGRS mapper is similar to / a part of PQS 1, 2, 3 (3G) from G4 hunter

PQS 1  and 2 (3G) from G4 Hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper. PQS 3 (3G) from G4 Hunter has a right frame-shift as compared to PQS 1  from QGRS mapper.

PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 4, 5 (3G) from G4 hunter

PQS 4 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper. PQS 5 (3G) from G4 Hunter has a right frame-shift as compared to PQS 2  from QGRS mapper.

By looking at  PQS 1, 2, 3 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as all three PQS have few common G-tracts due to overlap amongst all of these PQS.

By looking at  PQS 4, 5 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as both PQS have few common G-tracts due to overlap amongst both of these PQS.",taurine up-regulated 1;FLJ20618;NCRNA00080;LINC00080;non-protein coding RNA 80;long intergenic non-protein coding RNA 80;taurine upregulated 1 (non-protein coding);taurine up-regulated 1 (non-protein coding);TI-227H;taurine upregulated gene 1;TUG1;HSALNG0134930;NONHSAG033691.2;Taurine up-regulated 1
TUG1,prostate cancer,qPCR,up-regulated,31210296.0,Also Known As: TI-227H; LINC00080; NCRNA00080,8,"NR_110492.1, NR_110493.1, NR_002323.2, NR_152867.1, NR_152868.1, NR_152869.1, NR_152870.1, NR_152871.1","35, 34, 34, 12, 12, 34, 34, 35","31, 30, 30, 12, 12, 30, 30, 31","4, 4, 4, 0, 0, 4, 4, 4","0, 0, 0, 0, 0, 0, 0, 0",REVIEWED,"8 (7 - 2G, 1 - C-rich), 
8 (7 - 2G, 1 - C-rich), 
8 (7 - 2G, 1 - C-rich), 
3 (1 - 2G, 2 - C-rich), 
3 (1 - 2G, 2 - C-rich),
8 (7 - 2G, 1 - C-rich), 
8 (7 - 2G, 1 - C-rich), 
8 (7 - 2G, 1 - C-rich)","[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933 (2G);  -0.875, -0.918 (C-rich)];
[0.933 (2G);  -0.875, -0.918 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)]",Some PQS from QGRS mapper is similar to / a part of PQS (2G) from G4 hunter,"5 (3G);
5 (3G);
5 (3G);
0;
0;
5 (3G);
5 (3G);
5 (3G)  ","[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
0; 
0; 
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)]
","PQS 1 (3G) from QGRS mapper is similar to / a part of PQS 1, 2, 3 (3G) from G4 hunter

PQS 1  and 2 (3G) from G4 Hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper. PQS 3 (3G) from G4 Hunter has a right frame-shift as compared to PQS 1  from QGRS mapper.

PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 4, 5 (3G) from G4 hunter

PQS 4 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper. PQS 5 (3G) from G4 Hunter has a right frame-shift as compared to PQS 2  from QGRS mapper.

By looking at  PQS 1, 2, 3 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as all three PQS have few common G-tracts due to overlap amongst all of these PQS.

By looking at  PQS 4, 5 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as both PQS have few common G-tracts due to overlap amongst both of these PQS.",taurine up-regulated 1;FLJ20618;NCRNA00080;LINC00080;non-protein coding RNA 80;long intergenic non-protein coding RNA 80;taurine upregulated 1 (non-protein coding);taurine up-regulated 1 (non-protein coding);TI-227H;taurine upregulated gene 1;TUG1;HSALNG0134930;NONHSAG033691.2;Taurine up-regulated 1
TUG1,prostate cancer,"qPCR, Western blot, RIP, Dual luciferase reporter assay etc.",up-regulated,26975529.0,Also Known As: TI-227H; LINC00080; NCRNA00080,8,"NR_110492.1, NR_110493.1, NR_002323.2, NR_152867.1, NR_152868.1, NR_152869.1, NR_152870.1, NR_152871.1","35, 34, 34, 12, 12, 34, 34, 35","31, 30, 30, 12, 12, 30, 30, 31","4, 4, 4, 0, 0, 4, 4, 4","0, 0, 0, 0, 0, 0, 0, 0",REVIEWED,"8 (7 - 2G, 1 - C-rich), 
8 (7 - 2G, 1 - C-rich), 
8 (7 - 2G, 1 - C-rich), 
3 (1 - 2G, 2 - C-rich), 
3 (1 - 2G, 2 - C-rich),
8 (7 - 2G, 1 - C-rich), 
8 (7 - 2G, 1 - C-rich), 
8 (7 - 2G, 1 - C-rich)","[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933 (2G);  -0.875, -0.918 (C-rich)];
[0.933 (2G);  -0.875, -0.918 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)]",Some PQS from QGRS mapper is similar to / a part of PQS (2G) from G4 hunter,"5 (3G);
5 (3G);
5 (3G);
0;
0;
5 (3G);
5 (3G);
5 (3G)  ","[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
0; 
0; 
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)]
","PQS 1 (3G) from QGRS mapper is similar to / a part of PQS 1, 2, 3 (3G) from G4 hunter

PQS 1  and 2 (3G) from G4 Hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper. PQS 3 (3G) from G4 Hunter has a right frame-shift as compared to PQS 1  from QGRS mapper.

PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 4, 5 (3G) from G4 hunter

PQS 4 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper. PQS 5 (3G) from G4 Hunter has a right frame-shift as compared to PQS 2  from QGRS mapper.

By looking at  PQS 1, 2, 3 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as all three PQS have few common G-tracts due to overlap amongst all of these PQS.

By looking at  PQS 4, 5 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as both PQS have few common G-tracts due to overlap amongst both of these PQS.",taurine up-regulated 1;FLJ20618;NCRNA00080;LINC00080;non-protein coding RNA 80;long intergenic non-protein coding RNA 80;taurine upregulated 1 (non-protein coding);taurine up-regulated 1 (non-protein coding);TI-227H;taurine upregulated gene 1;TUG1;HSALNG0134930;NONHSAG033691.2;Taurine up-regulated 1
TUG1,prostate cancer,"Microarray, qPCR etc.",up-regulated,27556357.0,Also Known As: TI-227H; LINC00080; NCRNA00080,8,"NR_110492.1, NR_110493.1, NR_002323.2, NR_152867.1, NR_152868.1, NR_152869.1, NR_152870.1, NR_152871.1","35, 34, 34, 12, 12, 34, 34, 35","31, 30, 30, 12, 12, 30, 30, 31","4, 4, 4, 0, 0, 4, 4, 4","0, 0, 0, 0, 0, 0, 0, 0",REVIEWED,"8 (7 - 2G, 1 - C-rich), 
8 (7 - 2G, 1 - C-rich), 
8 (7 - 2G, 1 - C-rich), 
3 (1 - 2G, 2 - C-rich), 
3 (1 - 2G, 2 - C-rich),
8 (7 - 2G, 1 - C-rich), 
8 (7 - 2G, 1 - C-rich), 
8 (7 - 2G, 1 - C-rich)","[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933 (2G);  -0.875, -0.918 (C-rich)];
[0.933 (2G);  -0.875, -0.918 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)]",Some PQS from QGRS mapper is similar to / a part of PQS (2G) from G4 hunter,"5 (3G);
5 (3G);
5 (3G);
0;
0;
5 (3G);
5 (3G);
5 (3G)  ","[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
0; 
0; 
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)]
","PQS 1 (3G) from QGRS mapper is similar to / a part of PQS 1, 2, 3 (3G) from G4 hunter

PQS 1  and 2 (3G) from G4 Hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper. PQS 3 (3G) from G4 Hunter has a right frame-shift as compared to PQS 1  from QGRS mapper.

PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 4, 5 (3G) from G4 hunter

PQS 4 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper. PQS 5 (3G) from G4 Hunter has a right frame-shift as compared to PQS 2  from QGRS mapper.

By looking at  PQS 1, 2, 3 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as all three PQS have few common G-tracts due to overlap amongst all of these PQS.

By looking at  PQS 4, 5 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as both PQS have few common G-tracts due to overlap amongst both of these PQS.",taurine up-regulated 1;FLJ20618;NCRNA00080;LINC00080;non-protein coding RNA 80;long intergenic non-protein coding RNA 80;taurine upregulated 1 (non-protein coding);taurine up-regulated 1 (non-protein coding);TI-227H;taurine upregulated gene 1;TUG1;HSALNG0134930;NONHSAG033691.2;Taurine up-regulated 1
TUG1,prostate cancer,"qPCR, Flow cytometry assay, Western blot, Luciferase reporter assay, etc.",up-regulated,29967294.0,Also Known As: TI-227H; LINC00080; NCRNA00080,8,"NR_110492.1, NR_110493.1, NR_002323.2, NR_152867.1, NR_152868.1, NR_152869.1, NR_152870.1, NR_152871.1","35, 34, 34, 12, 12, 34, 34, 35","31, 30, 30, 12, 12, 30, 30, 31","4, 4, 4, 0, 0, 4, 4, 4","0, 0, 0, 0, 0, 0, 0, 0",REVIEWED,"8 (7 - 2G, 1 - C-rich), 
8 (7 - 2G, 1 - C-rich), 
8 (7 - 2G, 1 - C-rich), 
3 (1 - 2G, 2 - C-rich), 
3 (1 - 2G, 2 - C-rich),
8 (7 - 2G, 1 - C-rich), 
8 (7 - 2G, 1 - C-rich), 
8 (7 - 2G, 1 - C-rich)","[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933 (2G);  -0.875, -0.918 (C-rich)];
[0.933 (2G);  -0.875, -0.918 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)];
[0.933, 0.947, 0.978, 0.771, 0.8, 0.913, 0.888 (2G); -0.875 (C-rich)]",Some PQS from QGRS mapper is similar to / a part of PQS (2G) from G4 hunter,"5 (3G);
5 (3G);
5 (3G);
0;
0;
5 (3G);
5 (3G);
5 (3G)  ","[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
0; 
0; 
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)];
[1.404, 1.38, 1.362, 1.4, 1.245 (3G)]
","PQS 1 (3G) from QGRS mapper is similar to / a part of PQS 1, 2, 3 (3G) from G4 hunter

PQS 1  and 2 (3G) from G4 Hunter has a left frame-shift as compared to PQS 1 (3G) from QGRS mapper. PQS 3 (3G) from G4 Hunter has a right frame-shift as compared to PQS 1  from QGRS mapper.

PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 4, 5 (3G) from G4 hunter

PQS 4 (3G) from G4 Hunter has a left frame-shift as compared to PQS 2 (3G) from QGRS mapper. PQS 5 (3G) from G4 Hunter has a right frame-shift as compared to PQS 2  from QGRS mapper.

By looking at  PQS 1, 2, 3 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as all three PQS have few common G-tracts due to overlap amongst all of these PQS.

By looking at  PQS 4, 5 (3G) from G4 hunter, it appears that at a time only 1 GQ can be formed as both PQS have few common G-tracts due to overlap amongst both of these PQS.",taurine up-regulated 1;FLJ20618;NCRNA00080;LINC00080;non-protein coding RNA 80;long intergenic non-protein coding RNA 80;taurine upregulated 1 (non-protein coding);taurine up-regulated 1 (non-protein coding);TI-227H;taurine upregulated gene 1;TUG1;HSALNG0134930;NONHSAG033691.2;Taurine up-regulated 1
UCA1,prostate cancer,"qPCR, Luciferase reporter assay, RIP, Western blot",up-regulated,30940776.0,"Also Known As: CUDR; UCAT1; LINC00178; NCRNA00178; onco-lncRNA-36

Some (older-not checked for PQS) UCA1 clones ""other"" ncRNA (GU799565.1, GU799564.1, GU799563.1, GU799562.1 and GU799561.1) were also there in result.

Some (older, not checked for PQS) urothelial cancer associated 1a non-coding RNA (UCA1) ""other"" ncRNA (complete sequence, alternatively spliced-GU357550.1; note=""UCA1a; alternative splice product"") was also there in result.",1,NR_015379.3,10,10,0,0,REVIEWED,8 (C-rich),"[-0.837, -0.892, -0.911, -0.911, -0.911, -0.935, -0.818, -0.822 (C-rich)]",No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter,CUDR; UCAT1; LINC00178; NCRNA00178; onco-lncRNA-36
UCA1,prostate cancer,"Western blotting, Luciferase Reporter Assay, RIP, qRT-PCR",up-regulated,31954329.0,"Also Known As: CUDR; UCAT1; LINC00178; NCRNA00178; onco-lncRNA-36

Some (older-not checked for PQS) UCA1 clones ""other"" ncRNA (GU799565.1, GU799564.1, GU799563.1, GU799562.1 and GU799561.1) were also there in result.

Some (older, not checked for PQS) urothelial cancer associated 1a non-coding RNA (UCA1) ""other"" ncRNA (complete sequence, alternatively spliced-GU357550.1; note=""UCA1a; alternative splice product"") was also there in result.",1,NR_015379.3,10,10,0,0,REVIEWED,8 (C-rich),"[-0.837, -0.892, -0.911, -0.911, -0.911, -0.935, -0.818, -0.822 (C-rich)]",No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter,CUDR; UCAT1; LINC00178; NCRNA00178; onco-lncRNA-36
UCA1,prostate cancer,"qPCR, Western blot, RIP, Luciferase reporter assay",up-regulated,28209917.0,"Also Known As: CUDR; UCAT1; LINC00178; NCRNA00178; onco-lncRNA-36

Some (older-not checked for PQS) UCA1 clones ""other"" ncRNA (GU799565.1, GU799564.1, GU799563.1, GU799562.1 and GU799561.1) were also there in result.

Some (older, not checked for PQS) urothelial cancer associated 1a non-coding RNA (UCA1) ""other"" ncRNA (complete sequence, alternatively spliced-GU357550.1; note=""UCA1a; alternative splice product"") was also there in result.",1,NR_015379.3,10,10,0,0,REVIEWED,8 (C-rich),"[-0.837, -0.892, -0.911, -0.911, -0.911, -0.935, -0.818, -0.822 (C-rich)]",No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter,CUDR; UCAT1; LINC00178; NCRNA00178; onco-lncRNA-36
UCA1,prostate cancer,"qPCR, RNAi, Western blot, Cell proliferation assay etc.",up-regulated,27902466.0,"Also Known As: CUDR; UCAT1; LINC00178; NCRNA00178; onco-lncRNA-36

Some (older-not checked for PQS) UCA1 clones ""other"" ncRNA (GU799565.1, GU799564.1, GU799563.1, GU799562.1 and GU799561.1) were also there in result.

Some (older, not checked for PQS) urothelial cancer associated 1a non-coding RNA (UCA1) ""other"" ncRNA (complete sequence, alternatively spliced-GU357550.1; note=""UCA1a; alternative splice product"") was also there in result.",1,NR_015379.3,10,10,0,0,REVIEWED,8 (C-rich),"[-0.837, -0.892, -0.911, -0.911, -0.911, -0.935, -0.818, -0.822 (C-rich)]",No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter,CUDR; UCAT1; LINC00178; NCRNA00178; onco-lncRNA-36
UCA1,prostate cancer,"qPCR, RNAi, Western blot, RIP, Luciferase reporter assay, Cell proliferation assay etc.",up-regulated,28337266.0,"Also Known As: CUDR; UCAT1; LINC00178; NCRNA00178; onco-lncRNA-36

Some (older-not checked for PQS) UCA1 clones ""other"" ncRNA (GU799565.1, GU799564.1, GU799563.1, GU799562.1 and GU799561.1) were also there in result.

Some (older, not checked for PQS) urothelial cancer associated 1a non-coding RNA (UCA1) ""other"" ncRNA (complete sequence, alternatively spliced-GU357550.1; note=""UCA1a; alternative splice product"") was also there in result.",1,NR_015379.3,10,10,0,0,REVIEWED,8 (C-rich),"[-0.837, -0.892, -0.911, -0.911, -0.911, -0.935, -0.818, -0.822 (C-rich)]",No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter,CUDR; UCAT1; LINC00178; NCRNA00178; onco-lncRNA-36
UCA1,prostate cancer,"qPCR, RNAi, Western blot etc.",up-regulated,26550172.0,"Also Known As: CUDR; UCAT1; LINC00178; NCRNA00178; onco-lncRNA-36

Some (older-not checked for PQS) UCA1 clones ""other"" ncRNA (GU799565.1, GU799564.1, GU799563.1, GU799562.1 and GU799561.1) were also there in result.

Some (older, not checked for PQS) urothelial cancer associated 1a non-coding RNA (UCA1) ""other"" ncRNA (complete sequence, alternatively spliced-GU357550.1; note=""UCA1a; alternative splice product"") was also there in result.",1,NR_015379.3,10,10,0,0,REVIEWED,8 (C-rich),"[-0.837, -0.892, -0.911, -0.911, -0.911, -0.935, -0.818, -0.822 (C-rich)]",No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter,CUDR; UCAT1; LINC00178; NCRNA00178; onco-lncRNA-36
UCA1,prostate cancer,"RNA-seq, Microarray, qPCR, RNAi, Northern blot etc.",down-regulated,23728290.0,"Also Known As: CUDR; UCAT1; LINC00178; NCRNA00178; onco-lncRNA-36

Some (older-not checked for PQS) UCA1 clones ""other"" ncRNA (GU799565.1, GU799564.1, GU799563.1, GU799562.1 and GU799561.1) were also there in result.

Some (older, not checked for PQS) urothelial cancer associated 1a non-coding RNA (UCA1) ""other"" ncRNA (complete sequence, alternatively spliced-GU357550.1; note=""UCA1a; alternative splice product"") was also there in result.",1,NR_015379.3,10,10,0,0,REVIEWED,8 (C-rich),"[-0.837, -0.892, -0.911, -0.911, -0.911, -0.935, -0.818, -0.822 (C-rich)]",No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 hunter,CUDR; UCAT1; LINC00178; NCRNA00178; onco-lncRNA-36
UNC5B-AS1,prostate cancer,Luciferase reporter assay etc,up-regulated,32196578.0,Also Known As: UASR1,1,NR_038453.1,5,5,0,0,VALIDATED,3 (C-rich),"[-1.124, -1.045, -0.966 (C-rich]",No similarity to any PQS (2G) from QGRS mapper,0,0,No PQS found in G4 Hunter,UASR1
VPS9D1-AS1,prostate cancer,"RT-qPCR, Luciferase reporter assay",up-regulated,31918265.0,Also Known As: VPS9D1-AS1; MY,1,(NR_036480.1),20,16,4,0,VALIDATED ,"28 (8 - 2G, 2 - 3G, 18 - C-rich)","[1, 0.894 (3G), 0.87, 0.911, 0.911, 0.933, 0.911, 0.911, 0.957, 0.891 (2G), -0.946, -0.916, -0.956, -1.111, -0.936, -0.885, -0.957, -0.911, -0.878, -0.947, -0.958, -0.898, -0.947, -0.958,  -0.898, -0.833, -0.815, -0.939 (C-rich)]","PQS 7 (3G) of QGRS mapper is similar to / a part of PQS 1 (3G) of G4 hunter 

PQS 16 (3G) of QGRS mapper is similar to / a part of PQS 10 (3G) of G4 hunter ",2 (C-rich),"[-1.333, -1.366 (C-rich)]",No similarity to any PQS (2G) from QGRS mapper.,MYU
XIST,prostate cancer,"qPCR, Luciferase reporter assays, Western blot etc.",down-regulated,29212233.0,Also Known As: SXI1; swd66; DXS1089; DXS399E; LINC00001; NCRNA00001,1,NR_001564.2,71,71,0,0,REVIEWED,"31 (4 - 2G, 27 - C-rich)
","[-0.644, -0.746, -0.911, -1.846, -1.464, -0.911, -0.894, -0.911, -0.913, -1.106, -0.722, -0.933, -1.033, -0.978, -0.77, -0.75, -0.923, -0.713, -0.961, -0.911, -0.738, -0.78, -0.631, -0.894, -0.911, -0.891, 0.933, 0.836, 0.891, 0.772]",No similarity to any PQS (2G) from QGRS mapper,9 ( C-rich),"[-2.069, -1.749, -1.426, -1.391, -1.422, -1.079, -1.294, -1.4, -1.105 (C-rich)]",No similarity to PQS from QGRS mapper,SXI1; swd66; DXS1089; DXS399E; LINC00001; NCRNA00001
XIST,prostate cancer,"qPCR, Southern blot etc.",up-regulated,16261845.0,Also Known As: SXI1; swd66; DXS1089; DXS399E; LINC00001; NCRNA00001,1,NR_001564.2,71,71,0,0,REVIEWED,"31 (4 - 2G, 27 - C-rich)
","[-0.644, -0.746, -0.911, -1.846, -1.464, -0.911, -0.894, -0.911, -0.913, -1.106, -0.722, -0.933, -1.033, -0.978, -0.77, -0.75, -0.923, -0.713, -0.961, -0.911, -0.738, -0.78, -0.631, -0.894, -0.911, -0.891, 0.933, 0.836, 0.891, 0.772]",No similarity to any PQS (2G) from QGRS mapper,9 ( C-rich),"[-2.069, -1.749, -1.426, -1.391, -1.422, -1.079, -1.294, -1.4, -1.105 (C-rich)]",No similarity to PQS from QGRS mapper,SXI1; swd66; DXS1089; DXS399E; LINC00001; NCRNA00001
"XLOC_005327
LINC01564",prostate cancer,"Microarray, qPCR, RNA-FISH etc.",up-regulated,25307116.0,Also known as LINC01564; XLOC_005327; TCONS_00011314,1 (LINC01564),LINC01564 (NR_125841.1 ),2 (LINC01564),2 (LINC01564),0 (LINC01564),0 (LINC01564),VALIDATED (LINC01564),0,0,,0,0,No PQS found in G4 Hunter,XLOC_005327; TCONS_00011314
"XLOC_005327
LINC01564",prostate cancer,"Microarray, qPCR, RNAi etc.",up-regulated,25513185.0,Also known as LINC01564; XLOC_005327; TCONS_00011314,1 (LINC01564),LINC01564 (NR_125841.1 ),2 (LINC01564),2 (LINC01564),0 (LINC01564),0 (LINC01564),VALIDATED (LINC01564),0,0,,0,0,No PQS found in G4 Hunter,XLOC_005327; TCONS_00011314
XLOC_007697,prostate cancer,"Microarray, qPCR, RNA-FISH etc.",up-regulated,25307116.0,,1,NR_131213,1,1,0,0,VALIDATED ,0,0,,0,0,No PQS found in G4 Hunter,uncharacterized LOC105500239;lnc-SPATA31A6-60;NONHSAG052316.2
XLOC_007697,prostate cancer,"Microarray, qPCR, RNAi etc.",up-regulated,25513185.0,,1,NR_131213,1,1,0,0,VALIDATED ,0,0,,0,0,No PQS found in G4 Hunter,uncharacterized LOC105500239;lnc-SPATA31A6-60;NONHSAG052316.2
XLOC_008559,prostate cancer,"Microarray, qPCR, RNA-FISH etc.",up-regulated,25307116.0,,1,NR_131214.1,1,1,0,0,VALIDATED,0,0,,0,0,No PQS found in G4 Hunter,uncharacterized LOC105378427;lnc-RPP30-2;HSALNG0079635;NONHSAG006512.2;HSALNG0079639
XLOC_008559,prostate cancer,"Microarray, qPCR, RNAi etc.",up-regulated,25513185.0,,1,NR_131214.1,1,1,0,0,VALIDATED,0,0,,0,0,No PQS found in G4 Hunter,uncharacterized LOC105378427;lnc-RPP30-2;HSALNG0079635;NONHSAG006512.2;HSALNG0079639
XLOC_009911,prostate cancer,"Microarray, qPCR, RNA-FISH etc.",up-regulated,25307116.0,,1,NR_131215.1,4,4,0,0,VALIDATED,0,0,,0,0,No PQS found in G4 Hunter,uncharacterized LOC105500240;HSALNG0094550;lnc-HNF1A-1;NONHSAG012533.2
XLOC_009911,prostate cancer,"Microarray, qPCR, RNAi etc.",up-regulated,25513185.0,,1,NR_131215.1,4,4,0,0,VALIDATED,0,0,,0,0,No PQS found in G4 Hunter,uncharacterized LOC105500240;HSALNG0094550;lnc-HNF1A-1;NONHSAG012533.2
ZEB1-AS1,prostate cancer,"qPCR, Western blot etc",up-regulated,32275162.0,,6,"NR_024284.1, NR_148975.1, NR_148976.1, NR_148977.1, NR_148978.1, NR_148979.1","7, 5, 11, 14, 5, 5, ","6, 5, 10, 12, 4, 4","1, 0, 1, 2, 1, 1

PQS 1 of 1st, 4th, 5th and 6th variants are same.
PQS of 3rd variant and PQS 2 of 4th variant are different from each other and other variants as well.","0, 0, 0, 0, 0, 0",REVIEWED,"8 (1 - 2G, 2 - 3G, 5 - C-rich);
5 (C-rich); 
8 (1 - 2G, 1 - 3G, 1 - 4G, 5 - C-rich); 
15 (2 - 2G, 3 - 3G, 10 - C-rich),
3 (1 - 2G, 2 - 3G), 
2 (3G)","[0.986, 0.931, 0.891  [2G]]; [-0.96, -0.924, -0.915, -0.953, -0.721  [C-rich]];

[-0.96, -0.924, -0.915, -0.958, -0.721 (C-rich)];
 
[0.831 (2G);  0.863 (3G); 1.055 (4G); -0.96, -0.924, -0.915, -0.958, -0.721 (C-rich)] ; 

[0.986, 0.931, 0.768, 0.935, 0.915 (2G); -0.863, -0.965, -0.725, -0.661,  -0.766, -0.964, -0.96, -0.924,  -0.958, -0.721 (C-rich)]; 

[0.911 (2G); 0.986, 0.931 (3G)];

 [0.986, 0.931 (3G)] ","For Variant 1,
PQS 1 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

For Variant 3,
PQS 1 (3G) from QGRS mapper is similar to / a part of PQS (3G) from G4 hunter

For Variant 4,
PQS 1 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 2 (3G) from G4 hunter

For Variant 5,
PQS 1 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

For Variant 6,
PQS 1 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter","0;
0;
5 (3G);
0;
0;
0","0;
0; 
[1.37, 1.36, 1.362, 1.333, 1.391 (3G)]; 
0; 
0; 
0",No similarity to PQS from QGRS mapper,ZEB1 antisense RNA 1;ZEB1 antisense RNA 1 (non-protein coding);HSALNG0077083;NONHSAG005548.2;ZEB1-AS1
ZEB1-AS1,prostate cancer,"Western blot, Luciferase reporter, RIP",up-regulated,28830551.0,,6,"NR_024284.1, NR_148975.1, NR_148976.1, NR_148977.1, NR_148978.1, NR_148979.1","7, 5, 11, 14, 5, 5, ","6, 5, 10, 12, 4, 4","1, 0, 1, 2, 1, 1

PQS 1 of 1st, 4th, 5th and 6th variants are same.
PQS of 3rd variant and PQS 2 of 4th variant are different from each other and other variants as well.","0, 0, 0, 0, 0, 0",REVIEWED,"8 (1 - 2G, 2 - 3G, 5 - C-rich);
5 (C-rich); 
8 (1 - 2G, 1 - 3G, 1 - 4G, 5 - C-rich); 
15 (2 - 2G, 3 - 3G, 10 - C-rich),
3 (1 - 2G, 2 - 3G), 
2 (3G)","[0.986, 0.931, 0.891  [2G]]; [-0.96, -0.924, -0.915, -0.953, -0.721  [C-rich]];

[-0.96, -0.924, -0.915, -0.958, -0.721 (C-rich)];
 
[0.831 (2G);  0.863 (3G); 1.055 (4G); -0.96, -0.924, -0.915, -0.958, -0.721 (C-rich)] ; 

[0.986, 0.931, 0.768, 0.935, 0.915 (2G); -0.863, -0.965, -0.725, -0.661,  -0.766, -0.964, -0.96, -0.924,  -0.958, -0.721 (C-rich)]; 

[0.911 (2G); 0.986, 0.931 (3G)];

 [0.986, 0.931 (3G)] ","For Variant 1,
PQS 1 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

For Variant 3,
PQS 1 (3G) from QGRS mapper is similar to / a part of PQS (3G) from G4 hunter

For Variant 4,
PQS 1 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

PQS 2 (3G) from QGRS mapper is similar to / a part of PQS 2 (3G) from G4 hunter

For Variant 5,
PQS 1 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter

For Variant 6,
PQS 1 (3G) from QGRS mapper is similar to / a part of PQS 1 (3G) from G4 hunter","0;
0;
5 (3G);
0;
0;
0","0;
0; 
[1.37, 1.36, 1.362, 1.333, 1.391 (3G)]; 
0; 
0; 
0",No similarity to PQS from QGRS mapper,ZEB1 antisense RNA 1;ZEB1 antisense RNA 1 (non-protein coding);HSALNG0077083;NONHSAG005548.2;ZEB1-AS1
ZFAS1,prostate cancer,"qPCR, Western blot",up-regulated,32104094.0,Also Known As: HSUP1; HSUP2; C20orf199; ZNFX1-AS1; NCRNA00275,5,"NR_003604.3, NR_003605.2, NR_003606.3, NR_036658.2, NR_036659.2","13, 9, 12, 13, 4","11, 8, 10, 11, 4","2, 1, 2, 2, 0","0, 0, 0, 0, 0",REVIEWED,"2 (2G);
1 (2G);
2 (2G);
2 (2G);
0","[0.774, 0.628 (2G)];
[0.774 (2G)];
[0.774, 0.628 (2G)]; 
[0.774, 0.628 (2G)]; 
0",No similarity to any PQS (2G) from QGRS mapper,"3 (3G);
3 (3G);
3 (3G);
3 (3G);
0","[1.444, 1.438, 1.333 (3G)]; 
[1.444, 1.438, 1.333 (3G)]; 
[1.444, 1.438, 1.333 (3G)]; 
[1.444, 1.438, 1.333 (3G)];
0",No similarity to PQS from QGRS mapper,HSUP1; HSUP2; C20orf199; ZNFX1-AS1; NCRNA00275
Total no. of LncRNAs having Validated and Reviewed RefSeq status,,,,,,,,,,,,,,,,,,,
145,,,,,,,,,,,,,,,,,,,
